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Abstract 
Clinical depression and overweight or obesity (OW/OB) frequently co-occur. Either 
condition significantly increases risk of developing the other whilst being obese significantly 
reduces utilisation of psychotherapy. To date, the few interventions developed to treat clinical 
depression in adults with co-morbid OW/OB have combined standard interventions aimed at 
reducing depression or promoting weight loss from a conceptual framework based on 
depression and obesity as discrete conditions. The overall aim of the present research is to 
develop an integrated evidence-based program for clinical depression involving 
psychotherapy and regular exercise for adults with co-morbid OW/OB. We conducted a 
meta-analytic review investigating current treatments for symptoms of depression in adults 
with OW/OB. We compared three different exercise-based interventions among 36 adults 
with clinical depression and OW/OB in a randomised controlled clinical trial (RCT). To 
further understand the contributing factors influencing depression and treatment gains in this 
population, we conducted mixed methods research with a subgroup of participants who 
completed the RCT, including thematic analysis of 17 interviews. The findings from this 
research were then incorporated into a protocol paper for an RCT which will assess the 
impact of a tailored, evidence-based approach to treating clinical depression in overweight or 
obese adults. This novel approach combines elements of cognitive behaviour therapy, 
including schema, self-compassion and mindfulness-based approaches along with an 
evidence-based exercise program for depression. 
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1.1. Introduction 
Clinical depression is a significant social, public health and economic issue in today’s 
society. Typically recurrent (Solomon et al., 2000), it is associated with substantially reduced 
functioning and quality of life, medical morbidity and mortality (Bromet et al., 2011; Ferrari 
et al., 2013; Spijker et al., 2004). An increasingly common comorbid condition is overweight 
or obesity (OW/OB) (de Wit et al., 2010; Faith et al., 2011; Luppino et al., 2010; Stunkard, 
Faith, & Allison, 2003) which itself represents a major public health and economic issue 
(Ruhm, 2012) and is associated with elevated mortality and higher rates of hypertension, 
diabetes, cancer and other diseases (Aballay, Eynard, Diaz Mdel, Navarro, & Munoz, 2013; 
Cameron, Shaw, & Zimmet, 2004; Kahn, Hull, & Utzschneider, 2006; Kannel, D'Agostino, 
& Cobb, 1996; Norberg & Danielsson, 2012). Despite substantial research presenting a clear 
bidirectional link between clinical depression and OW/OB, many individuals with clinical 
depression are routinely screened out of treatment trials involving individuals with OW/OB– 
even trials investigating psychological symptoms (e.g. Andersen et al., 1999; Annesi & 
Unruh, 2008; Rubin et al., 2005). As a result, there is a paucity of research on clinical 
interventions for this burgeoning population (Faulconbridge & Bechtel, 2014) who likely 
present with a unique set of psychological and physiological factors which perpetuate their 
clinical depression and OW/OB. 
1.1.1. Clinical Depression: Definition and Prevalence 
According to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; 
American Psychiatric Association 2013) an episode of clinical depression is primarily 
characterised by depressed or irritable mood and/or anhedonia or loss of interest in almost all 
activities. Changes may also occur in weight, appetite, activity levels, sleep patterns, 
increased fatigue or decreased energy level, feelings of excessive guilt or worthlessness, 
indecisiveness, difficulty concentrating and self-harm or suicidality. The average age of onset 
for a first episode of clinical depression is 25.7 years. The lifetime and 12-month prevalence 
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estimates for high income nations in Europe and the Americas are 14.6% and 5.5% 
respectively (Bromet et al., 2011). Twelve month prevalence rates in Australia (5.2%) are 
similar to other developed counties (Henderson, Andrews, & Hall, 2000). Approximately 
85% individuals who have a first episode of depression will experience a subsequent episode 
in their lifetime and on average, individuals with clinical depression will have four episodes 
of depression of 20 weeks duration during their lifetime (Carr & McNulty, 2006). Given that 
symptoms of clinical depression include changes in activity and dietary behaviours, it is not 
surprising that the relationship between depression and OW/OB is receiving increasing 
interest in Western society.  
1.1.2. Overweight and Obesity: Definition and Prevalence 
Overweight (Body Mass Index, BMI1 > 25) and Obesity (BMI > 30) are estimated to 
directly affect 36.9% of men and 29.8% of women in developed countries worldwide – 
almost one-third higher than in 1980 (Ng et al., 2014). Prevalence rates in Australasia (63 per 
cent) North America (65.4 per cent) and Western Europe (54.5 per cent) are much higher 
than the global average (Australian Bureau of Statistics, 2011; Ng et al., 2014). 
Approximately 35 per cent of Australians are overweight and 28 per cent obese. Although the 
prevalence of overweight in Australia has risen modestly since the 1980’s (from 28.6% to 
35.0%) obesity has increased three-fold in the same period – from 9.4% to 28.0%. 
Overweight and obesity increase risk for a variety of significant cardiovascular diseases, 
(Kannel et al., 1996; Norberg & Danielsson, 2012) cancers, (Aballay et al., 2013) Type 2 
Diabetes, and metabolic syndrome (Aballay et al., 2013; Cameron et al., 2004; Kahn et al., 
2006). Yet together, OW/OB are considered one of the most preventable health conditions in 
the Western world (National Heart Foundation of Australia, 2007).  
1.2. Comorbid Clinical Depression and Overweight or Obesity 
1 BMI (Body Mass Index) is a commonly used index measure of weight and height (kg/m2). 
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An important bi-directional relationship appears to exist between OW/OB and 
depression, with each condition increasing the risk for developing the other. In a meta-
analytic review, Luppino et al., (2010) reported that individuals with depression at baseline 
were significantly more likely to be obese 11.6 years later than non-depressed peers (OR = 
1.58, 95% CI 1.33 to 1.87). Similarly, a systematic review of prospective community-based 
and cohort studies conducted by Faith et al. (2011) identified that eight of 15 studies (53%) 
assessing progression along the depression-to-obesity pathway, reported depression as a 
significant predictor of obesity, with odds ratios generally between 2.0 and 3.0. This 
systematic review by Faith et al. (2011) also assessed progression along the obesity-to-
depression pathway and found eight out of 10 studies reported significant associations. The 
corresponding adjusted odds ratios were generally between 1.0 and 2.0. Of particular note, 
the two studies with null findings were conducted in paediatric populations. Likewise, 
Luppino et al. (2010) found that individuals with baseline BMI > 25 were 1.55 times more 
likely to have depression at follow-up 12 years later compared to normal weight peers (95% 
CI 1.22 to 1.98). These results strongly suggest the possibility of an obesity-to-depression 
pathway. 
Further evidence of these associations appears in clinical settings, where the 
prevalence of co-morbid depression and OW/OB is high. For example Stunkard et al. (2003) 
provided collaborative care management to adults diagnosed with either clinical depression 
or dysthymia, of whom over 72% were incidentally overweight or obese. Similarly, Simon et 
al. (2008) found that American women with moderate to severe symptoms of depression as 
measured on the Patient Health Questionnaire (PHQ) were almost 2.3 times more likely to be 
obese than women with no symptoms of depression in a community based survey. Strikingly, 
Simon et al. indicated that obese individuals in this cohort were almost four times more likely 
to be depressed than their non-obese peers. According to Carpenter, Hasin, Allison, and Faith 
(2000), such women may be at greater risk of suicidal ideation relative to normal weight 
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peers (OR = 1.21, 95% CI 1.02 to 1.44). Whilst this research suggests it is highly likely a bi-
directional relationship exists between depression and obesity, there appear to be a myriad of 
contributing factors, many of which are still being investigated and deserve further 
exploration. 
1.2.1. Risk Factors and Comorbidities of Depression in Overweight or Obese 
Adults 
A variety of risk and protective factors in the aetiology of depression have been 
proposed. Genetics appear to play a role, with heritability estimates ranging from 40 to 70% 
(Craddock & Forty, 2006). Carr and McNulty (2006) assert that a family history of mood or 
anxiety disorders or trait neuroticism may increase risk for depression. Furthermore, 
childhood adversity, poor parental care or negative parent-child relationships are additional 
predisposing factors for depression, particularly in populations with co-morbid OW/OB 
(D'Argenio et al., 2009; Faith, 2002; Stunkard et al., 2003). Female gender and low 
socioeconomic status increase risk, especially for adults with co-morbid OW/OB (Faith, 
2002).  
Psychological factors. Severity of past major depression and major stressful life 
events may predispose, precipitate or exacerbate depression (Faith, 2002; Stunkard et al., 
2003). Three or more prior episodes of depression, or having poor social support predisposes 
individuals to further depression, even in response to more minor stressful life events (Carr & 
McNulty, 2006). Symptoms of binge eating disorder (BED) or night eating syndrome are 
particularly prevalent in populations with OW/OB and who experience depression. 
Furthermore, binge-eating behaviours often precede the onset of depression in individuals 
who are also OW/OB (Faith, 2002; Faulconbridge & Bechtel, 2014). 
Specific cognitive factors such as negative internal verbal commentary, concern with 
eating, weight and body shape, dietary restraint, body dissatisfaction and self-criticism/self-
doubt have been implicated in maintaining depression in OW/OB adults (Cooper & Fairburn, 
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2001; Decaluwé & Braet, 2005; Werrij et al., 2006). Interestingly, Wiltink et al. (2013) found 
a much stronger association between somatic-affective components of depression (e.g. lack 
of energy, fatigue)  and obesity than cognitive-affective components. Research has linked the 
early maladaptive schemas of Mistrust/Abuse, Emotional Deprivation, Insufficient Self-
Control, Failure, Abandonment/Instability and Enmeshment with clinical depression (Renner, 
Lobbestael, Peeters, Arntz, & Huibers, 2012) and to reduced quality of life in obese adults 
(Bidadian, Bahramizadeh, & Poursharifi, 2011) suggesting a unique constellation of core 
beliefs may contribute to both conditions. Taken together, somatic-affective factors and core 
schemas may be a priority target for intervention.  
Behavioural factors. Depression has been conceptualised as a state in which an 
individual develops a narrow response class, with limited engagement in behaviours that 
elicit positive reinforcement (Turner & Leech, 2012). Indeed, reduced activity levels are 
associated with increased risk for depression in the general population (Lopresti, Hood, & 
Drummond, 2013), however, OW/OB populations may be at even greater risk. Research 
conducted by Vallance et al. (2011) indicated that sedentary OW/OB adults were at far 
greater risk for developing depression relative to OW/OB adults who engaged in regular 
moderate to vigorous exercise as measured by ActiGraph accelerometers (OR = 3.09, CI 95% 
1.25 to 7.68). Sub-clinical binge eating behaviour is a significant risk factor for depression in 
overweight adults whilst anhedonia itself has been associated with uncontrolled eating, 
emotional eating and binge eating in the same population (Leehr et al., 2015). Such 
behaviours appear to temporarily improve mood. This also suggests the possibility of a 
downward spiral in which anhedonia and binge eating perpetuate each other (Keranen, 
Rasinaho, Hakko, Savolainen, & Lindeman, 2010). Chronic pain, sleep disturbance, weight 
discrimination, teasing and perceived negative verbal commentary, particularly in childhood 
and adolescence are common predisposing factors for depression in OW/OB adults, and are 
evident within an adult OW/OB population (Boutelle, Hannan, Fulkerson, Crow, & Stice, 
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2010; Gilbert, 2009; Luppino et al., 2010; Simon et al., 2008). Indeed, many of these factors 
increase the likelihood of social withdrawal (e.g. due to fatigue, pain or fear of teasing) and 
likely contribute to the emergence of unhelpful or self-critical cognitions described above. 
From the perspective of behavioural activation, such withdrawal would lead to a narrowing 
of response classes and reduced exposure to opportunities for positive reinforcement, 
subsequently increasing risk for depression and reduced activity (Turner & Leech, 2012).  
Physiological factors. Increased levels of pro-inflammatory markers such as C-
reactive protein (CRP), Interlukin-1 (IL-1), Interlukin-6 (IL-6) and Tumor necrosis factor-α 
(TNF- α) have been identified in  individuals with depression and individuals with obesity, 
and have therefore been implicated in the development of each condition (Dowlati et al., 
2010; Emery et al., 2007; Howren, Lamkin, & Suls, 2009; Liu, Ho, & Mak, 2012). In 
OW/OB, the major source of these pro-inflammatory markers are the adipocytes (adipose 
cells), with an accumulation of adipose tissue leading to increased circulating pro-
inflammatory markers (Greenberg & Obin, 2006). Shelton and Miller (2011) proposed that 
this adiposity-induced pro-inflammatory state linked OW/OB and depression. Weight gain 
may also be induced via the effect of chronic inflammation on insulin and leptin resistance 
(Milaneschi et al., 2012; Shoelson, Lee, & Goldfine, 2006) both of which help regulate 
glucose and fat metabolism and supress appetite respectively. 
Increased adiposity has also been linked to stress reactivity, with Pasquali and 
Vicennati (2000) asserting that abdominal obesity dysregulates the hypothalamic-pituitary-
adrenal axis leading to ‘functional hypercortisolism’ (i.e. supranormal cortisol production) 
further perpetuating weight gain via stress-induced calorie consumption (Epel, Lapidus, 
McEwen, & Brownell, 2001; Newman, O'Connor, & Conner, 2007). In patients with major 
depression, stress reactivity appears to be partially mediated by early-life stress and adverse 
events (Heim, Newport, Mletzko, Miller, & Nemeroff, 2008; Pace et al., 2006). Given the 
association early-life events have with the aetiology of co-morbid depression and OW/OB, 
21 
this reinforces the probability of a mediating link between early-life stress (e.g. childhood 
teasing), current stress reactivity, systemic inflammation, obesity and depression (Miller & 
Cole, 2012). Furthermore, there is typically a significant reduction in adipose tissue, pro-
inflammatory markers and symptoms of depression following weight loss and exercise 
interventions (Febbraio, 2007; Hamer, David Batty, & Kivimaki, 2011; Lopresti et al., 2013; 
Shelton & Miller, 2011; Vissers et al., 2013) indicating that treatments that target the cycle of 
inflammation, adiposity and depression require further investigation. 
In summary, there are a range of genetic, experiential, psychological, behavioural and 
physiological risk factors and comorbidities associated with depression in overweight or 
obese adults. Discrimination, adolescent teasing and perceived negative verbal commentary 
are further predisposing factors for depression in OW/OB adults. Historical depression, 
negative internal verbal commentary, self-criticism, shame, body dissatisfaction and a range 
of early maladaptive schemas may contribute to and perpetuate depression in OW/OB 
persons. Uncontrolled eating, binge eating and reduced physical activity is associated with 
depression in OW/OB persons. Finally, a variety of associations have been described 
between adiposity, stress reactivity and systemic inflammation which may contribute to 
depression in OW/OB populations. 
1.3. Current Treatments for Depression with Comorbid Overweight or Obesity 
International guidelines for treatment of clinical depression - irrespective of an 
individual’s weight - frequently include cognitive behaviour therapy, behavioural activation 
or structured physical exercise at 45 minutes per week at least three times per week for 10 
weeks or more (e.g. NICE, 2009; SIGN, 2010). Nevertheless, specific recommendations for 
individuals with co-morbid clinical depression and OW/OB are yet to be made. The OW/OB 
population may experience unique challenges not confronted by normal weight peers in 
engaging with and benefiting from various interventions. For example, depression often 
reduces motivation and engagement (Barlow, 2014; Beck, 1991; Carr & McNulty, 2006) 
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whilst weight related stigma is known to significantly impact treatment provision, experience 
and outcome (Fruh et al., 2016; Puhl & Heuer, 2010). Some clinicians describe that it can be 
difficult to activate a patient with depression and that low levels of general activity, low self-
worth, helplessness, hopelessness and withdrawal make engagement especially difficult 
(Seime & Vicers, 2006). Indeed, for depressed persons, obesity is associated with a lower 
likelihood of receiving psychotherapy as treatment and with shorter than recommended 
durations of psychotherapy (Boudreau et al., 2013). This is not surprising in light of the 
predisposing factors discussed above –patients who have experienced discrimination, teasing, 
or frequent negative verbal commentary may fear further shame, criticism or failure (Carr & 
McNulty, 2006; Cooper & Fairburn, 2001; Decaluwe & Braet, 2005). These factors may 
contribute to poorer initiation of treatment seeking behaviour, lower adherence or reduced 
benefit from interventions - especially exercise interventions - which have experienced 
increasing research attention and popularity in the community, including popular media (e.g. 
Mosley, 2013; Otto & Smits, 2011).  
Despite substantial research supporting a link between OW/OB and depression, 
weight is rarely a measure of interest in non-pharmacological treatment trials for depression 
(Aherne et al., 2017; Cuijpers et al., 2010)  whilst individuals with clinical depression are 
regularly screened out of treatment trials involving OW/OB samples (e.g. Andersen et al., 
1999; Annesi & Unruh, 2008; Rubin et al., 2005). Researchers indicate this is often because 
psychotropic medication can interfere with weight change, low mood can prompt relapse to 
over-eating, and depression can reduce adherence to interventions. As a result, much of the 
literature in this field is based on mood-change in sub-clinical or euthymic individuals 
(Faulconbridge & Bechtel, 2014). Whilst some weight-loss trials have been conducted on 
individuals with depression, (e.g. Linde et al., 2011) to our knowledge there are very few 
published papers investigating treatments for clinical depression in OW/OB adults. This 
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points to an important need for future research to investigate treatments for depression in 
OW/OB adults. 
The fundamental approach to research to date investigating co-morbid depression and 
OW/OB seems to be one of component integration; i.e. combining existing evidence-based 
treatments for clinical depression (e.g. psychotherapy, pharmacotherapy or exercise) and 
OW/OB (e.g. lifestyle intervention or behavioural weight-loss) concurrently. Pioneering 
combined interventions in the field, Faulconbridge, Wadden, Berkowitz, Pulcini, and 
Treadwell (2011) implemented two concurrent evidence-based treatment approaches; CBT 
for depression and behavioural treatment for obesity. Twelve women with clinical depression 
and co-morbid OW/OB attended group sessions conducted by a Clinical Psychologist weekly 
for 16 weeks (n of 6 per group, 90mins sessions). Half of each session was devoted to weight 
management (LEARN program, Fairburn & Brownell, 2002) and half to CBT for depression. 
Seventy-five per cent of participants completed the program (n = 9) for whom scores on the 
HRSD reduced from an average of 20.4 to 9.3. Six of the nine completers achieved remission 
(score of < 8 on HRSD). In a similar study, Pagoto et al. (2013), randomly assigned 161 
women with co-morbid obesity and depression to either Behavioural Activation, consisting of 
brief behaviour therapy for depression plus lifestyle intervention or Lifestyle Intervention 
alone over 6-months. The lifestyle intervention included recommendations regarding 
modifications for diet and exercise regimes. Depression scores (BDI-II) in the Behaviour 
Activation group (21.1 ± 5.7) and Lifestyle Intervention group (21.0 ± 5.9) reduced by 12.5 ± 
0.8 and 9.2 ± 0.8 post intervention and were maintained at 6 months follow-up. Interestingly, 
the primary intervention arms implemented by Faulconbridge et al. and Pagaoto et al.’s 
included a substantial component of regular exercise (approx. 150-180mins per week at a 
moderate intensity), although the component effect of exercise was not investigated further. 
Investigations into exercise interventions may be of particular interest for this population. 
First, as mentioned, regular exercise is recommended as part of clinical guidelines for 
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treatment of depression (e.g. NICE, 2009; SIGN, 2010). Second, regular exercise can 
potentially ameliorate the negative effects of adiposity, inflammation, low activity and 
depression (Febbraio, 2007; Ford, 2002).  
Indeed, recent research has started combining incrementally refined modalities of 
treatment. For example, Berman, Morton, and Hegel (2015) discuss the development of an 
11-week intervention program for women experiencing co-morbid clinical depression and 
OW/OB which integrates the acceptance-based Health at Every Size (HAES) paradigm and 
an evidence based cognitive-behavioural treatment for depression known as Acceptance and 
Commitment Therapy (ACT). Likewise, in a 12-month collaborative care model for primary 
care treatment of comorbid depression and obesity, Ma et al. (2015) outlined a yet to be 
conducted RCT investigating a technology enhanced (i.e. Fitbit, MyFitnessPal) treatment 
approach which integrates problem solving therapy, pharmacotherapy for depression and 
standard behavioural treatment for obesity. Despite these promising developments, utilising 
combined intervention options for clinical depression and OW/OB as discrete rather than co-
morbid concerns are not yet optimal. Future treatment protocols could be refined following 
careful consideration of extant literature investigating treatments for depression in an 
OW/OB population.  
These recent studies illustrate consecutive and concurrent treatment of depression and 
OW/OB is feasible and promising. Many of them utilised physical exercise. It remains 
unclear however, whether particular formats or types of exercise are more likely to increase 
engagement or treatment effect compared to alternative formats or types of exercise in 
OW/OB persons. The role of exercise as a treatment for depression in individuals with 
OW/OB therefore needs further attention. 
1.3.1. Exercise for Depression 
Research has indicated that exercise, i.e. planned, structured and repetitive bodily 
movement with the purpose of improving or maintaining one or more components of physical 
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fitness (Caspersen, Powell, & Christenson, 1985) may be a useful adjunctive approach to 
weight loss (Shaw, Gennat, O'Rourke, & Del Mar, 2006) and that CBT can be enhanced 
when a general “physical activity” program is included in therapy (Faulconbridge et al., 
2011; Gary, Dunbar, Higgins, Musselman, & Smith, 2010). This is especially so when 
structured exercise is included (Cooney et al., 2013). Research illustrates that exercise can be 
as effective as psychotherapy or pharmacotherapy in treating adults with clinical depression 
(Cooney et al., 2013), reduces depression in SSRI resistant populations (Trivedi et al., 2011), 
allows for a reduction in anti-depressant medication and reduces relapse for depressed 
patients (Deslandes et al., 2009). Subsequently, treatment guidelines have recommended 
exercise as a treatment or adjunctive treatment for mild to moderate depression for some time 
now (e.g. NICE, 2009, SIGN, 2010). Given that exercise may reduce the negative effects of 
adiposity, inflammation, low activity and low mood inherent in a depressed, OW/OB 
population, it is an excellent contender for inclusion in treatment and is worthy of further 
investigation.  
1.4. The Current Research 
The overarching aim of the present research is to propose an evidence-based 
intervention for clinical depression in individuals with OW/OB. Given the previous literature, 
it was anticipated that the program would incorporate professionally delivered psychotherapy 
and regular supervised exercise, both tailored to this particular population. Therefore, the 
studies were developed with several key defined themes, outlined here and further elaborated 
in the description of studies below.  
First, a critical aim was to systematically identify and evaluate existing interventions 
that are effective at reducing symptoms of depression in OW/OB adults. Such an analysis 
should help to inform the development of any future interventions. Second, given the 
likelihood that physical activity will be a component across intervention approaches (CBT, 
behavioural activation, structured exercise), and because exercise recommendations may 
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form part of primary care approaches (RACGP, 2018; Short et al., 2016)(RACGP, 2018; 
Short et al., 2016)(RACGP, 2018; Short et al., 2016)(RACGP, 2018; Short et al., 
2016)(RACGP, 2018; Short et al., 2016)(RACGP, 2018; Short et al., 2016), another aim was 
to further explore exercise as a specific intervention in this population. Specifically, this 
included examining the feasibility and effectiveness of various exercise interventions with 
potential for suitability and efficacy in ameliorating clinical depression in OW/OB adults. In 
addition, to evaluate engagement and responsivity, another aim included identifying and 
elucidating important factors in intervention design and implementation pertaining to clinical 
depression and OW/OB, by exploring client (i.e. participant) experience in exercise 
interventions. Finally, a fourth outcome was to propose, by way of integrating the above 
research and findings, a protocol for a randomised controlled trial (RCT) to assess the impact 
of a coherent intervention which includes psychotherapy and exercise for clinical depression 
in OW/OB adults. In support of the aims outlined above, four studies were conducted. These 
are outlined below. 
1.4.1. Overview of Studies 
1.4.1.1. Study One 
Study One (Chapter 2) – reports on a meta-analytic review exploring peer reviewed 
controlled trials investigating the efficacy of existing interventions on symptoms of 
depression in OW/OB adults. The meta-analytic review collates relevant intervention studies 
that might inform development of an evidenced based treatment program for depression in 
OW/OB adults. Because so few studies exist examining interventions for clinical depression 
in OW/OB adults, we expanded the pool of potential studies by screening any study 
measuring symptoms of depression as an outcome in this population. Our review suggests 
that various forms of pharmacotherapy, psychotherapy, exercise and lifestyle interventions 
hold promise for reducing symptoms of depression in OW/OB adults. At this stage, it seems 
the most beneficial treatments are those that include targeted treatment for depression (i.e. 
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cognitive behavioural approaches) alongside robust exercise and lifestyle modification 
programs. There is a clear need for further research on interventions specifically for clinical 
depression in OW/OB adults. 
1.4.1.2. Study Two 
Study Two (Chapter 3) includes an RCT examining the feasibility and efficacy of three 
formats of exercise interventions for clinical depression in OW/OB adults and associations 
between physiological variables and symptom reduction. Whilst a large body of research 
confirms that exercise is as effective as pharmacotherapy or psychotherapy in treatment of 
mild to moderate clinical depression and confers several health benefits to OW/OB persons 
(Cooney et al., 2013; Deslandes et al., 2009; Faulconbridge et al., 2011; Gary et al., 2010; 
Trivedi et al., 2011), little is known about whether such benefits confer to individuals with 
clinical depression and co-morbid OW/OB nor if these interventions are feasible within this 
population. Indeed, some recent commentary has suggested that certain formats of exercise 
e.g. high intensity intermittent exercise (HIIE), are not feasible for public health interventions 
(Biddle & Batterham, 2015) despite gaining increasing coverage in the general community 
and media (e.g. Mosley, 2013). Yet the impact of different formats on outcomes in this 
population remain relatively unknown. Given that exercise interventions may confer 
meaningful mood, metabolic and health benefits to a depressed person with OW/OB, it is 
important to address these questions. This RCT produced interesting findings. All formats of 
exercise had a similar effect on severity of depression, anxiety and stress and providing 
clinically significant change in depression severity in over half of participants who completed 
the 18-session trial. These findings help inform clinicians (general practitioners, psychiatrists, 
psychologists and exercise physiologists) that at least several types of exercise may be 
potentially beneficial for treating depression in adults with OW/OB, and that specific 
prescriptions beyond adequate intensity, volume and personal preference may not be 
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necessary. Our findings also show that HIIE is possible in an OW/OB population with 
clinical depression. 
1.4.1.3. Study Three 
The previously described study focused on clinical outcomes regarding depression, 
anxiety, stress and physiological variables of body composition and aerobic fitness over the 
course of an 18-session randomised controlled clinical trial of three exercise interventions for 
clinical depression in OW/OB adults. Yet exercise intervention studies that only examine 
outcome scores for depression may miss critical aspects of the patients’ experience, including 
those that relate to feasibility, engagement and adherence. Study Three (Chapter 4) therefore 
was a mixed-methods study which investigated participant experiences of exercise 
interventions in the RCT above. These issues are pertinent to using exercise as an adjunct, 
integrated or independent therapy for depression in OW/OB populations. This is especially so 
since, as mentioned, these individuals may experience unique challenges not confronted by 
normal weight peers such as exacerbated barriers with regard to motivation, engagement 
(Barlow, 2014; Beck, 1991; Carr & McNulty, 2006) and experience of treatment provision 
(Fruh et al., 2016; Puhl & Heuer, 2010). This mixed-methods study includes qualitative 
analysis of participant interviews and analysis of self-report measures, exploring factors 
relating to engagement, self-efficacy and the subjective experience of the exercise programs 
evaluated in the RCT (Study Two).  
In this study, exercise self-efficacy, subjective confidence to exercise, motivation and 
positive anticipation to and toward exercise were comparable between the three exercise 
conditions. Qualitative analysis revealed the importance of exercise variety, personal choice 
and intensity for ensuring engagement. A critical finding was that  rapport within the 
relationship between personal trainer and client was described as a chief facilitator of and 
motivator to exercise regularly. This was attributed to the trainer’s knowledge and expertise, 
and the sense of partnership, safety, trust and accountability that grew between participant 
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and exercise trainer. Further considerations for clinicians include recognising that participants 
may also bring a unique history and context to the intervention which seemed to activate self-
critical, punitive and discouraging intrapsychic dynamics, resulting in a sense of failure, 
shame and guilt. We discuss also the use of compassion-based approaches as a potential 
aspect of a tailored intervention for OW/OB, depressed individuals. 
1.4.1.4. Study Four 
Study Four (Chapter 5) draws together the findings from the three prior studies and 
describes an evidenced based intervention for clinical depression in OW/OB adults by way of 
a protocol paper (Study Four). Given the findings derived from research and our prior 
chapters, we sought to include elements of schema therapy and compassion focused therapy 
in our tailored cognitive behaviour intervention for depression in OW/OB adults. Gilbert 
(2009) outlined how attention tasks, imagery, and cognitive therapy for motivation, emotions, 
behaviour, and thinking or reasoning patterns can assist in fostering sensitivity, empathy, 
distress tolerance and a non-judgmental self-orientation that may be especially useful for 
persons with clinical depression and co-morbid OW/OB and we suggested this might be a 
valuable foundation for future interventions to be based on. Given the promise of exercise as 
an intervention for depression and its benefits related to OW/OB, the protocol includes a 
significant exercise component based on the findings and research discussed in preceding 
chapters. Chapter 5 therefore describes a protocol paper for a randomised controlled clinical 
trial comparing tailor-made intervention for depression in individuals with co-morbid 
OW/OB which includes psychotherapy and exercise to exercise alone or treatment as usual 
(i.e. standard cognitive behaviour therapy for depression). The tailor-made intervention aims 
to target the key factors we believe contribute to depression in this population whilst also 
improving engagement and adherence.  
1.4.1.5. Chapter 6 – General Discussion and Conclusion 
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Systematic Review with Meta-analysis of Treatments of Symptoms Depression in 
Adults with Overweight or Obesity. 
2.1. Introduction 
Clinical depression is a significant social and economic burden worldwide. Lifetime 
prevalence rates vary from 6.6 per cent in Japan to 21 per cent in France with high-income 
nations in Europe and the Americas averaging life-time prevalence rates of 14.6 per cent 
(Bromet et al., 2011; Meyer et al., 2001), a substantial increase over previous estimates  
(Andrade et al., 2003; Carta et al., 1995; Robins et al., 1984). Elevated symptoms of 
depression impair intra-psychic, interpersonal, vocational and physical well-being (Judd, 
Akiskal, Zeller, & et al., 2000; Keitner & Miller, 1990; Wella et al., 1989; Whisman & 
Bruce, 1999) and presents as a major risk-factor for overweight and obesity and obesity-
related morbidities and consequences (Malnick & Knobler, 2006; Manson et al., 1995). 
Overweight (BMI1 > 25) and Obesity (BMI > 30) are estimated to directly affect 
36.9% of men and 29.8% of women in developed countries worldwide – almost one-third 
higher than in 1980 (Ng et al., 2014). Prevalence rates in Australasia (62 per cent) North 
America (65.4 per cent) and Western Europe (54.5 per cent) are much higher than the global 
average (Ng et al., 2014). Together, overweight and obesity (OW/OB) are considered one of 
the most preventable health conditions and increase risk for a variety of significant 
cardiovascular diseases (National Heart Foundation of Australia, NHFA; 2007).  
Research has indicated a bi-directional relationship between OW/OB and clinical 
depression, with either condition alone increasing risk for developing the other (Luppino et 
al., 2010; Simon et al., 2008). Individuals with co-morbid depression and OW/OB may face 
particular risks to health and well-being (Markowitz et al., 2008) and are likely to experience 
                                                             




unique challenges not confronted by normal weight peers. For example, depression often 
reduces general activity, motivation and engagement (Barlow, 2014; Beck, 1991; Carr & 
McNulty, 2006) and can be exacerbated by chronic health conditions associated with OW/OB 
(Norberg & Danielsson, 2012). Co-morbid obesity also significantly reduces the likelihood of 
receiving treatment for depression and is associated with reduced treatment duration relative 
to normal weight peers (Boudreau et al., 2013). Furthermore, weight related stigma is known 
to significantly impact treatment provision, experience and outcome for clinical depression 
(Fruh et al., 2016; Puhl & Heuer, 2010) whilst depression negatively affects weight loss 
outcomes and health behaviour change (Pagoto et al., 2007). These factors may contribute to 
less frequent treatment seeking behaviours, lower adherence or reduced benefit from 
interventions. It is therefore important that clinicians are able to make well-informed 
decisions regarding the treatment of depression in OW/OB adults.  
2.1.1. Treatments for Comorbid Depression and Overweight or Obesity 
Treatment-as-usual for depression often involves psychotropic medication - most 
commonly SSRI’s - and/or psychotherapy. The National Institute for Health and Care 
Excellence (NICE) guidelines recommend cognitive-behavioural therapy (CBT) or 
Interpersonal Psychotherapy with medication for treatment of moderate-severe depression, 
with short-term Psychodynamic Psychotherapy and Behavioural Activation also included for 
mild to moderate depression (NICE, 2009). Nevertheless, specific recommendations for 
individuals with co-morbid clinical depression OW/OB are yet to be made.  
Based on the preceding discussion, one might postulate greater efficacy for clinically 
depressed, OW/OB persons when treatments include modules addressing the salient concerns 
most relevant to this population. To date however, few interventions for clinical depression in 
individuals with co-morbid OW/OB have been researched. Two studies, including one 




depression. In the RCT – researchers also found higher levels of remission compared to 
lifestyle intervention alone (Faulconbridge, Wadden, Berkowitz, Pulcini, & Treadwell, 2011; 
Pagoto et al., 2013). These studies used standard group CBT or Behavioural Activation for 
depression alongside weight reduction programs (i.e. lifestyle programs, exercise or 
behavioural weight loss).  Such combined treatments offer a strong foundation for treatments 
of comorbid depression and OW/OB. Nevertheless, current guidelines on managing clinical 
depression do not distinguish between non-OW/OB versus OW/OB persons with the 
condition (e.g. NICE, 2009; SIGN, 2010). Given that there are unique psychological and 
psychosocial challenges for this population, it is important to identify and understand which 
treatments are most effective at reducing depression in OW/OB persons. This systematic 
review aims to identify treatments (psychological, behavioural, pharmacological) for 
reducing symptoms of depression in individuals with co-morbid OW/OB and to evaluate their 
effectiveness relative to control conditions. We intended to use these findings to inform the 
development of a tailored intervention for depression in OW/OB adults, subsequently 
discussed in Chapter 5. A further aim of this review was to identify the factors which may 
contribute (or fail to contribute) to positive treatment outcomes in individuals with symptoms 
of depression and co-morbid OW/OB. We addressed the following questions: 
i. What are likely to be superior treatments compared to other treatments or control 
conditions for symptoms of depression in overweight or obese adults? 
ii. What are the common features of treatment associated with superior outcomes of 
depression in overweight or obese adults? 
2.2. Method 
2.2.1. Literature Search Strategy 
Several search strategies were piloted based on full-text searches of key words or 
subject headings related to symptoms of depression, dysthymia and to overweight and 




Loss, Body Fat, Adult, RCT, "randomized controlled trial", "clinical trial" were searched 
through full-text, title and abstracts in the following databases: CINAHL, Cochrane Database 
of Systematic Reviews, Cochrane Trials Register, EMBASE, Medline, ProQuest, (including 
PsychINFO and PsychArticles), ScienceDirect, Scopus, SportDiscus and Wiley Online 
Library (See Appendix A). Duplicates were discarded and the title and abstract of remaining 
papers reviewed for relevance. Eligibility assessment was performed independently by at 
least two authors (N.B. and either H.C. or S.B.). Papers considered potentially eligible were 
read independently and in full (N.B. and S.B.). Studies meeting the inclusion criteria were 
added to the review. Disagreement between the reviewers was resolved by consensus. The 
literature search was updated most recently in January 2017. Hand searching of reference lists 
from applicable papers, reviews and meta-analysis was conducted to identify further relevant 
publications. The last hand search was completed in March 2017. The review was conducted 
in accordance with PRISMA guidelines (Liberati et al., 2009). 
2.2.2. Study Selection 
As there are few studies investigating clinical depression in OW/OB adults and to 
gain a broad perspective on potentially effective treatments, we reviewed controlled trials 
measuring the effect of any treatment on symptoms of depression assessed via an established 
psychometric questionnaire (e.g. BDI-II or HAM-D) or interview in adults (aged ³ 18 years) 
who were overweight or obese (BMI2 ³ 25 kg/m2). Populations were generally healthy, 
however incidental health conditions (such as diabetes, hypertension) were permitted. 
Excluded were case studies, prospective cohort studies, studies reporting on child populations 
or animal research. Papers directly investigating interventions on specific medical conditions 
which may influence depression were excluded (e.g. CHD, DMII, PCOS, cancer) as were 
studies investigating the effect of interventions on age-related cognitive decline, bipolar 
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disorder, psychosis or anorexia nervosa. Given the potential for elevated disordered eating 
behaviours in OW/OB populations (Faith, 2002; Faulconbridge & Bechtel, 2014; Fitzgibbon, 
Stolley, & Kirschenbaum, 1993), samples with co-morbid binge eating disorder (BED) were 
included. Studies of duplicate populations were excluded and the largest sample with 
applicable data used. Only peer-reviewed studies available in English language prior to 
January 2017 were included. 
2.2.3. Data Extraction 
Outcome measures for depression severity were extracted independently by two 
authors (N.B. and S.B.). We extracted the mean and standard deviation or standard error for 
all reported conditions. When multiple measures of depression were reported, we used the 
most complete data available pre and post intervention. Where two or more outcome 
measures were available in these cases, we used data from clinician rated assessments in 
preference to self-report measures.  The following additional data were extracted: study and 
condition sample size, demographic information including age, gender, ethnicity, co-morbid 
conditions; treatment description including duration, frequency, provider and format and; 
study design, including use of power analysis, allocation ratio, intention to treat (ITT) and 
trial registration. Where appropriate data was not reported in the study manuscript, the listed 
contact author was e-mailed and/or telephoned and the necessary data requested. 
2.2.4. Risk of Bias and Data Analysis 
Risk of bias was assessed using the Cochrane Risk of Bias tool provided in the online 
systematic review platform, Covidence™. Where no detail was provided in the article 






2.2.5. Data Synthesis 
Data were organised according to type of control group, i.e. treatment as usual or active 
control vs. wait-list or placebo control, or minimum control - then by intervention. 
Intervention strategies included pharmacotherapy; evidenced-based psychotherapy; lifestyle 
intervention; diet; exercise; alternative therapy or combined interventions. Evidence-based 
psychotherapies were defined as any psychotherapy recommended in current guidelines on 
managing clinical depression. Furthermore, within the data synthesis, research on populations 
with clinical depression (i.e. Major Depression, Dysthymia) were summarised independently 
from research on non-clinical populations. A meta-analysis was conducted on 29 studies with 
sufficient data available, including data on sub-groups where applicable. We examined 
standard mean difference scores with 95 per cent confidence intervals (CI) between treatment 
and control conditions such that an outcome favouring treatment was indicated by a negative 
value, and outcomes favouring control or treatment as usual had a positive value. 
2.3. Results 
2.3.1. Study Selection 
Figure 2.1 illustrates the PRISMA flowchart of study selection. The key word search 
initially identified 5902 records. This included 59 citations from CINAHL, 1277 from 
Cochrane Database of Systematic Reviews and Cochrane Trials Register, 725 from 
EMBASE, 23 from Medline, 853 from ProQuest, (including PsychINFO and PsychArticles), 
738 from ScienceDirect, 709 from Scopus, 1 from SportDiscus and 1517 from Wiley Online 
Library. Following removal of duplicate records, 5371 records remained. Two-hundred-
ninety-four studies were available for full-text review after initial title and abstract screening. 
Of these, 33 were excluded on the basis of not being a controlled study. Sixty-eight were 
excluded being investigations on mixed-weight populations or non-overweight or obese 




depression (e.g. CHD or alcohol dependence) and 42 studies excluded participants with a 
diagnosis of depressive disorders or elevated symptoms of depression. Eighty-seven studies 
had no standardised measure of depression pre and post intervention. Duplicate sub-samples 
were found in 5 studies. Five papers were not available with full-text in English. A thorough 
and full assessment was conducted on the subsequent yield of studies. 
Figure 2.1. PRISMA flowchart 
2.3.2. Characteristics of Included Trials 
The systematic review included 36 studies (Figure 2.1), comprising a total of 2940 
participants. Sample sizes of the 36 studies varied between 15 and 231. Most studies recruited 
exclusively female (n = 20; 55.6%) or mostly female participants (i.e. > 75% to 99% ; n = 
12). Two studies (5.6%) recruited only male participants whilst one study (2.7%) 
predominantly recruited males (i.e. > 75 % to 99%). Publication year ranged from 1981 to 
2016. Twenty-six studies (72.2%) were conducted from out-patient, health clinic or 




study was conducted with shipboard U.S. Navy personnel (Dennis, Pane, Adams, & Qi, 
1999).  
Three studies (8.3%) examined samples with co-morbid clinical depression and 
overweight or obesity (Guerdjikova et al., 2012; Linde et al., 2011; Pagoto et al., 2013). A 
further three studies included a substantial number of participants with current or historical 
Major Depression (Arnold et al., 2002; McElroy et al., 2003; White & Grilo, 2013). Co-
morbid conditions additional to OW/OB and depression were present in 14 studies (38.9%). 
The majority of studies reported co-morbid BED alone (n = 9; 25.0%).  
The effect of the intervention on symptoms of depression was a main focus for fewer 
than a third of studies (n = 11; 31.6%). Thirteen studies (36.1%) reported between group 
results of treatment superior to alternative treatment or placebo. Two reported marginal but 
not significant results in favour of a treatment group. Of the remaining 21 studies without 
between group differences, 17 (47% of total sample) reported significant within group 
declines in depressive symptoms in the main intervention group. The lack of between group 
difference was primarily due to similar reductions in an active control condition and 
occasionally due to floor effects or large sample variance. 
2.3.3. Risk of Bias in Included Trials 
Table 2.1 below, illustrates the risk of bias of included trials. Very few studies 
reported sequence generation or allocation concealment procedures, despite being 
randomised trials. Two of the studies were non-randomised controlled trials (Fossati et al., 
2004; Park & An, 2006). As depression symptomatology is either self-reported or clinician 
rated, where the outcome-rating was not provided by an independent person, such studies 
were recorded as ‘high risk’ of being open to influence of bias.  Two studies had levels of 
dropout that may have influenced outcome data (Cook, Howard, & Mills, 1981; Gorin, 




& Spring, 2010; Lutze et al., 2013; McElroy et al., 2003; Pagoto et al., 2013). Two studies 
included other sources of potential bias (i.e. participation by family members and sponsorship 
from industry bodies ‘The Sugar Company’ and ‘Kellogg’s’; Esmaily et al., 2015; Surwit et 





Table 2.1.  Risk of bias table for studies included trials
 






2.3.4. Summary of Results 
Table 2.2. Summary of included trials. 
Study DEMOGRAPHICS (N; AGE; % 























Overall: n = 114; Age: 42.4(10.1); 
100% female; 61% White, 30% 
African American BMI: 36.8(4.3); Co-
morbid Dx: NR. 
RCT, NR, 2:1 
(CA condition 
had 2 participants 
assigned for every 
1 in the other 
conditions), ITT 
with LOCF, NR  







All groups: Access to YMCA wellness facility. 3x 20-40 minute 
sessions per week of moderate-intensity cardiovascular exercise. Six 
nutrition information sessions following ACSM guidelines. CA 
condition: One-to-one exercise support protocol emphasizing goal 
setting, relapse prevention, and other self-regulatory during monthly 
one-on-one meetings over 6 months. Based on social cognitive and 
self-efficacy theory. EX condition: Proper use of exercise apparatuses 
was demonstrated and followed up at the same frequency as the CA 
condition. Duration: 6 months. 
Appolinario 
2003 
Overall: BMI 30-45, Co-morbid 
Dx: BED with BES > 17 
(moderate), Hx of MDD: 37%. 
Sibutramine: n = 23 ; Age: 35.2(9); 
87% female; % White NR; BMI: 
NR, Weight 102.8(13.2), BES 
29.2(7.2), Binge days/week: 
4.1(1.8). Placebo: n = 25, Age: 
36.6(1.2); 90% female; % white 
NR; BMI: NR; Weight 98.7(12.9); 






parallel group; Y; 









Sibutramine hydrochloride (antiobesity agent) 
provided at 15 mg/d. Placebo: Identical appearance placebo pill. 







Fluoxetine: n = 30; Age: 41.9(9.7); 
93% female, 90% White, BMI: 
39.6(7.0); Placebo: n = 30; Age: 
40.8(9.0); 93%; 87%; 36.7(6.8), Co-














Fluoxetine; Placebo Fluoxetine: 20mg/day titrated to 60mg/day over 6 days. After two 
weeks on 60mg/day dosage could be increased to 80mg/day. Placebo: 
Identical protocol, placebo pill Duration: 6 weeks; Frequency: Daily, 
Provider: Clinic; Format: Individual. 
Bacon 
2002 
Overall: n = 78 (Diet-group: n = 23, 
Non-diet: n = 29); Age: 39.3(4.5); 
100% female; 100% White; BMI: 
35.7(3.6); Eating Restraint Scale score 
> 15.  







All groups: Duration: 24 weeks. Frequency: Weekly 90-minute 
sessions. Optional monthly group support sessions after 6 months; 
Provider: Experienced counsellor. Format: Group. Diet-group: 
Behavioural weight loss program; Provider: Registered dietitian. Non-
diet: Body-acceptance, eating behaviour modification, activity, 
nutrition and social support. 
Bennett 
1986 
Overall: n = 74 ; Age: 40.1; 100% 
female; % White NR; BMI: 32.7(NR); 
Co-morbid Dx: NR. 












All groups: Duration: 16 weeks; Frequency: (Group sessions wks 1, 2, 
3, 10, 15 & 16) individualised nutritional advice and social support. 
Cognitive Rehearsal: 1hr x 7 session in self-instructional training for 
eating behaviour modification; Insight Control: 1hr x 7 sessions 
training for ability to gain insight to automatic thoughts about eating, 
without behaviour change; Individual Contact Control: Contact 
session of 20mins x 7 non-directive discussion. Group Control: 
Group sessions only. 
Bowen 
2006 
Overall: n = 172 (Exercise group: n = 
86, Control group: n = 86); Age: 
61.0(NR) ; % Female: 100%; % White: 
86%; BMI: > 24.99; Co-morbid Dx: 
NR. 







All groups: Duration: 12 months. Provider: Exercise physiologist. 
Format: Group. Exercise group: Moderate-vigorous intensity aerobic 
exercise at home or an exercise facility. Gradual increase in intensity 
from 40% VO2max for 16mins/session to 60-75% VO2max for 
45mins by week 8. Included 5-10 minutes of light weight training. 
Included additional group contact, newsletters, phone contact and 







Overall: BMI > 30; 100% female; 
100% White; Co-morbid Dx: Post-
menopausal. Lifestyle only: n = 21; 
Age: 55.1(8.3); BMI: 37.8(5.9). 
Lifestyle + self-control: n = 23; Age: 
54.3(7.8); BMI: 35.1(5.0). 
RCT, N, NR, N, 
N  
BDI; Lifestyle 
change 9.1 (10.0); 
Lifestyle + self-






All groups: Duration: 24 weeks. Weekly sessions of 60-75 minutes. 
Provider: Clinical Health Psychologist and graduate student. Format: 
Group (n = 7-12). The LEARN Program emphasized self-monitoring, 
eating related stimuli control, physical activity, nutrition education, 
cognitive therapy associated with dieting and body image, goal setting, 
relationships and relapse prevention and weight maintenance. Lifestyle 
+ self-control skills: Additional content within class, didactic 
instruction, individual activities, and weekly out-of-class assignments. 
Based on Baumeister’s self-control theory. 
Cook 
1981 
Overall: n = 45 (Diet + Miansarin: n = 
21 ; Diet only, n = 24); Age: 
38.0(11.0); 95% Female; % White: 
NR; BMI: > 37.0.; Co-morbid Dx: NR. 
Double-blind 
RCT, N; N; N; N 
BDI; Diet + 
Miansarin 14.0 (8.0); 
Diet only 14.0 (7.0) 
Diet + Mianserin; 
Diet + Placebo 
All groups: Duration: 16 weeks, Frequency: Daily. Format: Individual. 
Diet: 320 kcal supplement containing 31g Protein, 44g Carbohydrate, 
2g Fats with vitamins and minerals. Diet + Miansarin: Additional 




Overall: 0% female;  % White: NR; 
Co-morbid Dx: NR. Treatment 
group: n = 21; Age = 31.9(7.1); BMI 
= 33.9(2.7); Control group: n = 18, 
Age = 30.4 (5.8); BMI = 33.0 (2.9).  
RCT; NR; NR; 
NR; NR 
CES-D; Weight-loss 
group: 20.1 (11.0); 






program "Level 1"). 
All groups: Duration 16 weeks. Exercise 1hr resistance and aerobic 
exercise 4x per week. Behavioural weight-loss: Frequency 1x per 
week 1hr meeting. Format: Group (7-12). Behaviour modification 
(eating slowly, keeping food out of sight); cognitive and emotional 
strategies to enhance self-efficacy, manage stress, increase social 
support and manage relapses. Diet: NCEP Step I Heart Health 
Guideline diet decreasing portions to reduce daily intake by 
500kcal/day. Calorie counting and food exchange. Provider: Navy 
Dietician. Control group: Nutrition fact-sheets and brochures 






Overall: 78% female, % White NR; 
Co-morbid Dx of BED. Combined 
group: n = 28; Age = 39.4 (12.1); BMI 
= 42.1 (6.9); Current MDD = 2; Past 
MDD = 8. Pharmacotherapy alone: n 
= 32, Age = 45.9 (13.6); BMI = 40.1 
(6.6); Co-morbid dx, Current MDD = 
3, Past MDD = 14. CBT alone: n = 25, 
Age = 43.4 (11.8); BMI = 41.1 (7.6), 
Current MDD = 3, Past MDD = 6. 
Control group: n = 31, Age = 44.1 
(10.2); BMI = 40.3 (7.1); Current 
MDD = 2, Past MDD = 12. 
RCT; Y; Y; NR; 
NR 












CBT alone; Control 
(Standard weight 
control treatment). 
All groups: Duration: 5 months; Frequency: 16 weekly 90-minute 
sessions (last 4 sessions bi-weekly); Provider: Supervised 
Psychiatrist/Doctoral level Psychologists; Format: Group and/or 
Individual. Modified LEARN program (Brownell) to include cessation 
of BE, reduction in overall distress, increased self-acceptance and 
weight loss. Focus on adopting 'healthy' lifestyle behaviours rather than 
achieving an ideal weight. Individual CBT: Based on treatment 
manual from Fairburn et al. Pharmacotherapy: Target dose of 60mg/d 
Fluoxetine (initial 20mg dose increased over 5 weeks) 
Esmaily 
2015 
Overall: % White: NR; Co-morbid 
Dx: NR. Curcumin-placebo: n = 15; 
Age: 38.84(11.12); 13% female; BMI: 
33.95(3.81). Placebo-curcumin: n = 
15; Age: 37.81(12.31); 11% female; 
















Curcumin; Placebo All groups: Duration: 30 days ; Frequency: Daily; Provider: Clinic; 
Format: Individual. Curcumin: C3 Complex® formula (comprising 
500mg curcumin, demethoxycurcumin and bisdemethoxycurcumin). 
Co-administration with 5mg bioperine® was used to enhance 
bioavailability of curcuminoids. hard gelatine capsules containing 500 
mg C3 Complex® plus 5 mg bioperine®. Placebo: Identical 
appearance contained bioperine® 5 mg alone. 
Fossati 
2004 
Overall: 100% female; % White: NR; 
Co-morbid Dx: BED. CBT alone: n = 
13; Age: 45.6(2.9); BMI: 36.4(1.9). 
CBT + N: n = 23; Age: 42.3(1.7); 
BMI: 34.4(1.4); CBT + N + PA: n = 
25; Age: 37.4(2.0); BMI: 35.6(1.1). 
Non-randomised 
trial; N; N; N; N 








All groups: Duration: 12 weeks. Frequency: Weekly, 1.5hr sessions of 
CBT for BED. Provider: NR Format: Group. CBT+N: Addition of 
'psychoeducative dietetic mistakes'. CBT+N+PA: Additional to above 
of physical activity recommendations of PA 30mins 3x weekly and 
increasing ADL's and 3x weekly planned exercise (swimming, 






Overall: n = 40 (split 50:50); 90% 
female; % White: NR; Co-morbid Dx: 
METS. Aerobic + Isokinetic exercise: 
Age: 41.6(NR); BMI: 37.9(NR). 









aerobic exercise + 
calorie restriction; 
Aerobic exercise + 
calorie restriction  
All groups: Duration: 8 weeks; Frequency: 3 sessions/week, Provider: 
Rehabilitation Facility; Format: NR. Dietary reduction of 25-35% 
baseline calories. Balanced diet of 15% protein, 30-35% fats; 50-55% 
carbohydrate and 2l fluid per day. Aerobic + Isokinetic group: 
20mins moderate intensity exercise (70% HRmax) aerobic exercise and 
15mins isokinetic strengthening exercise for knee and spine. Aerobic 
exercise alone: 30mins of moderate intensity exercise at 70% HRmax. 
Gorin 
2003 
Overall: n = 94 (CBT alone: n = 32; 
CBT-spouse: n = 31, Control: n = 31); 
Age: 45.20(10.03), 100% female; 86% 
White; BMI = 39.42(7.72); Co-morbid 
Dx: BED. 
RCT; Y; Y; Y; 
NR 





CBT with spouse 
All groups: Duration: 12 weeks, Frequency: 12 weekly sessions 90 
minutes each. Provider: Advanced Clinical Psychology doctoral 
students (supervised). Format: Group (6-11 participants).  CBT-
individual: CBT for BED developed by Telch and Agras (1992). 
Included self-monitoring, establishing healthy eating patterns (regular 
meal and snacks), relapse prevention strategies. Encouraged regular 
exercise program. CBT-spouse: Further informed by the CBT 
transactional model of family functioning and the interpersonal 
expectation model. Collaborative approach to treatment, facilitation of 
behaviour change and goal setting between spouse dyads. 
Guerdjik
ova 2012 
Overall:  Co-Morbid Dx: MDD & 
BED. Duloxetine: n = 20; Age: 
44.4(12.1); 80% female; % White: 
90%; BMI: 38.7(6.8). Control: n = 20; 
Age: 35.7(10.4); 95% female; % 










All groups: Duration: 12 weeks; Provider: NR; Format: Individual. 
Duloxetine: 30mg /day increased as tolerated to maximum 120mg 
after 42 days. Placebo: As intervention, Identical placebo pill. 
Kiernan 
2001 
Overall: % White: 88.7%; Co-morbid 
Dx: NR; Males: Diet-plus-exercise: n 
= 39, BMI: 30.7(2.1); Diet-only: n = 
40, BMI: 30.4(2.1); Control: n = 40, 
BMI: 30.7(2.2); Females: Diet-plus-
exercise: n = 42, BMI: 28.0(2.4); Diet-
only: n = 31; BMI: 28.0(2.1); Control: 
n = 39, BMI: 28.1(2.4). 









Diet-only; Diet + 
aerobic exercise; 
Control 
All groups: Duration: 12 months; Frequency: Variable; Format: 
Group. Diet-only: low-saturated fat and low-cholesterol diet (National 
Cholesterol Education Program Step 1 recommendations). Weekly, 
fortnightly or monthly classes with a registered dietitian. Diet + 
exercise: As diet-only + group based aerobic exercise 3d per week, 
increasing from 25-45+ minutes of exercise at 60-80% of HRmax over 






Overall: n = 150 (MB-EAT: n = 53; 
Psycho-ed: n = 50; Waitlist Control n 
= 47); Age: 46.55(NR); 88% female; 
% White: 87%; BMI: 40.26(NR), Co-
morbid Dx: BED et al. 











All groups: Duration: 9 weeks + 3 monthly boosters; Frequency: 
Weekly sessions of 1.5hrs; Provider: Clinical or Counselling 
Psychology Doctoral student or Masters level professional; Format: 
Group. MB-EAT: General and ED-specific mindfulness techniques, 
body awareness, self-acceptance, chair-yoga, body scan, elements of 
CT. Psychoeducational CBT: Based on Duke Diet and Fitness Centre 
treatment for clients with BED (e.g. identifying triggers, stress 
management, lifestyle modification, PMR, problem solving, social 
support). Waitlist control: No treatment, single contact mid 
intervention period only to encourage retention. 
Linde 
2011 
Overall: 100% female; % White: > 
75%; Co-morbid Dx: MDD; Weight 
loss only: n = 102; Age: 52.1(6.5); 
BMI: 39.5(7.7). Combined Weight 
loss + CBT: n = 101; Age: 52.3(6.2); 
BMI: 38.6(6.8). 
RCT, Y, NR, Y, 
N 
SCL-20 Depression; 
Weight loss only: 
1.82(0.59); 








All groups: Duration: 12 months; Frequency: 26 sessions total, 
tapering after 16 weeks and maintenance after 6 months; Format: 
Group (3-16 per group); Behavioural weight loss: 90mins sessions 
centred on behavioural goal setting, self-monitoring of caloric intake 
(1200-1500kcal/d), non-specified physical activity (500-2500kcal/wk), 
and body weight. Provider: Weight counsellor. Combined condition: 
120mins sessions incorporating behavioural weight loss program above 
and essential elements of CBT for depression, based on ‘Coping with 
Depression’ manual. Provider: Clinical Psychologist.  
Lutze 
2013 
Overall: n = 117 (HP n= 57; HC 
n=61); Age: 49.6(9.2); 0% female; % 
White: NR; BMI: 31.1(4.2); Co-
morbid Dx: NR. 
RCT; NR; Block 
allocation by BMI 










All groups: Duration: 52-weeks; Frequency: Daily; Format: 
Individual, in community. Provider: NA. Targeted isocaloric with 
moderate energy restriction macronutrient diet comprising high protein 
(HP; 35% protein, 40% carbohydrate, 25% fat) or high carbohydrate 
(HC; 17% protein, 58 % carbohydrate, 25% fat). Specific quantities of 
food were provided to 60% of caloric intake. Daily food diaries were 




Citalopram: n = 19, Age: 42.0(9.0); 
Female: 95%; White: 79%; BMI: 41.4 
(6.9); Co-morbid Dx: 100% BED, 21% 
MDD, 63% Lifetime MDD. Placebo: 
n = 19; Age: 39.2(21.0); 95% female; 
% White: 95%; BMI: 34.2(7.4); Co-
morbid Dx: 100% BED, MDD: 42%, 















All groups: Duration: 6-weeks; Frequency: Daily; Format: Individual; 
Provider: Medical Centre. Binge episodes were recorded in a diary, 
along with compliance. Citalopram: 20mg/d titrated to 60mg/d as 






Combined: n = 43; Age: 43(5.3); 86% 
female; %White: NR; BMI: 31.7(3.0); 
Co-morbid Dx: NR. Exercise alone: n 
= 47; Age: 42.3(6.6); 85% female; 
%White: NR; BMI: 31.3(2.6); Co-




N; N; Y; N; N 
POMS-D; HP-group: 
23.40 (1.09); HC-
group: 23.04 (1.05). 
Diet + Exercise vs 
Exercise alone 
All groups: Duration: 24 Weeks; Provider: Exercise Physiologist 
and/or Registered Dietician; Frequency: Weekly first 12 weeks then bi-
weekly assessment without instruction. Exercise frequency: 5d/week. 
Moderate pace walking expending 300-500kcal per day. Daily physical 
activity recorded in log. Diet + Exercise group: RD counselling on 
weight loss including meal replacement of 4x meal replacement daily 
and hypocaloric meal plan based on fruit, vegetable, whole grains, low-




Overall: n = 74; Age: 38.3(7.1); 100% 
female; % White: NR BMI: 33.1(4.3); 
Co-morbid Dx: 50% BED. 
RCT; N; N 
(randomised on 
BE status); Y; NR 
BDI; Scores 











treatment for BED. 
All groups: Duration: 15 weeks. Frequency: 1 day per week, 150 
minute session; Format: Group (7-8pp). Provider: Experienced 
therapist; CBT: Psychoeducation, cognitive therapy, behavioural 
experiments, self-monitoring and problem solving, maintenance, 
relapse prevention and recovery from relapse. Behavioural treatment: 
Nutrition education, healthy eating behaviours, exercise goals and 
calorie targets of 1500-1800kcal/day, behavioural monitoring and 
stimulus control techniques. 
Pagoto 
2013 
Overall: 100% female; Co-morbid Dx: 
MDD. Behaviour Therapy + 
Lifestyle Intervention: n = 78; Age: 
45.6(11.0); % White 82.1%; BMI: 
36.0(3.2); Co-morbid Dx: Anxiety 
24%, BED: 21%, ADHD: 26%.  
Lifestyle Intervention alone : n = 83; 
Age: 46.2(10.8); % White 88.0%; 
BMI: 34.8(3.3); Co-morbid Dx: 
Anxiety 30%, BED: 17%, ADHD: 
35%. 








All groups: Duration: 6 months; Frequency: Weekly; Provider: 
Therapist or health education counsellor, dietitian and/or exercise 
physiologist. Format: Group and Individual. Common lifestyle 
intervention: Calorie goals estimated to produce a weight loss of 0.5-
1kg per week and a goal of 30 min of moderate physical activity on 5 
days per week. Behaviour Therapy + Lifestyle: Initial course of 
Behavioural Activation for depression over 10 weekly sessions and 10 
telephone calls during maintenance. Lifestyle Intervention alone: 
Added attention control of 10 individual health education sessions and 
telephone calls.  
Painot 
2001 
Overall: n = 60 (CBT: n = 35; 
CBT+N: n = 25); Age: 42(2); 
100%female; %White: 100%; BMI: 
33(1). Co-morbid Dx: BED. 
RCT; N; N; N; N BDI; Both groups: 
17(2). 
CBT (TAU) vs. 
CBT + nutritional 
approach (fat 
content) 
All groups: Duration: 12 weeks. Frequency: 1x weekly, 1.5hrs each; 
Provider: NR; Format: Group. CBT: Introduction of eating schedules, 
modifying contents of meals, modification of behaviour toward 
forbidden/avoided food. Cognitive restructuring, identifying 
psychological patterns relating to food. CBT + nutritional approach: 
As CBT group + daily food records were kept to identify triggers and 
perpetuating factors. Information (qualitative and quantitative) about 






Overall: 100% female; % White: NR; 
Co-morbid Dx: NR; Intervention: n = 
21; Age: 39.29(4.43); ; BMI: 
27.36(2.39). Control: n = 21; Age: 












All groups: Duration: 12 weeks. Self-efficacy behavioural weight 
loss: Exercise: 2x per week; Diet education session: 1x prior to 
intervention start. Phone contact 2x per week on each of the above 
elements. Phone contact involved self-efficacy based strategies 
(checking HR, consultation on effects, obstacles, positive feedback). 
Exercise included aerobic and resistance training. Provider: Master of 
Athletics Prescription and Dietician Format: Individual, group and 
phone contact. Control group: NR. 
Riva 
2003 
Overall: n = 36, Age: 33.07(8.08), 
100% female; % White: NR; BMI: 
39.80 (6.10); Co-morbid Dx: BED. 









(ECT); CBT (TAU) 
All groups: Duration: 6 weeks. Frequency: Weekly/bi-weekly, 
Provider: Chartered Clinical Psychologists or Psychotherapist; Format: 
Individual and group. ECT: 15 sessions, including individual therapy 
(skills, psycho-pharmacological assessment, virtual reality therapy) 
group therapy (assertiveness, motivation), bi-weekly nutritional groups 
and physical activities (2hrs/day) primarily aerobic in nature. CBT 
group: 15 CBT individual and group sessions focusing on 




Overall: % White: NR; Co-morbid 
Dx: NR; Intervention: n = 69; Age = 
57.7(6.5); 59% female; BMI: 30.2 
(3.4);  Control: n = 71 ; Age = 57.4 
(6.5); 56% female; BMI: 31.2 (4.7). 









All groups: Duration: 3 years; Provider: Nutrition Counsellor; Format: 
Individual (or Group; Control only). Lifestyle intervention: 30mins 
moderate exercise based on daily physical activities, endurance 
exercise and no-cost, supervised circuit-type resistance training. Diet 
counselling included 7 face-to-face sessions in the first year and one 
session every 3 months thereafter, focusing on reducing fat intake < 
30% of total calories, reducing total calories, increasing fibre intake 
15g/1000kcal. Consumption of wholegrain cereal products, vegetables, 
fruit, low-fat milk and meat products, fats rich in unsaturated fatty 
acids were encouraged. Control: Verbal and written information 
regarding benefits of exercise, weight and diet medication at one 
session per year. 
Sarsan 
2006 
Overall: n = 76 (Resistance: 26; 
Aerobic: 26; Control: 24); % Female: 
100%; % White: NR; Co-morbid Dx: 
NR. Resistance Group:  Age: 
42.50(10.07); BMI: 33.73(2.92). 
Aerobic Group: Age: 41.65(7.62);  
BMI: 35.38(4.98). Control: Age: 
43.60(6.46);  , BMI: 35.54(3.67). 








(Information only)  
All groups: Duration 12 weeks: Provider: Rehabilitation Clinic 
Format: Group. Exercise groups: Flexibility exercises before and after 
the exercise. Frequency: 3d/week. Resistance group: 6-station 
resistance circuit involving upper, lower and core muscle groups 
progressing from 40% 1RM to 80% 1RM. Rest of 15-30s between sets. 
Aerobic group: Brisk walking for 15mins and stationary cycling at 50-






Overall: 100% female; % White: NR, 
Co-morbid Dx: NR. TBT: n = 12; 
Age: 43.1(10.3); BMI: 32.45(3.62). 
BCT: n = 12; Age: 39.6(10.7); BMI: 
32.82(3.20). 










All groups: Duration: 13 weeks; Frequency: 1x per week; Provider: 
Clinical Psychologist, Format: Group. All participants received 2-week 
low fat meal plans and recipe booklets that differed only in the amount 
of food and macronutrients (60% carbohydrate, 25% fat, and 15% 
protein). Encouraged to walk 30 mins/day, 3 days/week in a single 
bout. BCT:  CBT based on a decision-making model of women's food 
choice. Meal plan for 1800kcal/day.  TBT: Traditional weight loss 





Overall: n= 22 (CBT Group: n = 13 
Waitlist Control: n = 9. ); Age 20-60, 
BMI > 30, 100% female; % White NR. 
Co-morbid Dx: BED. 





All groups: Duration: 6 weeks. CBT: Frequency: Once weekly 
(90mins per session). Format: Group; Provider: Dietician. Shortened 
Apple & Agras CBT treatment for eating disorders, with discussion of 
homework followed by new content. Control: Waitlist control NS. 
Surwit 
1997 
Overall: 100% female; Co-morbid Dx: 
NR. High Sucrose: n = 20; Age: 
40.6(8.2); % White: 60%; BMI: 
35.93(4.8). Low Sucrose: n = 22; % 
White: 55%; BMI: 34.93 (4.4). 
RCT; Y; N; N; N BDI; High Sucrose: 
9.05(10.19); Low 
Sucrose: 6.23(4.00). 
High Sucrose LCD 
vs Low Sucrose 
LCD 
All groups:  Duration: 6 weeks; Frequency: Daily; Provider: NS; 
Format: Group/Individual. Description: Low-fat, high sucrose vs low 
sucrose diet (hypoenergetic, 4606kJ/d). All meals and snacks were pre-




Overall: Age: > 19yrs; 100% female; 
% White: NR; Co-morbid Dx: NR. 
CT: n = 20; BMI: 39.4(5.2); BT: n = 
21; BMI: 38.7(5.8); Control: n = 19; 





assignment; N; N; 
N; N 
BDI; CT: 17.9(10.5); 
BT: 15.8(8.4); 
Control: 19.6(7.8). 
CT; BT; Waitlist 
Control 
Intervention Groups: Duration: 8 weeks, Frequency 2hrs/week, 
Provider: Clinical Psychology Grad Students; Format: Group. BT: 
1,200–1,500 kcal/day directly  aimed  at  weight  reduction  via  fat  
reduced  diets  and  exercise adoption; CT: eclectic cognitive treatment 
program aimed at fostering insight into maladaptive behaviours, 
enhancing emotional well-being, and promoting regular physical 
exercise and non-disordered eating in the absence of any attempt at 
weight reduction; Waitlist Control: No treatment. 
Wadden 
1985 
Overall: n = 19 (PSMF: n = 9; PLFD: 
n = 10.); Age: 38.1(NR); 89.47% 
female; % White: NR. BMI: NR; % 
Overweight: 82.3%; Co-morbid Dx: 
NR.  
RCT, N, N, N, N BDI (Mean and SE); 
PSMF: 7.6(2.6); 
Liquid diet 9.1(2.2). 
Protein Sparing 
Modified Diet 
(PSMF) vs. Protein 
Liquid Formula 
Diet (PLDF) 
All groups: Duration: 8 weeks; Frequency; Daily: Provider: 
Researcher; Format: Individual. 1st Month: 1000-1200 kcal balanced 
diet (< 30% kcal from fat). Multivitamin and mineral supplement 
provided. Diet Diary kept. PSMF: 2nd Month: Protein Sparing 
Modified Fast, daily Protein 60-75g from lean meats. No more than 
450kcal/day. PLDF: 2nd Month: Optifast Protein Formula Liquid Diet, 




Notes: Demographic variables are reported as Mean ± Standard Deviation; NR = Not Reported; NS = Not Specified; Y = Yes; N = No; Dx = Diagnosis; BED = Binge Eating Disorder; BE = Binge Eating;  MDD = Major Depressive 
Disorder; BMI = Body Mass Index; HRmax = % of Maximum Heart Rate; % 1RM = % of One Repetition of Maximum Weight;  ITT = Intention to Treat Analysis; LOCF = Last observation carried forward; TAU = Treatment as Usual; 
CBT = Cognitive Behaviour Therapy; CT = Cognitive Therapy; BT = Behaviour Therapy; PMR = Progressive Muscle Relaxation; VLCD = Very Low Calorie Diet; LCD = Low Calorie Diet; BDI = Beck Depression Inventory; BDI-II 
Beck Depression Inventory-II; HAM-D = Hamilton Rating Scale for Depression; MHQ-d = Middlesex Hospital Questionnaire depression subscale; BSI = Brief Symptom Inventory; CES-D = Centre for Epidemiological Studies 
Depression Scale; HADS-D = Hospital Anxiety and Depression Scale depression subscale; IDS-C = Inventory of Depressive Symptoms (Clinician); SCL-20 = Symptom Checklist; POMS-D = Profile of Mood States depression subscale. 
Wadden 
1990 
Overall: 100% female; % White: NR; 
Co-morbid Dx: NR. VLCD: n = 8; 
Age: 44.3(9.0); BMI: 40.7(10); 
Balanced Diet Group: n = 7;Age: 
44.69(7.0); BMI: 44.6(9.0).  





All groups: Unspecified Behaviour Therapy; Duration 18 weeks. 
Frequency: Weekly sessions of 90minutes; Provider: Doctoral level 
clinical psychologists; Group (4-7 persons). VLCD group: Very low-
calorie diet (400-500kcal/day 15% Protein, 55% Carbohydrate, 30% 
Fat during weeks 1-2 then 70% Protein, 30% Fat following and return 
to prior diet in final two weeks). Diet group: 1200kcal/day balanced 
diet (15% Protein, 55% Carbohydrate, 30% Fat) 
Werrij 
2009 
Overall: n = 200 (CT Group: n = 96, 
Exercise Group: n = 104); Age: 45 
(12); 81% female; % White: NR; BMI: 
33.4 (4.6); Co-morbid Dx: NR;  
RCT; N; N; Y; N BDI; CDT: 10.01 
(6.82); EDT: 8.94 
(7.1). 
Group dietic + CT 
(CDT); Group 
dietic + Exercise 
(EDT) 
All Groups: Duration: 10 weeks. Frequency: Weekly, 2hr each, first 
half dietary intervention followed by 2nd hour CT/exercise as 
allocation. Provider: Dietician + CBT Therapist/Physiotherapist; 
Format: Group (max 12pp). Common dietic program: Nutritional 
education, food diaries, healthy cooking classes. Regular meal timing, 
mindful eating and food habit modification. Social support seeking. 
Guidelines on a healthy diet were provided, but not prescribed. CDT: 
Cognitive therapy to identify, challenge and change dysfunctional 
cognitions concerning eating, control, weight, shape and related 
schemas. Workbook was "Pleasantly Plump". EDT: 1-hour low 
intensity exercise program at gym. 
White 
2013 
Overall: 100% female; Co-morbid Dx: 
BED (approx. 50% w lifetime mood 
disorder). Bupropion: n = 31; Age: 
45.2(12.1); % White: 90%; BMI: 
36.2(6.6); Control: n = 30; Age: 












Bupropion; Placebo All groups: Duration: 8 weeks, Frequency: Daily; Provider: Research 
pharmacist; Format: Individual. 
Bupropion: Sustained release bupropion 300mg/d. Placebo: Identical 




2.3.5. Assessment of Publication Bias 
Visual inspection of the funnel plot (Appendix B) showed some asymmetry indicating 
possible small study effects. We then examined funnel plots based on control condition 
(active vs. inactive), and evidence of asymmetry occurred only for studies in the inactive 
control condition, supported by a statistically significant Egger’s test (p < .05, two-tailed).  
2.3.6. Meta-analysis on Selected Trials 
Analysis 1: Overall Intervention vs Inactive Control 
Heterogeneity: Tau2 = 0.35; Chi2 = 45.18, df = 18, (P < .001), I2 = 60.16% 
Figure 2.2. Standard mean difference in depression scores between psychotherapy and inactive controls. 
Thirteen studies and 19 intervention arms examined treatment against inactive or 
minimally active control (n = 981). Overall there was a moderate effect size in favour of 






Analysis 2: Overall meta-analysis vs TAU 
Heterogeneity: Tau2 = 0.38; Chi2 = 41.23, df = 15, (P < 000), I2 = 63.6% 
Figure 2.3. Standard mean difference in depression scores between psychotherapy and treatment as usual. 
Fifteen studies and 16 intervention arms investigated treatment against treatment as 
usual (n = 855). Overall there was no effect of treatment (d = -0.13; 95% CI = - 0.37 to 0.11). 
Analysis 3: Pharmacotherapy interventions 
 
Heterogeneity: Tau2 = 0.13; Chi2 = 5.94, df = 5, (P = .31), I2 = 15.75% 
Figure 2.4. Standard mean difference in depression scores between drug and placebo. 
Six studies (n = 266) examined the effectiveness of discrete pharmacological 




et al., 2005; Guerdjikova et al., 2012; McElroy et al., 2003; White & Grilo, 2013). Active 
medication included sibutramine hydrochloride (Appolinario et al., 2003), fluoxetine (Arnold 
et al., 2002; Devlin et al., 2005), duloxetine (Guerdjikova et al., 2012), citalopram (McElroy 
et al., 2003) or bupropion (White & Grilo, 2013). These studies varied from six to 20 weeks 
duration. All were individual format, with medication administered by a psychiatrist or 
pharmacist. All but one were conducted on mixed gender samples (White & Grilo, 2013) 
with co-morbid diagnosis of BED. All studies recorded prevalence of lifetime depressive 
disorders yet only one study (Guerdjikova et al., 2012) was conducted on participants with 
current Major Depression. Three studies were conducted in populations with elevated scores 
of depression at baseline (Appolinario et al., 2003; Devlin et al., 2005; Guerdjikova et al., 
2012). We found a moderate effect in favour of pharmacotherapy, d = – 0.41, (95% CI = – 
0.68 to – 0.14, p < .05).  
Analysis 4: Psychotherapy vs Inactive control 
Heterogeneity: Tau2 = 0.22; Chi2 = 12.15, df = 8, (P = .15), I2 = 34.13% 
Figure 2.5. Standard mean difference in depression scores between psychotherapy and inactive controls. 
Six studies (n = 368) examined the effectiveness of evidence-based psychotherapy 
against inactive controls (Bennett, 1986; Devlin et al., 2005; Gorin et al., 2003; Kristeller, 




Earle, 1998). In total, 9 intervention arms were available for analysis. All trials utilised 
cognitive behaviour therapy or in the case of Kristeller et al., mindfulness-based therapy. 
Three of these were RCTs involving evidenced based cognitive behaviour therapy for BED 
(Gorin et al.; Kristeller et al.; Shelley-Ummenhofer & MacMillan). These studies utilised 
brief interventions of six to 16 weeks, usually 90 – 120 minutes duration of group therapy 
with faded contact, administered by a Psychologist, Clinical Psychology, Doctoral 
Psychology students or a Dietician. Whilst no study was focused on populations with clinical 
depression per se, all cohorts had elevated severity of depression at baseline on their 
respective measures. Collectively, there was a moderate effect size in favour of 
psychotherapy, d = – 0.45 (95% CI = – 0.69 to – 0.19, p = .001).  
Analysis 5: Psychotherapy vs Treatment as usual
Heterogeneity: Tau2 = 0.36; Chi2 = 14.52, df = 5, (P < .05), I2 = 65.57% 
Figure 2.6. Standard mean difference in depression scores between psychotherapy and treatment as usual. 
Five studies examined evidenced based psychotherapy versus treatment as usual (n = 
427; Fossati et al., 2004; Nauta, Hospers, Kok, & Jansen, 2000; Painot, Jotterand, Kammer, 
Fossati, & Golay, 2001; Sbrocco, 1999; Werrij et al., 2009). A total of 6 intervention arms 
were available for analysis. Intervention duration ranged from 10 to 15 weeks of weekly 
group sessions, usually of 120 to 150 mins duration. Interventions were delivered by 




report intervention provider (Fossati et al., Painot et al.) Each intervention included some 
form of dietary modification. One study was a randomised control trial for treatment of BED 
(Nauta, 2000). The interventions by Fossati et al. (2004) included dietary advice and physical 
activity alongside dietary advice respectively in parallel to CBT and appear to be the most 
effective interventions compared to control (CBT alone) within this subgroup. The population 
investigated by Fossati et al. was the only sample with elevated symptoms of baseline 
depression in this analysis. Treatment as usual were evidenced based forms of cognitive and 
behaviour therapies or, in the case of Werrij et al., exercise and dietary advice alone. Overall, 
there was no difference between psychotherapy treatments and treatments as usual, d = 0.11 
(95% CI = – 0.26 to 0.48, p = .563).  
Analysis 6: Lifestyle vs Treatment as usual 
Heterogeneity: Tau2 = 0.63; Chi2 = 14.53, df = 3, (P < .05), I2 = 79.35% 
Figure 2.7. Standard mean difference in depression scores between Lifestyle interventions and treatment as 
usual. 
Four studies (Bacon et al., 2002; Carels, Darby, Cacciapaglia, & Douglass, 2004; 
Dennis et al., 1999; Park & An, 2006) were available to examine standalone lifestyle 
interventions against control (n = 169). Two studies were conducted on participants with 
elevated symptoms of depression at baseline (Dennis et al., 1999; Park & An, 2006). All 




et al.) or exercise programs (Dennis et al.). Park & An, (2006) did not specify the control 
condition. Lifestyle programs ran from 12 to 24 weeks, consisting of group sessions of 60 to 
90 minutes duration. All were provided by trained personnel. There was no treatment effect 
between lifestyle treatment and treatments as usual, d = - 0.40, (95% CI = - 1.08 to 0.26, p = 
.261). 
Analysis 7:  Exercise or diet vs control  
Heterogeneity: Tau2 = 0.463; Chi2 = 26.67, df = 7, (P < .001), I2 = 73.75% 
Figure 2.8. Standard mean difference in depression scores between exercise or diet and treatment as usual or 
inactive control (Sarsan, 2006). Note: (e) represents exercise intervention, (d) represents dietic intervention. 
Six studies and seven intervention arms were available to examine exercise (Bowen et 
al., 2006; Sarsan, Ardiç, Ozgen, Topuz, & Sermez, 2006) or dietary interventions (Lutze et 
al., 2013; Surwit et al., 1997; Wadden, Mason, Foster, Stunkard, & Prange, 1990; Wadden, 
Stunkard, Brownell, & Day, 1985) against control (n = 446). Dietary interventions focused on 
calorie restriction, using various forms of either low calorie or very low-calorie diets. 
Exercise intervention arms included aerobic (Sarsan, 2006a; Bowen, 2006) and resistance 
training (Sarsan, 2006). Bowen et al., (2006) compared exercise to weekly group stretching 
classes as control. Sarsan et al., compared aerobic or resistance training to an inactive 
information only control. All dietary interventions compared to alternative macronutrient 




500 kcal/day). Two studies were conducted over 12-months (Bowen et al.; Lutze et al.) whilst 
the remainder were of 6 to 18 weeks duration. Three studies included populations with 
elevated symptoms of depression (Lutze et al., 2013; Sarsan et al., 2006; Wadden et al., 
1990). There was a no treatment effect between exercise or diet and control treatments, d = - 
0.35, (95% CI = - 0.77 to 0.10, p = .124).  
2.3.7. Studies Not Included in Meta-analysis 
We were unable to include seven studies in the meta-analysis due to insufficient data 
following author contact (Annesi & Gorjala, 2010; Esmaily et al., 2015; Ghroubi et al., 2016; 
Kiernan, King, Stefanick, & Killen, 2001; Linde et al., 2011; Pagoto et al., 2013; Riva, 
Bacchetta, Cesa, Conti, & Molinari, 2003; Ruusunen et al., 2012). We discuss them here as 
they remain a rich source of information regarding suitable interventions for clinical 
depression in overweight or obese populations.  
Two studies examined the effect of evidence-based psychotherapy for clinical 
depression. Linde et al. (2011) randomly assigned overweight women with comorbid clinical 
depression (Major Depressive Disorder; MDD) to group therapy of either standard 
behavioural weight loss or a tailored weight loss and depression intervention. The tailored 
intervention consisted of CBT based on the Coping with Depression manual. Both 
interventions led to a significant reduction in moderate to severe depressive scores on the 
SCL-20, however no between group differences were found at post-treatment or follow-up.  
More recently, Pagoto et al. (2013) randomly assigned overweight adults with a diagnosis of 
clinical depression (MDD) to 10 weeks of behavioural activation followed by lifestyle 
intervention (BA) for the remainder of 6-months or lifestyle intervention alone with attention 
control over 6 months. Whilst weight loss was similar between groups, the condition 
including BA led to significantly greater reductions in depression at post treatment and 6-




post-treatment and follow-up compared to individuals experiencing lifestyle intervention 
alone.   
A further two studies examined the effect of lifestyle interventions. Annesi and 
Gorjala (2010) found the Coach Approach (regular exercise, nutrition and one-on-one support 
over 6 months) reduced depressive symptoms significantly more than exercise alone or 
information alone. In a large-scale 36-month, Finnish diabetes prevention study, Ruusunen et 
al. (2012) found overall reductions in relatively normal baseline depressive symptomatology 
and no group difference between standard lifestyle intervention and an information only 
control. One study examined a cognitive behavioural weight-loss program. In that study, Riva 
et al. (2003) compared standard CBT with exercise and nutritional therapy for BED in 
overweight adults to an enhanced nutritional and exercise program using Experiential 
Cognitive Therapy (ECT) that utilised 10 bi-weekly virtual reality sessions aiming to follow 
an exposure and response prevention protocol. Riva et al. suggested a greater reduction of 
BDI-II scores in the ECT group compared to the CBT group post-treatment (11-weeks). Both 
groups reduced symptom scores significantly. Ghroubi et al. (2016) examined the effect of 
adding isokinetic resistance training to aerobic exercise and calorie restriction – by up to 35% 
or baseline calories - over 8 weeks. The authors found both groups responded similarly on the 
Hamilton Rating Scale of Depression (HAM-D), reducing depression symptoms over time. 
Finally, one study investigated an alternative nutritional intervention. Esmaily et al. (2015) 
conducted a double-blind randomised, placebo control, cross-over trial providing 
Curcuminoids or placebo capsule over 30 days with a 2-week washout between treatments 
(curcumin-placebo vs placebo-curcumin). No significant effect of Curcumin on symptoms of 







To the best of our knowledge, this is the first systematic review to investigate 
treatments for symptoms of depression in OW/OB adults. We aimed to identify which 
treatments are superior to alternative treatments or control conditions in this population and 
to better understand which treatment features were associated with better outcomes for 
depression.  
Overall, treatment was statically superior to inactive or minimally active control. 
Pharmacotherapy and evidence-based psychotherapy especially were statistically superior to 
inactive control. In this regard, fluoxetine, sibutramine hydrochloride (now discontinued) and 
various forms of cognitive and behaviour therapy including those incorporating mindfulness-
based therapy were associated with improvements in depression. This suggests that clinicians 
can consider these existing psychotherapy or pharmacotherapy treatments for depression 
when targeting depression in OW/OB adults. 
Compared to treatment as usual, overall and within sub-group analysis, there were 
only marginal differences between modified treatments and treatment as usual, however 
Fossati et al. (2004) illustrated traditional CBT could be enhanced with nutritional advice and 
regular physical exercise. Whilst there was large methodological variability between studies 
(i.e. treatment type, adjunctive treatments, duration, sample size, severity of initial depressive 
symptomatology), these results suggest that existing treatments, specifically pharmacotherapy 
or cognitive and behavioural therapies are useful in treating symptoms of depression in 
OW/OB adults compared to no treatment or minimal intervention. This helps establish 
evidence in favour of current treatments as effective for treating symptoms of depression in 
this population. Studies that appeared to have the larger effect on symptoms of depression 
were conducted in populations with elevated symptoms at baseline (e.g. Appolinario et al., 




et al., 2006; Tanco et al., 1998). Nevertheless, given that few studies in our sample examined 
clinically depressed samples and only one of these contributed to meta-analysis, there should 
be caution in generalising results to clinical depression. 
Only three studies were conducted on overweight or obese populations with a current 
diagnosis of MDD (Guerdjikova et al., 2012; Linde et al., 2011; Pagoto et al., 2013). Three 
further studies had samples with substantial numbers of participants with MDD (Arnold et 
al., 2002; McElroy et al., 2003; White & Grilo, 2013). Fluoxetine was superior to placebo 
(Arnold et al.). Evidence-based psychotherapy, either CBT or BA were as effective or 
superior to standard weight loss or lifestyle interventions alone (Linde et al., 2011; Pagoto et 
al., 2013). There were some common treatment components in these studies. For example, 
Linde et al., pointed out that both interventions in their trial (behavioural weight loss vs. 
CBT) included substantial components of behavioural activation, problem solving skills, 
cognitive restructuring and social support. Pagoto et al. effectively utilised a behavioural 
activation approach to treating depression. Therefore, clinicians might find these components 
are worthwhile inclusions in effective interventions. It may also be important for clinicians to 
sequence depression treatment prior to weight loss interventions where weight loss or eating 
behaviour change is a focus of therapy (Pagoto et al.). Indeed, Pagoto et al. found that 
participants who remitted from depression also experienced greater weight loss than those 
who continued to meet criteria for depression post-treatment. Nevertheless, the lifestyle 
intervention also produced reasonable remission rates (approx. 60-70% in BA vs 40-50% 
Lifestyle alone) suggesting it is a useful component in treatment. Furthermore, there is some 
evidence that lifestyle interventions are superior to exercise alone or information only control 
conditions (Annesi & Gorjala, 2010) but as our meta-analysis revealed, general attempts to 
enhance existing lifestyle interventions (e.g. with non-dieting approaches, self-control or self-
efficacy skills) have proven challenging. This is in part because lifestyle interventions - as 




Ferreira, Sharma, Sadeghirad, & Kolahdooz, 2016). Generalisations regarding clinical 
depression are problematic for many of the included studies examining lifestyle interventions, 
which were conducted with individuals experiencing normal or mild depressive 
symptomatology.  
 Only two studies investigated exercise alone (Bowen et al., 2006; Sarsan et al., 2006). 
This is surprising given the evidence supporting the use of exercise as a treatment for mild to 
moderate depression – either alone or as an adjunct to pharmacotherapy/psychotherapy and 
the benefits of physical activity for OW/OB populations (Cooney et al., 2013; Deslandes et 
al., 2009; Krogh, Nordentoft, Sterne, & Lawlor, 2011; Silveira et al., 2013). Data from our 
review indicates that aerobic or resistance exercise may be most useful when added to 
nutritional and/or cognitive-behavioural approaches to treatment (Fossati et al., 2004; 
Melanson, Dell'Olio, Carpenter, & Angelopoulos, 2004). Our findings are similar to two 
recent meta-analytic reviews which found that aerobic and resistance exercise are effective in 
treating depression in the general population (Krogh et al., 2011; Silveira et al., 2013). The 
pooled SMD calculated from these studies was -0.40 (95% CI: -0.66 to – 0.14) to -0.61 (95% 
Ci: -0.88 to – 0.33) respectively, in favour of exercise. However, the beneficial effect on 
mood appears to persist only as long as one engages in regular exercise (Krogh et al., 2011). 
At the very least, exercise seems to be superior to information only controls in the treatment 
of mild symptoms of depression (Sarsan et al., 2006) in overweight adults. One reason for the 
dearth of data on exercise studies in the present review is likely that investigations into the 
effect of exercise on depression do not typically recruit populations with co-morbid OW/OB, 
and such individuals may be less likely to engage in a study that includes exercise as a central 
component regardless of whether they are a population of interest or not. Future studies could 
aid research into this population by reporting psychological findings stratified by BMI, 
recruiting specifically from populations that are also OW/OB and investigating participant 




adherence for adults with clinical depression and OW/OB. Exercise interventions in OW/OB 
adults with clinical depression warrant further research, especially investigations seeking to 
increase engagement in exercise, examining exercise type, or exercise as an adjunct to 
pharmacotherapy and/or psychotherapy.  
All dietary interventions considered in our study were low or very low-calorie 
interventions either in isolation or combined with exercise. Results were mixed. Very low 
calorie diets may be superior to balanced low calorie diets when combined with behaviour 
therapy (Wadden et al., 1990), however conferred no further advantage when paired to 
cognitive therapy relative to pairing with exercise (Painot et al., 2001). Very low calorie diets 
might lead to problems with adherence in this population (e.g. Cook et al., 1981). One study 
showed adding exercise to dietary interventions did not seem to enhance outcomes of dietary 
intervention alone (Kiernan et al., 2001) whilst adding diet to an exercise intervention had a 
superior effect on depressive symptoms compared to exercise alone in one study (Melanson 
et al., 2004). Generalisations in this case would be unreasonable given the methodological 
variability and limited number of studies available for consideration. We can only conclude, 
as Cezaretto et al. (2015), recently did, that the impact of specific changes in dietary habits on 
depression in OW/OB populations remains unclear. 
 These findings build on previous guidelines (e.g. NICE, 2009) and meta-analytic 
reviews which indicate that exercise (Silveira et al., 2013), lifestyle interventions (Cezaretto 
et al., 2016), psychotherapy and pharmacotherapy (Pampallona, Bollini, Tibaldi, Kupelnick, 
& Munizza, 2004) are effective interventions for symptoms of depression. Specifically, our 
research suggests that psychotherapy (CBT, BA, mindfulness-based therapy), 
pharmacotherapy (fluoxetine, duloxetine), exercise (aerobic or resistance) and lifestyle or 
behavioural weight loss interventions could be useful treatments for depression in 




goals (e.g. to improve mood, reduce disordered eating, reduce weight etc.) in mind alongside 
the underlying factors contributing to depression in each case. 
2.4.1. Limitations of the Current Study 
The current study has some limitations. Very few studies documented the prevalence 
of current or historical major depression in their samples and even fewer sought to include 
populations with current clinical depression. Indeed, most studies were conducted on 
populations with relatively normal or mild depressive features or in which depression was an 
outcome of secondary interest. Although those samples that did have elevated severity of 
depression at baseline also appeared to have the largest change relative to control conditions, 
given the lack of clinically depressed individuals across studies, caution should be used when 
interpreting our pooled outcome data.  
We chose to exclude studies that removed participants if they had clinical depression 
or elevated symptoms of depression. This criterion led to the removal of several studies that 
may have shed more light on our primary research question, although at the cost of 
applicability. We did however include a large number of studies (n = 13) that included 
populations with BED. This enhances the ecological validity of our findings as disordered 
eating, clinical depression and OW/OB frequently co-occur (Appelhans et al., 2012; 
Faulconbridge & Bechtel, 2014). We also excluded studies that did not utilise a control 
condition. There are likely to be many studies, particularly in emerging fields of 
interventional research that used alternative designs. However, excluding studies without a 
control condition likely improved the quality of the data and ensured we could make some 
conclusions about relative superiority across studies. The majority of studies were conducted 
on female or mostly female (> 75% of n) populations precluding confident generalisation of 
the findings above to males. Furthermore, heterogeneity in intervention (type, duration, 




This makes it difficult to determine from pooled outcome data the precise mechanisms 
contributing to most favourable outcomes and suggests researchers are searching for the most 
optimal interventions to apply for this population. Until a greater body of research exists 
behind each variation of intervention, precise treatment guidelines are difficult prescribe. 
2.4.2. Conclusion 
There is a well-established body of research addressing pharmacotherapy, 
psychotherapy, lifestyle modification and exercise for depression in the general population. 
However, recommendations regarding treatment of depression in OW/OB adults have not 
been widely identified. In this review, we found that existing treatments for depression, 
including behavioural activation, cognitive behaviour therapy, pharmacotherapy, lifestyle and 
behavioural weight loss interventions, and exercise are commendable to clinicians seeking to 
treat depression in an OW/OB population. Mindfulness based cognitive therapy warrants 
further research. Compared to inactive control or placebo, pharmacotherapy or psychotherapy 
were effective at reducing symptoms of depression. In contrast, no class of modified 
intervention was superior to active treatment-as-usual, primarily due to modified and active 
TAU being effective for reducing symptoms of depression. Dietary and exercise interventions 
for clinical depression in adults who have OW/OB remain under-researched. Future research 
should seek to clarify which types of exercise or dietary protocols may be most effective for 
reducing symptoms of clinical depression in adults with OW/OB. Finally, with regard to 
reporting of research, randomisation procedures and outcome data (i.e. mean and variance) 
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Chapter 3 – Study Two  
Effects of High Intensity Intermittent, Steady State and Personal Preference Exercise 
on Clinical Depression in Adults with Overweight or Obesity: A Randomised 
Controlled Clinical Trial. 
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Effects of High Intensity Intermittent, Steady State and Personal Preference 
Exercise on Clinical Depression in Adults with Overweight or Obesity: A 
Randomised Controlled Clinical Trial. 
3.1. Introduction 
Clinical depression and overweight/obesity (OW/OB) are considered common 
conditions in modern Western society (Bromet et al., 2011; Ng et al., 2014). Depression has a 
12-month prevalence of approximately 5.4 per cent (Australian Bureau of Statistics; ABS, 
2008) and 63 per cent of Australians are overweight or obese (ABS, 2015). It is not 
surprising then to find that depression and OW/OB frequently co-occur (Werrij, Mulkens, 
Hospers, & Jansen, 2006). Indeed, within Australia, Carey et al. (2014) found that the 
prevalence of depression among normal-weight primary care patients was 12% (95% CI = 
8.5 to 14.0) yet depression among obese patients increased to 23% (95% CI = 17.8 to 29.0). 
Research also shows that the presence of one condition greatly increases risk for developing 
the other (Simon et al., 2008). Overweight particularly increases risk for somatic symptoms 
of depression (e.g. lack of energy, sleep disturbance) and suicidal ideation (Carpenter, Hasin, 
Allison, & Faith, 2000; Wiltink et al., 2013). Despite this co-occurrence, few programs 
currently exist to treat co-morbid depression and overweight/obesity.  
Research has indicated that exercise—planned, structured and repetitive bodily 
movement with the purpose of improving or maintaining one or more components of physical 
fitness (Caspersen, Powell, & Christenson, 1985)—is a useful adjunctive approach to weight 
loss (Shaw, Gennat, O'Rourke, & Del Mar, 2006) and that standard cognitive behaviour 
therapy (CBT) for mood and anxiety concerns can be enhanced when a general “physical 
activity” program is included in therapy (Faulconbridge, Wadden, Berkowitz, Pulcini, & 
Treadwell, 2011; Gary, Dunbar, Higgins, Musselman, & Smith, 2010). This is especially so 
when structured exercise is applied in treatment (Cooney et al., 2013). Systematic reviews 
indicate that exercise can be as effective as psychotherapy or pharmacotherapy in treating 
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adults with clinical depression (Cooney et al., 2013), and further research has shown it 
reduces depression in SSRI resistant populations (Trivedi et al., 2011), allows for a reduction 
in anti-depressant medication and reduces relapse for depressed patients (Deslandes et al., 
2009). Furthermore, treatment guidelines recommend exercise as a treatment or adjunctive 
treatment for mild to moderate depression in the general population (e.g. NICE, 2009, SIGN, 
2010).  
Despite such promising findings, only 40 per cent of mental health care practitioners 
recommended physical activity to their clients (Phongsavan, Merom, Bauman, & Wagner, 
2007), substantially less than prior reports, which indicated 83 to 93 per cent of psychologists 
had recommended physical activity to clients (Barrow, English, & Pinkerton, 1987; Burks & 
Keeley, 1989). In a primary health care context, Australian General Practitioners provide 
advice about exercise to approx. 18 per cent of patients (Short et al., 2016). Furthermore, 
fewer than 25 per cent of primary health care patients receive information about the type of 
exercise to engage in (Short et al., 2016). Together, these findings suggests that medical and 
mental health clinicians might have sub-optimal understanding of how to construct and 
implement evidenced-based exercise programs for mental health concerns and that this 
limitation may influence their decision not to consider exercise as a component of evidence-
based practice (Phongsavan et al., 2007; Ranjbar et al., 2015). Previous intervention studies 
on depression in adults with OW/OB have followed general treatment approaches, 
incorporating increases in physical activity alongside evidence-based psychotherapy and/or 
lifestyle modification (Faulconbridge et al., 2011; Linde et al., 2011; Pagoto et al., 2013). 
These treatments achieve significant weight loss and reductions in depressive symptoms. A 
relative shortcoming regarding these and similar interventions has been the limited research 
regarding feasibility, suitability and efficacy of the physical activity/exercise components 
employed as treatment for depression in adults with OW/OB with clinical depression. This is 
especially important since individuals with co-morbid depression and OW/OB may face 
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particular risks to health and well-being (Markowitz et al., 2008) and are likely to experience 
unique challenges not confronted by normal weight peers. It is well established that 
depression often reduces general activity, motivation and engagement (Barlow, 2014; Beck, 
1991; Carr & McNulty, 2006) and can be exacerbated by chronic health conditions associated 
with OW/OB (Norberg & Danielsson, 2012). Furthermore, individuals with clinical 
depression and OW/OB are less likely than normal weight peers to receive treatment for 
depression, often engage in treatment for less time (Boudreau et al., 2013), confront 
substandard treatment experience due to weight related stigma and benefit to a lower degree 
in terms of treatment outcome (Fruh et al., 2016; Puhl & Heuer, 2010) and health behaviour 
change (Pagoto et al., 2007). It is therefore important that clinicians are able to make well-
informed decisions regarding the use of exercise for treatment of depression in adults with 
co-morbid OW/OB and that we understand how this population responds to such exercise and 
physical activity in treatment.   
Current research indicates important exercise variables in treatment of depression for the 
general population include type (aerobic, resistance or combined), intensity (above 65-75% VO2max), 
volume (around 1000Cal per week), frequency (3-5 sessions per week), and compliance (Chu, 
Buckworth, Kirby, & Emery, 2009; Dunn, Trivedi, Kampert, Clark, & Chambliss, 2005; Krogh, 
2009; Rethorst, Wipfli, & Landers, 2009; Singh et al., 2005; Trivedi et al., 2011). Supervision and 
individual tailoring of interventions may also be important, although findings have been mixed 
(Ranjbar et al., 2015; Silveira et al., 2013). A recent meta-analysis confirms the above (Silveira et al., 
2013). An element of personal preference (e.g. client selection of exercise type, intensity) may also 
be relevant, however such research is in its infancy (Busch, Ciccolo, Puspitasari, & Nosrat, 2015). 
Given this, two formats of exercise in particular – High Intensity Intermittent Exercise (HIIE) and 
personally selected interventions warrant further investigation. High Intensity Intermittent Exercise 
consists of brief repeated bouts of intense exertion (e.g. 30 seconds of cycling at 100% VO2peak 
power output) followed by recovery bouts (e.g. 2 minutes of cycling at 50% VO2peak power output) 
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repeated in alternating fashion throughout the session. High intensity exercise especially has gained 
recent popularity in the community, in part thanks to wide media coverage (e.g. Mosley, 2013) but is 
not without criticism. For example, Biddle and Batterham (2015) argued high intensity exercise 
could not be an effective public health intervention due to the psychologically aversive nature of 
intense exercise. Indeed, to date, no studies have examined high intensity aerobic exercise above 
90% of aerobic capacity (VO2peak) as a treatment for depression. Similarly, few studies have 
examined personal selection of exercise format or type, yet exercise interventions with an element of 
personal preference may improve symptoms of depression over and above interventions which are 
prescribed in their entirety (Doose et al., 2015). This warrants further investigation. 
In Chapter 1, we outlined in detail the potential moderators and mediators between obesity 
and depression. A leading hypothesis regarding moderators of the obesity-depression relationship 
has been the idea of HPA axis dysregulation (Lopresti, Hood, & Drummond, 2013). The typical 
presentation is one of increased corticotropin-releasing hormone (CRH), hypersecretion of cortisol, 
impaired responsiveness to glucocorticoids and insulin resistance. Notably, it has been suggested that 
these changes are a consequence of two factors. The first is altered secretory dynamics of 
corticotropin (ACTH) and hyper-responsiveness of the HPA axis - especially during chronic or 
acutely stressful events. The second seems to be the functional hypercortisolism, possibly due to 
increased liver, abdominal or visceral adipose tissue (Pasquali & Vicennati, 2000). Regular, 
moderate intensity exercise has been shown to be protective against future HPA axis dysfunction and 
may be useful in remediating such dysfunction in certain populations (Aslam, Imanullah, Asim, & 
El-Menyar, 2013; Tsatsoulis & Fountoulakis, 2006). 
Early studies found no or mixed relationships between body fat and depression. For example, 
Annesi (2004) found no association between body fat and change in depression score in older, 
overweight women enrolled in a 10 week weight-loss program. Nevertheless, a number of studies 
have found abdominal fat (also called ‘central fat’) appears to mediate an obesity-depression 
relationship, more so than BMI and even after controlling for lifestyle factors (Rivenes, Harvey, & 
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Mykletun, 2009; Zhao et al., 2011). Wyshak (2011) illustrated that independent of weight status, 
greater body fat was associated with depression (OR = 2.22, 95% CI: 1.39 to 3.54) although in this 
study, body fat was estimated by demographic parameters rather than direct measurement. Visceral 
but not subcutaneous fat and Beck Depression Inventory scores are correlated (r = 0.45; Ludescher et 
al., 2008). Indeed, visceral fat is three times higher in individuals with clinical depression relative to 
non-depressed controls and is associated with impaired insulin sensitivity and dysregulation of 
glucocorticoids (Greggersen et al., 2011). More recently, Yamamoto et al. (2016) found elevated 
depression scores and impaired fasting insulin levels in men with higher levels of visceral fat mass 
but not subcutaneous fat. This suggests that visceral fat especially contributes to the obesity-
depression pathway, via dysregulation of the HPA-axis and impairments to insulin sensitivity. 
It is well documented that even light exercise can modify visceral fat mass in overweight 
individuals. Systematic reviews indicate that aerobic exercise is particularly effective and may be 
superior to resistance training for altering visceral fat mass and body composition (Ismail, Keating, 
Baker, & Johnson, 2012; Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007). Higher 
intensity and greater volumes of exercise enhance visceral fat loss (Irving et al., 2008; Ohkawara et 
al., 2007). Specifically, a minimum of 10 METS/week or approximately 150mins/week of moderate 
intensity exercise has been found adequate to reduce visceral fat mass (Ismail et al., 2012).  Higher 
intensity appears especially important for resistance training, where high intensity is superior to 
lower intensities (Dutheil et al., 2013). Recent commentators have asserted that whilst the 
physiological benefits of high intensity exercise are fairly clear, it is not a feasible intervention for 
the general population due to its physically uncomfortable and psychologically aversive nature 
(Biddle & Batterham, 2015). Given that HIIE holds promise regarding some of the aetiological 
factors of co-morbid depression and OW/OB, research should confirm whether it is an effective and 
suitable exercise for this population and determine the most suitable formats before clinical 
recommendations are made. 
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Whilst much is known about exercise for depression in the general population (Cooney et al., 
2013), very little is understood about the efficacy of exercise programs in adults with depression and 
comorbid OW/OB. The aim of the present study is to understand which formats, types and intensities 
of exercise may be effective at reducing clinical depression in adults with OW/OB. We also sought 
to determine the suitability of high intensity exercise above 90% VO2peak as a treatment for clinical 
depression and in particular, for adults with co-morbid OW/OB. Finally, we aim to explore how such 
interventions affect potential mediators of the obesity-depression relationship, including body 
composition, body fat and visceral fat mass in this population. These are important foundational 
stones within the field, informing development of evidenced based exercise interventions that can be 
integrated into a cognitive-behavioral treatment program for depression in individuals with co-
morbid OW/OB.  
We employed a 3 (condition: moderate intensity steady state, vs moderate intensity personal 
preference vs high intensity intermittent exercise) x 3 (time: pre, mid, post) design. We chose an 
active control intervention (Moderate Intensity Steady State; MISS) which represents a basic 
exercise recommendation to an individual with comorbid overweight and depression from a General 
Practitioner (e.g. Short et al., 2016). Such an active control is likely to improve depressive symptoms 
to a reasonable degree.  
3.1.1.  Hypothesis 
Given that higher intensity exercise may have a greater effect on symptoms of depression in 
normal weight adults (Chu et al., 2009; Singh, 2005), we expect that individuals engaging in High 
Intensity Intermittent Exercise (HIIE) will experience a greater reduction in depressive symptoms 
than individuals engaged in the active control condition. Similarly, because Doose et al. (2015) 
indicated that personal preference is an important aspect of treating depression with exercise, we 
hypothesise that participants in the Moderate Intensity Personal Preference (MIPP) condition will 
experience a greater reduction in depression than active control (MISS).  It is well documented that 
depression’ has a high comorbidity with anxiety and stress. Correspondingly, it is understood that 
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anxiety and stress abate with exercise interventions (Salmon, 2001). As such, we expect all 
conditions to improve on measures of anxiety and stress. Since the duration of the intervention 
program is brief and due to the lack of a nutritional component including calorie restriction or dietary 
advice, we expect only small reductions in BMI, body weight or fat mass. We expect significant 
improvements in aerobic capacity across all conditions. 
3.2. Method 
3.2.1. Recruitment 
Individuals from the metropolitan community of Perth, Western Australia were 
recruited via community notices posted at local shopping centre and town tall notice boards, 
cafés, Universities and third parties including General Practitioners and Psychologists. 
Recruitment methods included posters, flyers, a newspaper advertisement and social media 
advertising from February 2014 to February 2016. The study protocol was approved by 
Murdoch University Research Ethics and Integrity Office (Project No. 2013/204) and was 
registered with the Australian and New Zealand Clinical Trials Registry (ACTRN: 
12614000097640). 
3.2.2. Inclusion and Exclusion Criteria  
Enrolment was open to men and women aged 18- 45 years, who were experiencing a current 
episode of depression according to Structured Clinical Interview. Participants had to be willing to 
delay new therapy for the duration of participation1, had a BMI greater than 25 and understood 
written and spoken English. Anti-depressant use was permitted provided unchanged dose 3 weeks 
prior to participation and throughout the intervention. Exclusion criteria included regular 
psychotherapy, previous cardiovascular incident or cardiovascular disease, intellectual impairment, 
serious or unstable medical conditions, substance dependence requiring rehabilitation, personality 
disorder, current or historical mania, hypomania or anorexia nervosa, current or recent bulimia 
                                                        
1To ensure participants received appropriate treatment, they were informed that professional evidence-based 
treatment for any psychological issue could be commenced at any time. In such cases the participant’s data 
would be excluded from analysis. 
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nervosa, current suicidal ideation, self-harm of a clinically significant nature or a suicide attempt in 
the prior 2 years. Women who were pregnant or attempting to become pregnant were also excluded 
from participation.  
3.2.3. Randomisation Protocol 
A random series was generated using an online random number generator 
(www.random.org). After collection of baseline measures, each participant was assigned to a 
condition via sealed envelope drawn in sequence. 
3.2.4. Initial Screening and Semi-Structured Clinical Interview 
Applicants were provided with an information letter regarding the study and participation 
(Appendix C). Phone screening was conducted by a member of the research team who was 
completing postgraduate training in Clinical Psychology. Individuals who did not meet obvious 
exclusion criteria were invited to provide informed consent and undergo a thorough screening via the 
Research Version of the Structured Clinical Interview for DSM-IV (SCID-I/NP). During this intake, 
individuals also completed Stage 1 of the Exercise and Sports Science Australia Adult Pre-Exercise 
Screening System (ESSA APSS, Appendix D), the Beck Depression Inventory-II (BDI-II), 
Depression, Anxiety and Stress Scale (DASS-21) and had their height and weight measured. 
Individuals who endorsed exercise risk items on the ESSA APSS were required to provide a written 
statement from their doctor or specialist reporting them safe to exercise and in particular, engage in 
supervised maximal exertion required by the VO2peak assessments. Demographic data (see Appendix 
E) were also collected. Eligible persons were invited to take part in the study. Those who met 
exclusion criteria at any stage or who withdrew from the study were debriefed and provided with 
information regarding relevant psychological services.  
3.2.5. Participants 
 A total of 41 adults were invited to take part in the study. Four participants withdrew 
due to scheduling difficulties prior to the first week of the program and one withdrew prior to 
commencing their first week due to a decline in their clinical condition, which warranted direct 
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psychological treatment. As a result, 36 participants completed the program and were included in the 
analysis. Demographic data and baseline characteristics are shown in Table 3.1, below.  
3.2.6. Materials 
3.2.6.1. Primary Clinical Outcome Scales 
Primary outcome measures were assessed at baseline and post intervention. 
Depression. Severity of depression was measured via the Beck Depression Inventory (BDI-
II; Beck, Steer, and Brown (1996), see Appendix F). The BDI-II is a 21-item self-report 
questionnaire with excellent validity (Wang & Gorenstein, 2013) and reliability (e.g. Cronbach’s a = 
.93; Beck et al., 1996). Scores range from zero to 63, with scores below 13 indicating lower than 
mild depression, above 13 suggesting mild depression, with moderate (20-28) and severe (29 and 
above) depression represented by higher scores. BDI-II scores correlate strongly to SCID-I 
endorsement of items corresponding to Major Depressive Episode with scores above 16 having high 
sensitivity (84%) to clinical depression (Sprinkle, Sprinkle, Lurie, Insko, & Atkinson, 2002). 
Depression, Anxiety and Stress. The short form Depression, Anxiety and Stress Scale 
(DASS-21; Lovibond & Lovibond, 1995) is a 21 item self-report questionnaire measuring 
depression, anxiety and stress symptoms over the previous week. Reliability of the DASS-21 is high 
in clinical and community samples (Cronbach’s a .87-.91) with adequate subscale convergent and 
discriminant validity to validated measures of depression and anxiety and an excellent three factor 
structure  (Antony, Bieling, Cox, Enns, & Swinson, 1998). Scores are multiplied by two to allow 
comparison to normative data for the DASS-42, producing a score up to 42 per subscale. Symptom 
severity is illustrated along with the DASS-21 in Appendix G. 
3.2.6.2. Secondary Outcome Scales 
VO2peak assessment. To accurately tailor exercise intensity and assess aerobic capacity, 
maximal exertion (VO2peak) assessments were conducted on Velotron Pro Cycle Ergometric units 
pre, mid and post intervention (See Appendix H for protocol). Participants experienced 
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incrementally increased workload every 2 minutes until they could no longer maintain a cadence of 
60 revolutions per minute or elected to discontinue the assessment due to fatigue or discomfort. 
Body composition, visceral fat mass, height and weight. Body composition including 
visceral fat mass were measured via whole body scan on a Hologic Discovery Series W, Model: 010-
1549 Dual-energy X-Ray Absorptiometry (DXA) Scanner. Height was measured using a wall 
mounted stadiometer. Weight was measured using a digital industrial platform scale (accuracy to 
.005 kg). Body composition, height and weight were measured with participants barefoot and 
dressed in light sports attire.  
3.2.7. Procedure 
Participants progressed through the intervention as depicted in the flow diagram 
below. All sessions were individual format and took place between 7am and 7pm weekdays 
under supervision of an allocated 4th year exercise physiology student receiving supervision 
from an Accredited Exercise Physiologist. Sessions took place in the environmentally 
controlled Exercise Physiology, Performance or Strength and Conditioning Laboratory at 





Figure 3.1. Pathway of participation following enrolment. 
3.2.7.1. Structured Exercise Program 
Each session commenced with a 5-minute warm up and concluded with a 5-minute cool 
down (stretching and light aerobic activity). Participants wore Polar T31 Heart Rate monitors 
throughout, provided an overall session RPE and session rating as positive, neutral or negative (data 
not shown). Appropriate exercise intensity was achieved by calculating the VO2peak power 
relationship from the initial aerobic capacity assessment and subsequently used as workload on 
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Moderate intensity steady state condition (MISS) – active control. Participants were asked 
to ride a Wattbike Pro stationary cycle at 60% VO2peak for 30 minutes per session. The trainer 
encouraged participants to maintain this intensity at a consistent rate. Power output was monitored 
on the Wattbike Pro on-board computer. 
Moderate intensity personal preference condition (MIPP). Individuals in the MIPP 
condition were asked to exercise at a moderate intensity (i.e. 60% VO2peak or an RPE of 13-14 if 
power output could not be directly measured). Participants were encouraged to self-select the type of 
exercise they performed (e.g. aerobic or resistance training) and the equipment used (e.g. stationary 
cycle, rowing machine, treadmill, circuit machines or free-weights, medicine balls, swiss balls etc.) 
with guidance from the trainer. Indoor (as above) and outdoor activities (e.g. jogging, walking, 
outdoor resistance training with dumbbells or medicine balls) were available. The trainer provided 
instruction and modification of exercise performance and technique as required. Participants were 
encouraged to use a similar protocol for at least 2-3 weeks to allow progression but were able to 
modify their program via novel equipment or exercises as desired. 
High-intensity intermittent exercise condition (HIIE). Participants in the HIIE condition 
performed 12 alternating bouts of 30 seconds high-intensity cycling (100% VO2peak) followed by 2 
minutes of lower intensity cycling (50% VO2peak) per session on a Wattbike Pro stationary cycle. 
This equated to 6 minutes of high-intensity cycling and 24 minutes of recovery cycling at the lower 
intensity during each 30-minute session. This protocol was based on a number of cycle protocols 
adopted by this lab in similar cohorts i.e. sedentary adults with OW/OB (e.g. Raman et al., 2018; 
Sim, Wallman, Fairchild, & Guelfi, 2014, 2015). Trainers encouraged participants to fully engage 




3.3.1. Demographic and Baseline Data 
Table 3.1 below shows the demographic and baseline data for the sample and by condition. A 
series of one-way ANOVA indicated the baseline demographics, anthropomorphic and psychological 
variables were not significantly different across conditions. 
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Table 3.1. Demographic, and baseline anthropomorphic and psychological variables. 
Characteristic Overall (n = 
36) 
HIIE (n = 
11) 
MIPP (n = 
13) 




Age (SD), years 30.39 (8.17) 31.64 
(8.02) 
29.31 (8.95) 30.42 
(7.97) 
p = .794 
Female, % 77.8 72.7 76.9 75.0 p = .769 
BMI (SD), kg/m2 33.74 (6.84) 32.75 
(8.42) 
32.71 (5.89) 35.75 
(6.31) 
p = .472 
Body Fat (SD), % 40.69 (7.16) 38.64 
(7.82) 
40.89 (7.67) 42.35 
(6.03) 
p = .472 








p = .751 
Aerobic Capacity 
(SD), ml/kg/min  
22.45 (5.16) 24.19 
(5.77) 
22.40 (4.29) 20.90 
(5.35) 
p = .321 
Ethnicity, n 
    
p = .338 
European 28 10 11 7 
 
African 3 - 2 1 
 
Asian 3 - 1 2 
 
Indian 1 1 - - 
 
Other 1 - - 1 
 
Marital Status, n 
    
p = .834 
Married 9 5 2 2 
 
Single 24 6 11 7 
 
Divorced 2 - 1 1 
 
Widowed 1 - - 1 
 
Education (part or completed), n 
   
p = .532 
Higher Degree 4 1 1 2 
 




3 1 2 1 
 
High School 2 1 - 1 
 
Employment, n 
    
p = .512 
Full-time 11 5 3 3 
 
Part-time 14 4 7 3 
 
Unemployed 11 2 4 5 
 
Psychometrics 
     
BDI-II score (SD) 25.17 (7.61) 22.82 
(5.23) 
24.15 (6.38) 28.42 
(9.85) 
p = .179 
DASS-21 sub scale 
scores* 
     
Depression 
(SD) 
17.66 (9.52) 21.64 
(9.11) 
12.67 (9.66) 19.00 
(8.15) 
p = .061 
Anxiety (SD) 10.51 (8.17) 9.45 (5.37) 7.58 (5.32) 14.42 
(11.16) 
p = .105 
Stress (SD) 19.34 (7.44) 22.00 
(5.14) 
16.58 (7.41) 19.67 
(8.76) 
p = .220 
*DASS-21 scores scaled to DASS-42 equivalency as per Lovibond & Lovibond (1995). 
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3.3.2. Data Analysis 
Data analysis were performed using commercially available software program (SPSS Inc., 
Version 24 for OSX; IBM, 2017). To manage small sample size, variance and a missing data point, 
the primary data were analysed using a linear mixed model with each primary outcome as the 
dependent variable. We conducted a 3 (condition: MISS vs MIPP vs HIIE) x 2 (time: pre vs post) 
ANOVA on each secondary outcome. Main effects of condition indicate between condition 
differences in psychometric/anthropomorphic measures, the main effect of session represents change 
from baseline to completion of the program. An interaction suggests differential efficacy between 
conditions, over time. Finally, we explored correlational relationships between baseline depression 
and baseline anthropomorphic data and change in anthropomorphic data. We also examined the 
associations between change in depression and change in anthropomorphic data. 
3.3.2.1. Anthropomorphic Data 
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Table 3.2. Change in BMI, Weight, Total Body Fat, Visceral Fat and Aerobic Capacity 
(Pre – Post) 
      
Measure 




Pre Post Change Pre Post Change Pre Post Change  
BMI (SD), kg/m2 32.75 (8.03) 
32.44 








(6.46) - 0.13 (0.90) p = .269 
Body weight (SD), kg 96.90 (22.88) 
95.95 








(20.98) - 0.36 (2.46) p = .224 
Total Body Fat (SD), % 38.64 (7.45) 
37.27 








(6.89) 0.51 (1.78) p = .027* 












(266.49) - 30.58 (51.57) p = .691 













(5.04) 2.55 (2.78) p = .230 




Table 3.2 (previous page) shows pre and post intervention mean BMI, body weight and body 
fat percentage, visceral fat mass and mean aerobic capacity (VO2peak) by condition. Mean body mass 
index values did not change significantly with time, or by conditions. Both the HIIE and MISS 
conditions reduced BMI slightly, whilst the MIPP condition showed slight increases in BMI. The 
HIIE condition lost a similar amount of body weight as the MISS condition, whilst those in the MIPP 
condition gained a small amount of body weight. However, mean weight change over time was not 
significant, nor was the difference in mean weight change between conditions. Mean body fat 
percentage did not differ significantly across time or by condition, however a small crossover 
interaction was observed F (2,33) = 4.06, p < .05.  Whilst simple contrasts revealed no significant 
differences, participants in the HIIE condition reduced body fat by 1.36 percentage points, and those 
in the MIPP condition reduced body fat by 0.82 percentage points. Individuals in the MISS condition 
gained on average 0.51 per cent body fat points. All conditions tended to reduce visceral fat mass 
over time F (1,33) = 3.674, p = 0.06, and across conditions, there was large within-participants 
variability. Whilst individuals in the MIPP condition lost approximately two to three times the 
visceral fat mass of individuals in the alternate conditions, no main effect of condition or interaction 
was observed. There was a significant improvement in aerobic capacity across time F (1,33) = 
22.763, p < .000. Individuals in the HIIE condition improved the most (4.53ml/kg/min vs 
2.52ml/kg/min; MIPP vs 2.55mlkg/min MISS) however the difference between conditions was not 
significant, nor was the interaction between time and condition. 
Analysis examining the relationships between initial depression severity and physiological 
measures indicated a moderate positive association between baseline visceral fat mass and DASS-21 
baseline depression scores (r = .40, p = .018) which remained significant when controlling for overall 
body fat and BMI. No other correlational analysis was significant. 
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3.3.3. Primary Outcomes 
Beck Depression Inventory 
 
Figure 3.2. Mean scores (± SEM) for the Beck Depression Inventory-II, pre, mid and post intervention. 
Mean BDI-II scores are presented in Figure 3.2 above. Symptoms of depression improved 
significantly across sessions one to nine, 95% CI (4.61, 10.95) and one to 18, 95% CI (8.07, 14.30) 




Figure 3.3. Mean scores (± SEM) for the DASS-21 Depression subscale, pre, mid and post intervention. 
Depression severity scores as measured on the DASS-21 are displayed in Figure 3.3 above. A 
main effect of session F (2, 63.76) = 9.62, p < .001 indicated that symptoms of depression improved 
significantly across sessions one to nine, 95% CI (1.89, 8.14) and sessions one to 18, 95% CI (3.37, 
9.50). There was no significant main effect of condition, however the condition by session 
interaction was significant, F (4, 52.07), p = .01. A significant pairwise comparison indicated that 
individuals in the HIIE condition experienced more severe DASS-21 depression at baseline than 
individuals in the MIPP condition 95% CI (1.29, 16.22). Pairwise comparisons indicated HIIE, 95% 
CI (5.79, 16.76) and MISS 95% CI (2.58, 13.08) but not MIPP condition, improved significantly 































DASS-21 Anxiety  
 
 
Figure 3.4. Mean scores (± SEM) for DASS-21 Anxiety, pre, mid and post intervention. 
Severity of anxiety scores (DASS-21) are presented in Figure 4 above. Linear mixed model 
indicated a main effect of session, indicating significant change between session one and 18, 95% CI 



























Figure 3.5. Mean scores (± SEM) for DASS-21 Stress, pre, mid and post intervention. 
Figure 3.5 shows the mean scores for DASS-21 Stress, pre and post intervention. Linear 
mixed modelling revealed a main effect of time, F (2, 63.68) = 10.354, p < .001. Overall, severity of 
stress experienced by participants improved significantly across sessions one to nine, 95% CI (0.45, 
5.56) and sessions one to 18, 95% CI (3.20, 8.21). Whilst the main effect of condition was not 
significant, the condition by session interaction was FI (4, 63.67), = 5.3, p = .001, with pair-wise 
comparisons indicating significantly lower scores in the HIIE and MISS condition relative to the 
MIPP condition mid intervention, 95% CI (-14.58, -1.13); 95% CI (-14.16, -1.01).  
3.3.4. Reliable and Clinically Significant Change 
For psychological outcomes, reliable change was calculated for each participant. 
According to Jacobson and Truax (1991), the Reliable Change Index is a function of the 
sample pre and post-test means, the standard error of the difference between pre and post-test 
for the sample and test-reliability. Index scores above 1.96 indicate a statistically reliable 

























reliable change in mood, we examined whether their post intervention score fell below a cut-
off representing clinically significant change. These values were determined based on 
normative values for out-patients with a diagnosis of Major Depressive Disorder (Antony et 
al., 1998; Steer, Ball, Ranieri, & Beck, 1999) and population norms for adults in the 
Australian community (Crawford, Cayley, Lovibond, Wilson, & Hartley, 2011). The results 
were extremely similar to those computed using alternative clinically significant change 
methods (i.e. Button et al., 2015; Ronk, Korman, Hooke, & Page, 2013).  
 
Figure 3.6. Percentage of participants by condition with clinically significant change for all 
psychometric outcome variables. 
Figure 3.6 above shows the percentage of individuals in each condition exhibiting 
clinically significant change over time. Chi-square calculations indicated the only significant 
effect of condition was on the DASS-21 measure of depression, X2 (2, n = 36) = 2.76, p = .05. 
Following examination of Chi-squared residual values with Bonferroni adjustment of type I 
error to µ = .008, there was a trend toward significance (X2 = 5.78 p = .016) indicating fewer 
individuals in the MIPP condition improved on the DASS-21 measure of depression than 





Previous studies investigating treatments for clinical depression in adults with OW/OB 
have followed general approaches incorporating increases in physical activity alongside 
evidence-based psychotherapy and/or lifestyle modification (Faulconbridge et al., 2011; 
Linde et al., 2011; Pagoto et al., 2013). Individuals engaging in these treatments achieve 
significant weight loss and reductions in depressive symptoms. A relative shortcoming has 
been the limited investigation regarding suitability and efficacy of physical activity/exercise 
employed in such treatments, especially given that adults with OW/OB with clinical 
depression may face particular difficulties with exercise specific motivation, initiation 
(activation), adherence and weight associated stigma compared to normal weight peers. 
The primary aim of the present study was to understand which evidenced based formats, 
types and intensities of exercise are feasible and effective interventions for clinical 
depression in adults with co-morbid OW/OB. To our knowledge, this is the first study to 
directly investigate structured, supervised exercise as a treatment for clinical depression in 
adults with OW/OB. We observed substantial improvements in depression across 
conditions. While there were no significant differences between conditions on physical or 
psychological outcome variables, a trend toward favorable physiological outcomes was 
found across conditions. 
3.4.1. Clinical Effect of Exercise on Psychological Symptoms 
Depression. As expected, all conditions showed significant reductions in depression 
across sessions, however the between condition differences anticipated i.e. that HIIE and 
MIPP conditions would improve to a greater degree than those in the MISS condition, were 
not observed. Approximately 55 per cent of participants across conditions experienced 
clinically significant change as measured on the BDI-II. This treatment effect is similar to 
prior findings showing a 61 per cent remission rate for adults with OW/OB and depression 
following 6 months of behaviour activation therapy for depression and lifestyle intervention 
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(Pagoto et al., 2013). Similar clinically significant change (CSC) scores for depression were 
identified for the HIIE and MISS conditions as measured by the DASS-21. The relatively 
lower proportion of individuals in the MIPP condition experiencing CSC for DASS-21 
depression could be due to their lower baseline scores compared to the other conditions. 
Given the random allocation procedure, this would most likely be an artifact of smaller 
sample size and randomisation (i.e. chance). Nevertheless, given the consistent trend seen in 
Figure 3.6, in which HIIE and MISS CSC scores are greater than those in the MIPP 
condition across outcomes, it is possible that exercise type contributed to this effect. 
Specifically, future research should examine the nuances of how exercise type (aerobic vs. 
resistance), format (interval vs. continuous) and preference (selected vs. prescribed) interact 
with treatment outcomes in this population. 
Our findings suggest that exercise - even over relatively short durations – can be an 
effective anti-depressant in a clinically depressed adults with co-morbid OW/OB. One 
potential advantage of this is the relatively lower cost of exercise interventions compared to 
psychotherapy and lifestyle intervention which usually require highly trained professionals 
(dieticians and psychologists) to administer therapy over several months. Given that 
individuals who are OW/OB and experience clinical depression are typically less likely to 
receive and make full use of traditional treatment for depression than normal weight peers 
(Boudreau et al., 2013), the possibility of an alternative treatment with good face validity is 
an important consideration. Our findings also indicate that format (i.e. interval, steady state) 
or type (aerobic, anaerobic, personal preference) of exercise may not be especially pertinent 
to treatment efficacy, provided sufficient dosages are met and that exercise remains 
engaging for the individual. This is important because it allows variety, patient choice and 
practicality (e.g. of access to equipment, financial resources) to determine exercise 
treatment within previously defined parameters (i.e. of volume and dose).  
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To our knowledge, this study is the first to examine exercise intensities above 90% 
VO2max in a sample with clinical depression. We found high intensity and moderate 
intensity exercise formats lead to similar reductions in depression. These results are similar 
to a recent randomised controlled trial by Helgadóttir, Hallgren, Ekblom, and Forsell (2016) 
which illustrated that light, moderate and vigorous exercise produced comparable 
reductions in depression for clinically depressed, normal weight adults following 12-weeks 
of exercise.  In contrast, prior research indicated that higher intensity (i.e. 65-75% VO2max) 
exercise can be superior relative to lower intensity exercise for reducing symptoms of 
depression (Chu et al., 2009; Singh, 2005). Several factors may contribute to this apparent 
contradiction. In the present study, participants were overweight or obese and depressed. It 
may be that higher intensity exercise holds a relatively less potent advantage in this 
population than in a non-overweight population i.e. that compared to normal weight peers 
with depression, adults with depression and OW/OB, who have differences in body weight, 
body composition, hormonal or neuroendocrine dysfunction, or differences in self-
perception and engagement, may have differential capacity to benefit from HIIE for 
symptoms of depression. Nevertheless, given the mixed results of prior research it is 
important to consider alternative explanations. Participants in Singh’s (2005) study were 
aged over 60 years and engaged in weight-lifting for 8 weeks. Differences in age, exercise 
type (resistance training vs cycling) and duration of intervention may have been 
contributing factors. Furthermore, resistance training may have improved mobility and 
stability in this older adult population, reducing falls-risk and associated anxiety thereby 
indirectly reducing depression. This could over-state the impact of high intensity activity on 
depression in general older adult populations relative to middle aged adults. In finding 
higher intensity exercise superior to lower intensities, Chu et al. (2009) utilized aerobic 
activity over 5 weeks. Participants in the low intensity condition exercised at a lower 
intensity (40-55% VO2peak) than participants in our MISS condition (60% VO2peak). 
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Furthermore, participants in their high intensity condition (65-75% VO2max) exercised at an 
intensity only slightly above the intensity in our lower intensity conditions. It may be that 
these between conditions difference in intensity are sufficient to account for our current 
finding. That is, whilst higher intensity (65-75% VO2max) may be superior to low intensities 
around 40% VO2max, there may be little difference between 70% and 90-100% VO2max – at 
least regarding depression outcomes.  
A further consideration is that by administering high intensity training in interval 
format, the overall session intensity was reduced, potentially leading to a smaller effect 
compared to a session of high intensity exercise without intermittency or with a higher 
average intensity. Specifically, whilst participants in our HIIE condition exercised in 
alternating bouts of 100% VO2peak and 50% VO2peak, the average time-weighted session load 
was 60% of VO2peak power output. It could be argued that overall session intensity is more 
important than maximum in session intensity or that HIIE sessions should be modified to 
increase the average session intensity - e.g. work intervals of 120% VO2peak or a 1:3 
work:rest ratio, as opposed to the 1:4 work:rest ratio employed in the present study. Finally, 
contrary to recent commentary by Biddle and Batterham (2015), HIIE under supervision in 
the current study appeared well tolerated.  
Ultimately, our findings support prior research indicating that various exercise 
intensities are similarly effective for reducing symptoms of clinical depression (Helgadóttir 
et al., 2016) and extends this to adults with co-morbid OW/OB.  
While reduced CSC scores in the MIPP condition may be in part attributable to 
between condition differences in baseline severity and small sample size, it is important that 
future research considers the interplay between personal preference and treatment 
outcomes. Few studies have examined the role of personal preference on clinical outcome 
in trials involving exercise for depression. Doose et al., (2015) showed that self-selected 
intensity (averaged at moderate) led to large reductions in depressive symptoms and 
 114 
improvements in aerobic capacity in women with major depression. Our research extends 
these findings and indicates that type and format of exercise can be self-selected whilst 
achieving clinically significant gains at least as robust as HIIE and MISS exercise over 
time. A key difference between our research and that of Doose et al. was that the latter 
prescribed the exercise activity (treadmill use) but allowed participants to select a preferred 
intensity, whilst we employed a prescribed intensity (moderate) but within a personally 
selected exercise activity (weight lifting, running, cycling etc.). Individuals within Doose et. 
al’s study were also within a normal weight range. These findings, taken together suggest 
that personal preference (type, intensity and format) may be a variable of interest in future 
research and in treatment of depression, regardless of weight status. Interestingly, Doose et 
al. found nearly one quarter of participants dropped out, and those that completed the 8-
week program attended only 58 per cent of sessions. It may be that allowing participants to 
select the type and format of exercise increases adherence over and above simply selecting 
intensity - perhaps due to increased engagement, self-efficacy, control or ownership 
participants take as a result of the broader self-selection. Future research should endeavor to 
clarify the key aspects of personal preference are optimal for engagement and treatment 
effect.  
The above are key findings given the importance exercise interventions may have in 
improving mood, body composition and reducing inflammation (Chu et al., 2009; Keating 
et al., 2014; Shiraev & Barclay, 2012) in a clinically depressed population with co-morbid 
OW/OB. Until now, no studies have examined the psychological effect of exercise alone in 
populations with clinical depression and OW/OB.  These findings broaden the scope of 
potential evidenced-based exercise interventions available to psychologists and deepen our 
understanding of exercise interventions for depression.  
Anxiety & Stress. We expected all conditions to show reductions in anxiety and 
stress across sessions. A main effect of session but not condition was observed for anxiety 
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and stress. Floor effects for anxiety and stress are not uncommon in exercise literature 
(Ensari, Greenlee, Motl, & Petruzzello, 2015) and even in our sample experiencing 
depression, individuals in the HIIE and MIPP conditions had mild symptoms of anxiety. 
Anxiety was on average, moderate in the MISS condition. Stress was within the mild to low 
moderate severity range across conditions (Lovibond & Lovibond, 1995). Our findings 
indicate that HIIE and MISS interventions are effective in reducing mild to moderate levels 
of anxiety and stress in adults with clinical depression and OW/OB. This is similar to 
previous meta-analytic findings in non-overweight and depressed individuals (Ensari et al., 
2015) which indicated that exercise was effective for reducing anxiety in adults and that 
high intensity exercise was superior for this purpose compared to lower intensities. 
Interestingly, other meta-analytic research indicated the anxiolytic effects of exercise on 
trait anxiety require a minimum of 10-weeks, whereas Petruzzello, Landers, Hatfield, 
Kubitz, and Salazar (1991) reported that anxiety may improve after just one session of 
exercise (Ensari et al.). Our findings are therefore important given the paucity of research 
on such symptomatology in this population and adds to the literature which indicate that 
moderate and higher intensity exercise are effective at reducing state anxiety and stress over 
relatively short periods (Ensari et al., 2015; Salmon, 2001) in a clinically depressed 
population of adults with OW/OB. 
3.4.2. Physiological Findings 
We found a moderate positive correlation between visceral fat mass and initial 
depression scores, similar to prior research (Ludescher et al., 2008). Improvement in body 
composition, body weight and aerobic fitness were not the main focus in the present study. 
Nevertheless, we found a trend toward reduced visceral fat mass and greater aerobic 
capacity across conditions over time. In general, no condition was clearly superior to others 
at improving physiological variables, however individuals in the HIIE condition lost a 
significantly greater amount of body fat than individuals in the MISS condition and 
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somewhat more (66%) than individuals in the MIPP condition, although the latter was not 
significant.  
No association was found between change in depression and baseline or change in 
physiological variables. Systematic reviews indicate that aerobic exercise is particularly 
effective at improving visceral fat mass and may indeed be superior to resistance training 
(Ismail et al., 2012; Ohkawara et al., 2007). Higher intensity and greater volumes of 
exercise typically enhance visceral fat loss (Irving et al., 2008; Ohkawara et al., 2007). 
Indeed, a minimum of 10 METS/week or approximately 150mins/week of moderate 
intensity exercise has been found adequate to reduce visceral fat mass (Ismail et al.). This is 
a greater dose than the present study, (i.e. typically 90-minutes of exercise per week). 
Higher intensity appears especially important for reducing visceral fat mass via resistance 
training, where it is superior to lower intensities (Dutheil et al., 2013) and we found a 
similar phenomenon as with respect to overall body fat reductions. Overall, the trend 
toward improvements in body composition and visceral fat mass are promising and indicate 
all formats of exercise examined may hold utility for reducing adipose and visceral fat mass 
thereby leading to less systemic inflammation which has been implicated in the aetiology of 
depression in obese individuals (Lopresti et al., 2013).  
Future research should continue to explore associations between body composition, 
visceral fat mass and depressive symptoms especially when such research also examines 
inflammatory markers (e.g. TNF-a, CRP, IL-1, IL-6) which may play a mediating role 
within the bidirectional obesity-depression relationship (Lopresti et al., 2013). 
3.4.3. Summary of Results 
This is the first study to examine the efficacy of exercise alone in a clinically 
depressed, OW/OB cohort of adults. We found that all interventions were similarly 
effective at reducing elevated depression symptomatology and at reducing mild to moderate 
levels of anxiety and stress. This is the first study to show HIIE and moderate intensity, 
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personally selected interventions are well tolerated in clinically depressed adults with co-
morbid OW/OB. Our findings suggest that format, type and intensity may be of secondary 
importance to dose, engagement and adherence. The present study contributes to the need 
for research into effective exercise interventions for this population. 
3.4.4. Limitations 
It is noteworthy that individuals volunteering for a trial such as ours must have 
enough interest and motivation to enquire, attend screening and enroll such that they may 
be on a pre-existing trajectory of recovery from depression. Therefore, without a wait-list 
control, we cannot exclude the possibility of spontaneous recovery from an episode of 
depression during study enrollment. We recognize the methodological limitation inherent in 
the relatively small number of participants in each condition. One effect of this was reduced 
power available for statistical analysis. Nevertheless, the present study builds on previous 
research in a consistent and logical manner.  
Although the differences in pre-intervention depression, anxiety and stress on the 
DASS-21 were not significant, some might argue that with greater power a significant 
difference may have occurred and that using each baseline variable as a covariate in 
statistical analysis would have been appropriate (alternatively however, greater sample size 
may have reduced the discrepancy as randomisation took effect). To make the most of a 
relatively small sample size in this feasibility study, we chose to use GLMM – a more 
robust analysis considering the effects of missing data.  A second concern was the relative 
low baseline score for depression as rated by the DASS-21 of the MIPP condition. This may 
have contributed to a floor effect within the sample. It is important to note however that 
with a larger sample, such differences would likely reduce and between condition 
differences may be more apparent. Future research implementing methodological 
modifications - i.e. increased sample size or randomisation based on severity of depression - 
could help to ameliorate these concerns.  
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A further limitation was the short duration of the programs. The exercise intervention 
programs in our trial were designed for completion over 18 sessions. Most participants 
concluded the program within 6-7 weeks. Whilst this is clearly promising from a treatment 
perspective, whether such interventions are viable in this population over longer periods 
requires further investigation. A final limitation was the lack of follow-up. The small-scale 
pilot nature of the program limited additional follow-up, however future intervention 
studies should enquire if and to what extent participants have continued exercising and the 
relative stability of any recovery from depressive symptoms following initial treatment to at 
least 12-months following the initial intervention. Follow-up is important for exercise based 
interventions for depression because it appears that the treatment effect of exercise on 
depression persist only for as long as one continues to exercise (Krogh, Nordentoft, Sterne, 
& Lawlor, 2011). The results of the present study should spur further research into exercise 
for depression in adults with OW/OB and help practitioners make suitable 
recommendations to clients with OW/OB and patients seeking exercise treatment for 
depression. 
3.4.5. Future Research and Clinical Implications 
 Whilst we have outlined some general areas for future research the following specific 
areas are ripe for investigation. The present study did not seek to replicate prior research on 
depressed, non-overweight samples examining frequency or dose response to exercise (e.g. 
Dunn et al., 2005; Trivedi et al., 2011). Future research should seek to clarify these 
fundamental relationships in a clinically depressed population who are also OW/OB. To gain 
a better understanding of how exercise protocols similar to the ones described in our 
preceding research are experienced by individuals in treatment, investigators should seek a 
more nuanced understanding of how individuals with depression and OW/OB experience 
various types of exercise. Specifically, qualitative analysis of interview data may yield 
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answers regarding how best to implement such protocols and which factors are may affect 
engagement, adherence and clinical efficacy. 
Regarding future quantitative investigations, examining the differential effects of 
various high intensity exercise protocols comparing maximum in session versus session 
average intensity on symptoms of depression would be clinically useful. That is, 
understanding the impact of various work-rest ratios or maximum intensities corresponding 
to a greater percentage of VO2peak. Such a design would provide answers regarding the 
differential importance of intensity and the best format within HIIE from which to deliver an 
adequate ‘dose’ of intensity. Similarly, research on personal preference should confirm which 
aspects of preference are beneficial (e.g. preference directed toward activity type, format, 
intensity etc.) and if, or at what point personal preference becomes deleterious factor in 
exercise treatments for depression.  
Finally, whilst the pairing of optimal evidence-based exercise interventions with CBT 
requires further research, we offer the following tentative ideas about how exercise might be 
utilised within CBT for depression in a population that is also OW/OB: Given past research 
(Busch et al., 2015; Chu et al., 2009; Doose et al., 2015; Dunn et al., 2005; Singh, 2005; 
Trivedi et al., 2011) and our current results, we advocate evidence-based exercise 
interventions apply aerobic or resistance training exercises in high intensity interval or 
moderate intensity steady state format. Such exercise interventions should aim to engage 
individuals in 45 to 60-minute sessions, 3-5 per week over at least 10-12 weeks. Personally 
selected intensities or activities may be utilised provided sufficient dosages are met.  
The current research adds to our understanding of exercise interventions for treating 
depression in adults with OW/OB. We found meaningful and comparable reductions in 
depression for all intervention formats, and promising results regarding anxiety and stress. It 
is hoped future research will continue to refine evidence-based exercise interventions to 
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compliment tailored cognitive behavioural interventions targeting clinical depression in 
overweight adults.  
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Engagement and Experience in Exercise Programs for Clinical Depression as an 
Adult with co-morbid Overweight or Obesity: A Mixed Methods Evaluation. 
4.1. Introduction 
There is an emerging understanding that a specific focus on populations with 
comorbid depression and overweight or obesity (OW/OB) is important in providing clearer 
treatment recommendations (e.g. Faulconbridge, Wadden, Berkowitz, Pulcini, & Treadwell, 
2011; Pagoto et al., 2013). In part, this requires research, such as randomised controlled trials 
(RCT’s), that evaluates outcomes of specific interventions. Perhaps just as important 
however, is an exploration of process and engagement in such interventions to maximise the 
translation of such research into clinical practice.     
Research exploring the subjective experience of clinically depressed and overweight 
or obese (OW/OB) adults during exercise interventions is sparse. Relatively more has been 
said about the treatment of depression with exercise from a quantitative than qualitative 
perspective. Often RCT’s, this research tends to focus on outcome rather than process and 
engagement. Yet a qualitative analysis is likely to enrich our understanding of such 
individuals’ experience of exercise interventions that might otherwise be missing from a 
singular focus on quantitative outcomes. Important qualitative aspects may include 
motivations, perceived barriers, benefits and facilitators. It is also essential to identify these 
issues as they relate to exercises’ utilisation as therapy for adults with clinical depression and 
OW/OB, which may help address concerns for clinicians hesitant to employ exercise in 
treatment of depression (Pollock, 2001).  
 Limitations that impact the use of exercise in treating depression exist. In general, 
clinical depression leads to low levels of activity, including physical exercise (Patten, 
Williams, Lavorato, & Eliasziw, 2009). Within the general population, up to 50% of those 
commencing an exercise program discontinue within 6-months (Turley, 2000, as cited in 
Pollock, 2001). Given that individuals with depressive symptoms are more likely to 
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discontinue exercise programs than non-depressed peers (DiMatteo, Lepper, & Croghan, 
2000; Teixeira et al., 2004) it is paramount that research explore what factors affect 
acceptability, engagement, and adherence. It is unfortunate, yet not surprising that only 40 
per cent of mental health care practitioners and around 18 per cent of General Practitioners 
recommended physical activity to their clients (Phongsavan, Merom, Bauman, & Wagner, 
2007; Short et al., 2016). Clinicians may have a limited understanding of how best to 
construct and implement evidenced-based exercise programs for mental health conditions, 
which may influence their decision not to consider exercise as a component of evidence-
based practice (Phongsavan et al., 2007; Ranjbar et al., 2015).  Indeed, clinicians often 
describe that it can be difficult to activate a patient with depression and that low levels of 
general activity, low self-worth, helplessness, hopelessness and withdrawal make 
engagement especially difficult (Seime & Vicers, 2006). Research also indicates that 
individuals with depression have significantly lower levels of motivation and volition but 
similar outcome expectations regarding exercise behaviours compared to non-depressed 
controls (Kramer, Helmes, Seelig, Fuchs, & Bengel, 2014). This suggests that initiating and 
adhering to a regular exercise plan would be a common difficulty for individuals with clinical 
depression.  
Since individuals with depression have lower levels of self-efficacy (Robinson-Smith, 
Johnston, & Allen, 2000; Sacco et al., 2005) it has been proposed that exercise self-efficacy 
may influence adherence and ultimately, treatment outcomes. In respect of regular exercise, 
this moderating effect appears to be even greater for individuals with depression or with 
higher BMI (Kangas, Baldwin, Rosenfield, Smits, & Rethorst, 2015). Prior research on 
exercise interventions and subsequent exercise self-efficacy is mixed. Studies have reported 
increases in exercise self-efficacy following regular exercise (Jung, Bourne, & Little, 2014; 
McAuley, Bane, & Mihalko, 1995; Singh et al., 2005) although not exclusively so (e.g. 
Singh, Clements, & Fiatarone, 1997). Exercise intervention studies that examine solely 
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outcome scores for depression may miss critical aspects of the patients’ experience, including 
those that relate to engagement and adherence. Some of these issues are pertinent to using 
exercise as an adjunct or independent therapy for depression in OW/OB populations.  Such 
findings may also inform development of tailored cognitive-behaviour therapies for 
depression in adults with OW/OB, where treatments employ exercise or physical activity as a 
key component. 
Within the general community, the most common motivations to exercise are to lose 
or maintain weight, improve appearance or to manage a health condition (Hoare, Stavreski, 
Jennings, & Kingwell, 2017). Similar results are found in overweight individuals (Guess, 
2012). To our knowledge, qualitative research on populations with co-morbid depression and 
OW/OB involved in exercise interventions is yet to be published. However, a number of 
studies have examined normal weight participants perception of physical activity in treatment 
of depression within a primary care or community context. Individuals with depression often 
find exercise an acceptable treatment (Searle et al., 2011) and typically believe the benefits of 
exercise are due to distraction from negative thoughts, modification of neurochemical and 
hormonal pathways or via the structure, routine and socialization that can come with regular 
exercise (Carter, Morres, Repper, & Callaghan, 2016; Searle et al., 2011). Common 
perceived barriers include low mood, amotivation, lack of confidence, low self-efficacy, 
limited understanding of exercise techniques or regimes and situational factors including 
work demands, limited spare time or no one to exercise with (Carter et al., 2016; Danielsson, 
Kihlbom, & Rosberg, 2016; Hoare et al., 2017; Rogerson, Murphy, Bird, & Morris, 2012). 
Individuals in the depths of a depressive episode often feel unable to exercise by themselves 
and the relationship with an exercise therapist seems to be integral to treatment benefits 
(Danielsson et al., 2016). Indeed, prior research indicated that GP referral schemes which 
include ongoing contact between doctor and patient may enhance exercise program 
adherence compared to referrals made without such support (Isaacs et al., 2007; Taylor, 
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Doust, & Webbom, 1998). There are also some key considerations which may inhibit 
engagement in exercise for this population. For example, individuals with depression 
regularly describe feeling “inadequate” when they experience difficulties completing exercise 
successfully (Searle et al., 2011). Danielsson et al. noted many participants “feel like an 
outsider” during exercise sessions. These issues may be particularly important in the context 
of working with adults who have OW/OB, for whom shame, self-criticism and social stigma 
can be regular and distressing (Gilbert et al., 2014; Gilbert, Baldwin, Irons, Baccus, & 
Palmer, 2006). These concerns may perpetuate unhelpful cognitions related to clinical 
depression (e.g. critical self-schemas, excessive worthlessness and guilt and a sense of being 
a failure). Therefore, individuals with co-morbid depression and OW/OB potentially 
experience a particular set of challenges compared to normal weight depressed peers or 
individuals who are OW/OB and euthymic. 
Important variables in treatment of depression with exercise include type (aerobic, resistance 
or combined), intensity (i.e. above 65-75% VO2max), volume (around 1000Cal per week), frequency 
(3-5 sessions per week), and compliance (Chu, Buckworth, Kirby, & Emery, 2009; Dunn, Trivedi, 
Kampert, Clark, & Chambliss, 2005; Krogh, 2009; Rethorst, Wipfli, & Landers, 2009; Singh, 2005; 
Trivedi et al., 2011). Collaborative supervision, individual tailoring and personal preference within 
sessions also appear to be important characteristics involved in engagement (Busch, Ciccolo, 
Puspitasari, & Nosrat, 2015; Ranjbar et al., 2015). Given this, two formats of exercise in particular – 
High Intensity Intermittent Exercise (HIIE) and personally selected interventions may engage 
individuals experiencing depression in an effective exercise treatment.  
High Intensity Intermittent and personally selected exercise might afford individuals with 
depression a greater sense of exercise mastery compared to moderate or prescribed interventions via 
either perceived control (self-selection) or repeated exposure (as in HIIE). These factors may in turn 
enhance motivation, enjoyment of sessions and engagement, subsequently contributing to greater 
symptom reduction. Indeed, enjoyment is considered an important predictor of long-term exercise 
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adherence, at least in non-depressed samples (Dishman et al., 2005). Recent literature suggests that 
HIIE may be more enjoyable than moderate-intensity steady state exercise whilst increasing exercise 
self-efficacy comparably to moderate intensity steady state exercise (Bartlett et al., 2011; Jung et al., 
2014). High intensity interval exercise has also received criticism, with assertions that whilst it 
confers benefits, its psychologically aversive nature makes it unviable as a longer term intervention 
(Biddle & Batterham, 2015), therefore clarification is required regarding individual preferences and 
motivations to engage in and experience of HIIE if it is to be considered a viable exercise 
intervention.  
Recently, Busch et al. (2015) asserted that due to the high variability in preferred form and 
structure of exercise amongst individuals with depression, programs should be flexible to increase 
acceptability and engagement. Since there is some evidence suggesting at least moderate intensity is 
required to ensure a treatment effect (Cooney et al., 2013; Dunn et al., 2005), it is expected that 
personally selected exercise (e.g. a mix of cycling, jogging, resistance training, indoor rowing, 
medicine ball work etc.) may be more engaging and acceptable to individuals than prescribed 
exercise. Very little research has been conducted on how different types of exercise programs are 
perceived by exercisers (Foster et al., 2015) and to our knowledge, there has been no investigation 
into exercise preferences of adults who with OW/OB and depression. This research is essential if 
engaging intervention programs are desired. 
The aim of the present study therefore, is to gain a more nuanced insight into the experience 
of exercise as a treatment for depression in adults with clinical depression and OW/OB, including the 
specific challenges facing this particular group. We sought to combine a qualitative exploration with 
quantitative evaluation of self-efficacy, motivation, confidence to exercise and positive anticipation 
of future sessions for participants who had engaged in one of three conditions within a randomised 
control clinical trial of exercise sessions with a personal trainer over approximately 6 weeks. This 
research is part of a larger study, described previously (Chapter 1). The three conditions included 
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HIIE, Moderate Intensity Steady State (MISS) and Moderate Intensity Personal Preference (MIPP) 
exercise. 
4.1.1. Hypotheses 
i) We expect self-efficacy and confidence to exercise to improve across sessions 
for all groups.  
ii) We expect motivation, enjoyment and positive anticipation to improve to a 
greater extent and to a higher absolute level across sessions in the HIIE and 
MIPP conditions relative to the MISS condition. 
4.2. Methods 
4.2.1. Design and Context 
To explore OW/OB participants experience of exercise as treatment for depression 
and understand factors which may contribute to engagement, we employed a mixed methods 
design. This research was part of a larger randomised controlled clinical trial investigating 
the feasibility and effects of exercise on clinical depression in adults who are OW/OB 
(ANZCTRN: 12614000097640). The present study was approved by Murdoch University 
Research Ethics and Integrity Office (Project No. 2013/204) under the parent study. 
Individuals taking part in the trial were invited to participate in a semi-structured interview 
held within one to four weeks of their final exercise session. Participants had experienced 18 
sessions of individually supervised exercise in one of the three conditions, over 
approximately 6 weeks. Typically, three 30-minute sessions occurred per week with 5-minute 
warm up and cool down. Exercise conditions consisted of either steady-state stationary 
cycling at moderate intensity (MISS), moderate intensity personal preference exercise (MIPP; 
a collaboratively designed resistance program, interval training, other aerobic or a 
combination, either indoors or outdoors) or high intensity intermittent exercise performed on 
a stationary cycle (HIIE). Participants had their fitness (VO2peak) and body composition 
accurately measured (body weight, BMI and Dual-energy X-ray Absorptiometry (DXA) 
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scan) pre and post intervention; heart rate, RPE and power output were measured and 
displayed (as available) within each session.  
4.2.2. Inclusion and Exclusion Criteria 
 All participants were required to provide informed consent for the interview and to 
have completed their program of exercise in the RCT. Enrolment to the RCT was open to 
men and women aged 18- 45 years, who were experiencing a current episode of depression 
according to Structured Clinical Interview. Participants had to be willing to delay new 
therapy for the duration of participation, had a BMI greater than 25 and understand written 
and spoken English. Anti-depressant use was permitted provided unchanged dose 3 weeks 
prior to participation and throughout the intervention. Exclusion criteria included regular 
psychotherapy, previous cardiovascular incident or cardiovascular disease, intellectual 
impairment, serious or unstable medical conditions, substance dependence requiring 
rehabilitation, diagnosed (or suspected) personality disorder, current or historical mania, 
hypomania or anorexia nervosa, current or recent bulimia nervosa, current suicidal ideation 
or self-harm of a clinically significant nature or a suicide attempt in the prior 2 years. Women 
who were pregnant or attempting to become pregnant were also excluded from participation. 
Further details of the RCT can be found in Chapter 3. 
4.2.3. Participants 
Eighteen adults agreed to take part in the interviews. Five had been allocated to each 
of the MISS and HIIE conditions and eight to the MIPP condition. Sixty-one per cent were 
classified as obese. Baseline quantitative data are presented in Table 4.1 below. Collection of 
demographic and mood data occurred during the screening interview for the RCT, whilst 
anthropomorphic data were collected at baseline (weight, height) and once enrolled (body fat, 
aerobic capacity) described in Chapter 3. 
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Table 4.1. Baseline Demographic, Mood and Anthropomorphic participant data. 
Characteristic Overall 
Age (SD), years 31.39 (8.64) 
Female, % 72.22% 
BMI (SD), kg/m2 33.78 (7.28) 
Body Fat (SD), % 38.26 (7.99) 
Aerobic Capacity (SD), ml/kg/min  23.03 (4.32) 











Education (part or completed), n 
Higher Degree 3 
Bachelors 11 
Vocational/Diploma 2 
High School 2 





BDI-II score (SD) 26.89 (7.20) 
DASS-21 sub scale scores*  
Depression (SD) 17.41 (7.84) 
Anxiety (SD) 10.06 (7.07) 
Stress (SD) 22.18 (7.01) 
Co-morbid Anxiety Disorder 7 
Co-morbid Binge Eating Disorder 4 
*DASS-21 scores scaled to DASS-42 equivalency as per Lovibond & Lovibond (1995). 
4.2.4. Interviews 
Participants were informed that the semi-structured interview was expected to take 
approximately 30-minutes and would occur individually. Participants were told the interview 
was an opportunity to reflect upon their experience of the program with a researcher and to 
provide feedback regarding the program. Semi-structured interviews took place one to two 
weeks following completion of the program at the University Psychology Clinic in a quiet 
and private interview room. One interview was conducted from this room via Skype ™ as the 
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participant had travelled overseas. Interviews were based on a topic guide and conducted by a 
member of the research team. The topic guide was developed over three pilot interviews with 
other participants on exit from the controlled trial. The interviewer started with the open 
question ‘Tell me about your experience of the program’ and continued with the natural 
conversation of the participant and with the guide serving as a prompt. Topics covered by the 
guide included i) aspects found enjoyable or motivating, ii) barriers or challenges faced, and 
iii) desired modifications to the program. We also promoted participants to share any 
perceived iv) changes in their emotional, cognitive or physical state, and v) changes to their 
views on exercise. The spontaneous reflections of participants were explored. When the 
relationship with the personal trainer was brought up by the participant, we also asked how 
they experienced it and to share what factors they found helpful or challenging about it. 
Leading questions were avoided. Reflective questions were used to clarify or expand 
participants’ responses. Most interviews lasted 20 to 45 minutes, were audio recorded and 
subsequently transcribed by a professional transcription service with substantial academic 
transcription experience. Research indicates qualitative data collection should continue to 
‘saturation’ - until no new themes emerge and data replication begins to occur (Schreier, 
2012).  
4.2.5. Self-Report Measures 
The quantitative data for this study were collected during participation in the RCT. 
These scales were administered between the first and second session, at mid-point and at 
completion of the 18th session. Administration between the first and second session was 
designed to provide participants with some initial exposure to their exercise program so that a 
subjective assessment based on experience could be made via the self-report scales. 
Exercise self-efficacy. Self-efficacy to engage in exercise was measured via the Bandura 
Self-Efficacy to Regulate Exercise Scale (SERES; Bandura (2006), see Appendix I). Respondents 
were asked to rate 18 statements from 0 to 100, reflecting their confidence to engage in their regular 
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exercise routine under a variety of circumstances (e.g. ‘After a vacation’ or ‘when I feel physical 
discomfort from exercise’). The SERES has demonstrated excellent reliability (e.g. Cronbach’s a of 
.95) and robust concurrent validity with maximal exertion tests of physical fitness in clinical samples 
(Everett, Bronwyn, Yenna, & Patricia, 2009). Exercise self-efficacy was measured pre and post 
intervention only. 
Visual analogue scales (VAS). VAS scales of 110mm length were used to assess subjective 
motivation, enjoyment, positive anticipation of and confidence to engage in exercise (See Appendix 
J) following session one yet prior to session three then post intervention. Such scales are commonly 
used to measure motivation and attitudes toward exercise in samples of mood and anxiety patients 
engaged in exercise interventions (e.g. Knapen et al. (2009); Stenström, Boestad, Carlsson, Edström, 
and Reuterhäll (1997)). Administration following session one was designed to allow participants 
some exposure to the exercise format prior to rating. 
4.2.6. Data Analysis 
Given the exploratory nature of the study, we analysed the interview data using a multi-
step iterative inductive approach, undertaking thematic analysis as suggested by Braun and 
Clarke (2006). Initially, familiarisation with interview data was essential. The primary 
analyst (N.B.) read and re-read the transcriptions - immersing in the content. During this 
process, reflective observations and thoughts were noted. Second, preliminary coding took 
place across the entire data set. Third, emergent themes were identified by looking for 
patterns, connections and divergences in the coded material. Simultaneously the codes were 
passed through these themes generating new themes or until saturation occurred. Fourth, 
themes were reviewed in relation to the coded extracts and the data set. This included 
collapsing themes deemed to be sub-themes into a higher-level class. A thematic map was 
then generated. Fifth, themes were clearly defined and refined to distill their essence and 
determine what aspect of the data each theme captured. Finally, selected extracts were 
identified to provide vivid and compelling examples of the themes. To enhance 
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confirmability of the data (Nowell, Norris, White, & Moules, 2017), a second researcher 
(H.C.) also engaged in the thematic analysis of the interview data using the same iterative 
multistep process described. Independent analysis was complimented with peer debriefing 
and testing for referential adequacy by comparing codes against raw data, to facilitate 
credibility and confirmability of the data analysis and identification of emerging themes. 
Quantitative data were analysed using a 3 (condition) by 3 (session) way repeated 
measures ANOVA and 3 x 2 way ANOVA. A main effect of session indicates change in the 
respective dependent variable over time whilst a main effect of condition indicates a between 
condition difference in dependent variable. An interaction reflects contrasting effects between 
conditions, over sessions. 
4.3. Results 
To explore participant experiences, we present subjective self-report measures of 
exercise self-efficacy, confidence and motivation to exercise, positive anticipation and 
subjective enjoyment of sessions. We follow this with a description of participant experiences 
during the exercise interventions, by way of qualitative interview data. 
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4.3.1. Quantitative Results 
4.3.1.1. Exercise Self-efficacy 
 
Figure 4.1. Mean Self-efficacy to Regulate Exercise scores (±SEM), pre and post intervention. 
Mean self-efficacy to regulate exercise scores are displayed in Figure 4.1 above. 
Although Figure 4.1 indicates marginal improvements in self-efficacy across sessions for the 
HIIE condition, and no apparent change in either the MIPP or MISS condition, overall, mean 
self-efficacy did not change significantly following the intervention (i.e. no main effect of 
session), nor were there any significant main effects of condition. The interaction between 




















4.3.1.2. Perceived Confidence to Engage in Exercise Routine for 12 Weeks 
 
Figure 4.2. Mean scores (±SEM) of Confidence to engage their exercise routine for 12 weeks as measured on a 110 point 
VAS, pre and post intervention. 
Mean scores of confidence to exercise in their respective routine for 12 weeks is 
featured in Figure 4.2 (above). Neither main effect of session or condition, nor their 
interaction was significant.  
















































Figure 4.3. Mean Motivation scores (±SEM) as measured on a 110 point VAS, pre and post intervention. 
Figure 4.3 (above) displays means for subjective motivation to exercise. Motivation increased 
significantly across sessions, F(2,29) = 4.25, p < .05. The main effect of condition was not 
significant. 
4.3.1.4. Positive Anticipation of Exercise Sessions 
 
 
Figure 4.4. Mean Positive Anticipation scores (±SEM) as measured on a 110 point VAS. 
Figure 4.4 above shows mean positive anticipation to engage in their intervention, for each 
condition. Overall, positive anticipation increased significantly across sessions, F(2,29) = 11.83, p < 






























4.3.1.5. Enjoyment of Exercise Sessions 
 
Figure 4.5. Mean Session Enjoyment scores (±SEM) as measured on a 110 point VAS. 
Mean session enjoyment scores are charted in Figure 4.5 above. Enjoyment of 
sessions increased significantly across sessions, F(2,29) = 4.97, p <.05. Neither the main 
effect of condition nor the condition by session interaction was significant, indicating similar 
levels of enjoyment between conditions across sessions. 
4.3.2. Qualitative Results 
Themes relating to participant’s experience in the program are summarised in Table 
4.2. Analysis revealed six main themes and 16 sub-themes. The themes included: A) 
Awareness of self in relation to exercise and exercisers, B) Looking for change, C) Managing 
competing demands, D) Importance of rapport and relationship with the personal trainer, E) 
Sustainability of new behaviours, F) Suggestions regarding a more desirable program. 

























Table 4.2. Participants broad experience of the exercise intervention 
Topic/Category Theme/Subcategory 
A. Awareness of self in 
relation to exercise and 
exercisers 
i. Can I do this?  
ii. What do they think of me?  
iii. Not belonging (Sense of being apart) 
B. Looking for change i. I’m (not) changing and it’s slow 
ii. Identifying benefits 
iii. Creating ways to find success 
C.  Managing competing 
demands 
i. Barriers and Challenges 
ii. Facilitators 
D. We’re in this together i. Creating a sense of trust and safety 
ii. Knowledge and expertise 
iii. Adequate still works, perhaps not as well 
E. Sustainability of new 
behaviours 
i. Exercising into the future  
ii. I’m having doubts 
iii. Problem solving for sustainability 
F. A more desirable program i. Qualities of a good program 
ii. Exercise alone is not enough 
 
4.3.3. Awareness of Self in Relation to Exercise and Exercisers 
Many participants discussed feeling self-aware and self-conscious, particularly in 
relation to exercising and at the beginning of the program. Individuals expressed a sense they 
did not belong amongst ‘exercisers’ and most participants discussing self-awareness 
conveyed an expectation of negative social evaluation from others. Some expressed doubt 
about being able to complete an exercise program.  
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Can I do this? 
Doubts about completing the program were not uncommon during the initial weeks, 
P047-44 (21F, MIPP) said: “I think that at the start of it, I probably thought, you know, I 
wonder if I’ll be able to do the full six weeks or if I will go to every single one every single 
week…[in the past] in relation to exercise I probably would not exercise that much or would 
have ideas that I was going to exercise and going to do something and then I wouldn’t do 
it.”. P039-36 (25F, HIIE) expressed her doubts this way: “It felt like too much effort, I feared 
I would fail. I wouldn’t be able to do it, because I had gotten so big.”. 
What do they think of me? – I don’t belong here. 
In articulating their sense of self-consciousness and not belonging, one participant 
P046-43 (43F, MIPP) said: “There’s all these fit people and they’re all - you know, they look 
good and they obviously know what they’re doing and stuff and I just felt I don’t really have 
a place here”. Another, P008-6 (27M, MIPP), talked of being self-conscious because of his 
weight: “There’s sort of a self-conscious aspect to it, you know what I mean, being like 
overweight and not being fit and not really knowing what I’m doing. Sort of especially, like 
quite a few times, you know, it’s obviously – what’s it called – the sports centre or whatever 
it’s called. And often there’s other people and stuff in there, so just sort of shutting that out 
and ignoring it and just focusing on what I need to do.” Comparisons like this, of self to 
other exercisers, differentness and not belonging, were not uncommon. Participant P030-27 
(26M, HIIE) discussed his self-awareness in relation to other gym goers: “I was just 
generally looking a bit awkward really, because when you go to gyms and things, everyone's 
usually quite muscly and fit there, and you feel a bit out of place sometimes. So I feared I 
could look a bit awkward.” Participant P008-6 (27M, MIPP) expanded on their prior 
response with similar sentiment: “Feeling self-conscious, you know what I mean, especially 
around the [gym], mostly everyone else is pretty fit and they obviously know what they’re 
doing and there’s guys doing ridiculous things on bikes and everything else, you know. And 
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it’s sort of like – I suppose, like, a lot of doubts were there in that regard. You know, just 
feeling incompetent if you will or like I shouldn’t be there, you know what I mean.”. 
In discussing expectations regarding social judgement, P046-43 (43F, MIPP) 
postulated what others might be thinking: “Just the thought of what people would – they 
would look at me and go, “Oh my God, no wonder you’re going to the gym. You really need 
to and you shouldn’t be wearing that” and it’s like well suck it up, I’ve got a budget, this is 
all that fits, so hey that’s what I’m wearing….”. Some participants had a more diffuse sense 
of awkwardness – P043-40 (28M, MISS) said: “I was most concerned about people, 
clothing, don’t know what to wear. Perceptions, I guess. I don’t actually recall any specific 
thoughts. I just kind of assumed that it would be awkward, I guess.” Over time, some of these 
concerns abated, if only slightly. The same participant talked about finding it far easier to 
consider exercising publicly after the program. But not without some trepidation, especially if 
they were known to the onlooker: “Yeah, so it’s much easier now to imagine exercising in 
front of other people. To go to the gym and not sort of feel freaked out that you would have to 
exercise.  Like, I still kind of – like, I’m not sure if I would actually exercise regularly at the 
gym here at the university because not only is it in front of people, but it is in front of people 
that you may potentially know.  And that sort of, for some reason for me, just does cause 
some anxiety and I retreat from that quite quickly.”. 
In sum, for these participants, engagement in exercise - especially in a gym 
environment - came with a sense of “otherness” through social comparison, fear of negative 
evaluation, and negative self-judgements or shame. Whilst some of these concerns were on 
general self-doubt about capacity to master exercise, others were specific to weight related 
stigma and appearance which might persist despite exposure to the exercise context. 
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4.3.4. Looking for Change 
 I’m (not) changing and it’s slow 
A majority of participants described regularly looking for changes that might be 
occurring. Many highlighted the benefits of exercise yet noted that change was slow. Some 
wondered about how to move forward when change was not readily apparent. Participant’s 
commentary highlighted the importance of creating multiple ways to measure change. 
Progress in these areas seemed to be a wellspring for their sense of accomplishment, 
motivation and exercise self-efficacy. 
Participant P045-42 (43F, MIPP) said making changes was what motivated her to take 
part in the trial – “I think it came at a time where I was going - I was searching things out 
because I was really starting to slip back into where I'd been a couple of years previous and I 
could feel the walls sort of closing in on me, and I knew that at some point I needed to start 
doing something to address that. I had spoken to my GP and I hadn't really had a satisfactory 
outcome from that. So I just happened to see this and thought, you know what, why not give it 
a go? It might do some changes or it might start me on a path that helps me with some 
changes.”. In contrast, participant P049-46 (20F, MIPP) disclosed she had considered 
withdrawing from the program having not seen expected results early on: “Actually, I was 
just thinking if I should just drop out because I was like this is so difficult and I have to drive 
to school and just do this thing. But at that point in time, when I still hadn’t seen the results, I 
was just like ‘oh my god, I’m wasting my time, I’m wasting my fuel coming down to do the 
exercise and wasting time’, like I should just drop out and stuff like that. In the end, when I 
think about it, I’m like it’s actually quite worth it because I drive down to school to exercise 
three times a week and I end up losing weight. So that should be considered an improvement 
as such.”. Describing the slow nature of change in desired outcomes, participant P007-5 
(36F, MISS) recalled “We [the trainer and her] used to make comments about like, “The 
weight’s still intact.”  I’m just paddling away and so we just had a joke about it.”. She 
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further explained her evolution: “But then I was starting to feel, I guess, when I was on the 
bike and I just started thinking about being nicer to myself and then, I finally got - I kinda felt 
myself come out a little bit, come out of my shell and just I felt - it’s much more quicker to 
talk to people before.” 
Identifying benefits 
Often when discussing change, participants shared subjective benefits of the program. 
These included elevated mood, distraction from unhelpful thoughts or unpleasant mood 
states, socialisation with trainer, improved fitness, greater energy levels, improved sleep 
quality, less day-time fatigue, a sense of relaxation, reduced somatic symptoms, the pleasure 
of exercise, greater general activity levels and changes in eating habits. In particular, the 
framing of these benefits were used to maintain motivation and commitment to engage in 
exercise. 
Discussion around improved mood and using exercise to help regulate mood was 
common: “I’m really enjoying exercise, my mood definitely improved as well. I just have 
more energy, which is nice. I was definitely really unfit before I started and I was quite down 
and tired all the time and I reckon that’s definitely changed..….Like I said I did not like the 
gym at all, now I do.  Just small things like that. Maybe [I] see it differently, because I know 
if I don’t exercise I'm just going to be in a crap mood all day.  Whereas I know if I go then I'll 
be in a good mood after. When I'm in a really crap mood and I don’t want to go, I still go 
because I know that it will improve it. My fitness improved a lot and I know I did lose a lot of 
weight, like I said before, so clothes were fit better. I could see changes which was good.” - 
P038-35 (21F, HIIE). Participant P022-19 (43F, HIIE) mentioned that following exercise, “I 
think generally I was happier, my body pains had eased. They hadn't gone away, but they had 
eased. So I was a little bit more lively say in the morning. I wasn't cramping as much as I do. 
So yeah I could attribute a sense of wellbeing to the program.”. Whilst P011-8 (33F, HIIE) 
said: “I felt calmer because I was exercising.  I did get pretty sick.  I had – I think it was a 
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sinus infection, during it, but apart from that, I went through a couple of sort of life events 
that were very, very stressful. And I think that doing that exercise really assisted my coping 
skills and it was something to pour my negative – what I view as my negative energy into, and 
that was quite a conscious thought in some of the sessions.  During the 30 seconds where you 
had push yourself, during that 30 seconds, that thought whatever it was on that particular 
session that that was what was driving those 30-second bursts, so – Yeah.  It – So I think 
allowed me to be a bit – go in there, push it out and then when you leave, you kind of leave it 
behind.” 
One regularly mentioned subjective benefit was a sense of satisfaction and 
achievement. Participant P008-6 (27M, MIPP) said: “I was kind of pleased and surprised that 
I got through it, if you know what I mean.  Like, it felt quite rewarding for me, I thought, that 
I finished it – even though there were, like I said, a couple of delays and I missed a couple of 
sessions for reason X, Y, Z. But I did manage to see it through and didn’t give up half way 
through or sort of, you know, pike out.  I don’t know, it was a good feeling – it was like I had 
accomplished something, do you know what I mean. I think the actual finishing was a goal 
almost, you know.  Like, achieving it sort of always feels pretty good, I think. Especially 
because that, for me, like I said, it was sort of stepping outside the comfort zone, you know 
what I mean. It wasn’t something that I was familiar with, it wasn’t something I sort of – I 
wasn’t sure if I’d be able to finish it, you know. So getting through it, for me, was – like, I felt 
great about it.” 
Some participants appeared to use their new exercise habit as a platform for making 
additional health behaviour changes. Participant P045-42 (43F, MIPP) reported “…I've got 
more energy, and that happened, as I said to you, really quite quickly in the program. It's 
changed my eating habits, I don't feel as hungry as I used to. Even come that 3:00 o'clock 
kind of blood sugar dip kind of thing I didn't experience any problems or anything like that, 
and some times I've eaten, I eat fruit. So I'm eating less, but I've also changed what I'm eating 
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as well.”. Another participant P039-36 (25F, HIIE) recalled “I used to find myself getting 
depressed quite a lot and I’d comfort eat. And yes, since then I just haven’t really - I’ve had, 
like, small moments like that, but I’ve been able to recognise them and I’ll make myself go to 
the gym instead of sitting and eating comfort food, or I’ve been able to make those changes, 
whereas before I would have just sat home and ate two packets of Pringles.”. Participant 
P030-27 (26M, HIIE) talked about their experience during the program “so usually I might 
take the car to somewhere, but during - just down to the shopping centre of whatever. But 
during - when I felt fitter, I actually did walk the short distances, a couple of kilometers 
instead of driving there.”. This participant discussed improvements more broadly too “I think 
my mood was generally improved, less sort of nervous sometimes, less worryful. Instead of 
getting up in the morning without much sense of purpose, it gave me a sense of purpose to get 
up and get ready, get out.”. 
Creating ways to find success 
In looking for changes, participants talked about the elusiveness of expected markers 
for change – often scale weight loss - and then discussed the value of having several 
measures of change. These alternative measures included subjective well-being or decreased 
depressive symptomology, increased fitness capacity measured by the VO2peak testing, 
greater strength or endurance in daily activities or during exercise, measured via on the 
onboard computer or by achieving additional repetitions/lifting more weight, within-session 
recovery measured by heart-rate normalisation and weight loss and body recomposition 
measured by DXA.  
In contrast to participants struggling to find change, described previously, P030-27 
(26M, HIIE) said “I felt quite positive about the improvement I made over the course of the 
six weeks. Especially with the VO2 results, that was a tangible one and the [DXA] scan, it 
gives some tangible numbers on the changes that had happened over that time.”. Participant 
P011-8 (33F, HIIE) used onboard technology to track their progress and develop exercise 
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self-efficacy: “So the whole thing’s challenging, but over the weeks, because of the 
technology and I could see what my heart rate was doing and things like that, I could see that 
during the rest times that my heart rate was coming down quicker. So all of that was a 
challenge to see how hard I could push myself in the cycling and see instantly how quick – it 
took to get my heart rate back down to a certain point”. Several other participants described 
the DXA scan highlighted changes not otherwise clearly apparent: “I was really - though I 
didn't actually say it or show it to you, after we did that scan thing, I thought that was really 
good. Because it was such a concrete measure to say something, and I think if everybody did 
exercise periods and knew you could do that [a DXA scan] then it would be so much more 
encouraging for people to continue exercising. I was pretty proud of myself, even though I 
said to other people I was unhappy about [gaining] the three kilos of muscle weight... I 
gained more muscle than I lost fat. I was pretty proud of myself at the same time” – P045-42 
(43F, MIPP). Participant P024-21 (43F, HIIE) noticed that despite not noticing changes in 
their appearance, their body composition had improved: “After you did that [DXA] scan it 
made me realise even though I didn't see a lot of difference it [the exercise] did make a 
difference.”. 
In summary, exposure to exercise and the experience over time provided evidence and 
reasons for maintaining adherence to their program. Whilst change could be slow, looking 
broadly for benefits (e.g. in mood, energy levels, sense of achievement, fitness, eating 
behaviours or body composition) seemed to give participants greater satisfaction with their 
achievements and subsequent motivation and determination to continue. 
4.3.5. Managing Competing Demands 
Fourteen participants discussed the challenges of managing competing demands 
involved in regularly exercising one to one with a trainer at an exercise facility. Several 
voiced psychological and practical aspects of their experience that seemed to facilitate their 
adherence. 
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 Barriers and Challenges 
A number of barriers and challenges were identified by participants. The most 
common were insufficient time or time management that was perceived as sub-optimal, other 
commitments – including family responsibilities, work and study, travel time, limited 
motivation, low mood, fatigue or illness. Some participants described anxiety as a barrier.   
Time and effective time management were often cited as challenges: “There were 
time clashes because my timetable was very hectic and I was often rushing to get – like, I was 
late numerous times… But it was just my own time management. A chairing session could run 
late, had to drop my son home, came back, so I was about five minute[s] late, but I was still 
coming…. But the time to get there and organise myself is sometimes a little bit hectic, but 
that’s just poor time management on my behalf, so I can work that out.” – P046-43 (43F, 
MIPP). 
As in the quote above, these challenges were tied not just to exercise being in 
competition with other commitments but also with low mood states: “I would sit at work 
going oh God, I've had a horrible day, or I'm really tired, I've got lots on after work, and now 
I've got to go and exercise kind of thing, or I've got to stop what I'm doing and I'd really 
rather finish this and run. But I have to go because I have to go. So actually turning up was 
by far the hardest thing. Once I was here, I was great. Afterwards - but it was just that get my 
act together to go, yeah.” – P045-42 (43F, MIPP). Illness could also play a role and was 
mentioned by three participants, for instance, P011-8 (33F, HIIE) said: “When I was sick I 
didn’t make some sessions, and then on two occasions – Excuse me – I was away for work, 
but the – my study just got pushed back a week, so – But – Yeah. When I wasn’t well, I always 
sort of spoke to [my trainer] about that anyway. If I ever didn’t make a session, that was 
why.”.  
Three participants raised anxiety regarding social evaluation (described in greater 
detail previously) as a barrier; P043-40 (28M, MISS) illustrated: “When I’m thinking about 
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it, because it was so often where I’d be five or ten minutes late, and the fact that it only took 
me five minutes to walk there, did make me think that there was some sort of anxiety sort of 
thing going on where it was pushing me to not go and it was kind of only the urgency of being 
late that finally pushed me up and over. So that was something I still really kind of need to 
think about a bit more. Because I probably wanted the experience, but just the anxiety about 
being in front of other people, I guess, new people, being exposed.”   
Facilitators 
In describing factors that facilitated adherence, participants mentioned scheduling, 
flexibility in making up for missed sessions, noticing progress, accountability and the 
relationship with their trainer.  
P045-42 (43F, MIPP), citing their challenges above, elaborated on how they managed 
to overcome these and remain engaged: “So if I'd made an appointment, I agreed to turn up, 
and she and I got on well and we had fun during our sessions. I think it was probably two 
things, I think it was [my trainer] herself and the fact that I'd made an appointment with her. 
Also, very early on I saw the benefits of having more energy, and that became really 
apparent to me, because I had been really struggling with tiredness up until that point, and 
as I saw that so quickly I just wanted to keep that going.”. P047-44 (21F, MIPP) said: “I 
think that, like I said, having the accountability for the exercise was really good, it was really 
beneficial. I probably just always did exercise a bit begrudgingly. But without the 
accountability there, I probably wouldn’t do it as often as I should.”.  
P035-32 (23F, MISS) meanwhile put their thoughts like this: “I’ve always wanted to 
do exercise, it’s just expensive and hard to find the time. I was pretty nervous at the start 
because I hadn’t exercised in so long. I was kind of just looking forward to being forced into 
being active.”. Scheduling sessions and flexibility to make up for missed sessions emerged as 
a helpful facilitator for maintaining momentum and engagement. “I found it pretty easy to 
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stick to. Once I set my mind to it I just made sure I was free to do it.  If I couldn’t come in for 
one session, we worked out another one.” .  
P024-21 (43F, HIIE) also discussed these themes: “I guess I push myself a bit more 
now after having to make that commitment to go, have someone else depend on you…One 
week I think I did an extra one because if the following week I was only doing two I might’ve 
done an extra one the week before or week after. So it kind of evened out. I think one week I 
might’ve been away but then just got back into it, and because we planned ahead a bit it 
wasn't left up in the air.”  
Therefore, participants experienced contextual (e.g. time, competing responsibilities), 
personal (e.g. illness) , and psychological (e.g. mood, fatigue, anxiety) concerns as barriers to 
exercise. The sense of negative social evaluation described in preceding themes recurred here 
creating a sense of internal resistance. In contrast, facilitators of engagement included 
scheduling of ‘make-up’ sessions, accountability to the personal trainer and being aware of 
positive changes. 
4.3.6. We’re in this Together: Importance of Rapport and Relationship with the 
Trainer 
One of the key themes to emerge was from participant’s reflections on the 
relationship and rapport with their personal trainer. Almost all indicated their trainer was 
instrumental to adherence and gaining benefit from the program. Three aspects of this 
relationship emerged as particularly important. Creating a sense of trust and safety between 
participant and trainer, the value of the trainer’s knowledge and expertise and having a trainer 
to commit or be accountable to were commonly described as important. In this way, creating 
a healthy and robust rapport was a key element for engagement. Past experiences often 




Creating a sense of safety and trust 
When the exerciser-trainer relationship worked well, it frequently seemed to establish 
a quality of trust and safety which created a place from which participants could risk making 
changes whilst being vulnerable through exercise: “It was nice to be able to like – because 
usually when I go to the gym I feel very conscious and having [my trainer] encourage me, it’s 
kind of like okay, so you’re not making fun of me, you have my back. I kind of realise that 
people don’t usually care about me when I go to the gym – which, I mean, yeah, like in a 
good way like that. People are not like making fun of me or something like that. Because I’ve 
had bad experiences where in the past I would go with my cheer team when I was in 
secondary school and then they would judge people, so I get worried that people will judge 
me, but that’s not the case, I guess… [my trainer] understood I had a lot of things going on, 
so she was very flexible. If I said I suddenly can’t make it, and she would go ‘it’s okay, we 
can just push it to this date’... So she was very nice about it. And she was very encouraging. 
Like, if I said I really don’t want – it’s like I’m trying to give up, especially the first few 
lessons, and she was like ‘it’s okay, just three more’ or ‘12 more’. And she’d just really focus 
on that. And the whole company thing, because I didn’t use my phone, so I talked to her 
instead and she was just talking back and stuff like that. So it was kind of nice having a 
person to talk to.” – P049-46 (20F, MIPP). 
P046-43 (43F, MIPP) contrasted her current experience with her trainer in the 
randomised control trial with a trainer she worked with when much younger: “I didn’t think I 
was able to do something like that, like, even with a back injury and then progressing 
through slowly with the help of my trainer and being supported through all of that, it made 
me feel quite good about myself… I’ve had personal training before and, I mean, this was 
when I was in my mid-20s, and I’m 40 now. And it was literally like Commando yelling. You 
know, ‘you’re useless’, ‘you’re this’. I didn’t need belittling. I feel belittled enough as it is 
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within myself and I didn’t know what to expect as far as how they were going to be and so on. 
So it was nice that they weren’t that way. I thought I’m going to get grilled and I’m going to 
feel even worse in something else that I know I’m already bad at. But it wasn’t like that at 
all.”  
P008-6 (27M, MIPP) described how this safety and trust lent itself to achieving 
breakthroughs without being overcome by a sense of failure: “[My trainer] knew just how to 
push me a bit further than I would have myself, but not too far that I’d fail, if you know what I 
mean. I suppose you could say she could read it very well, you know. She knew what she was 
doing and then she’d push me sort of enough, but not too much, you know what I mean. So 
you felt like you’d broken through some barriers and stuff, but not that you’d fall in a heap 
and not want to come back…  She was very professional, but she was also – you could just 
chat to her, you know what I mean.  Like, she was very approachable.”. 
 This sense of rapport through safety and trust most commonly took time to develop – 
P007-5 (36F, MISS) put it this way: “I felt like I didn’t know if I was able to connect [with 
my trainer] or I felt - I really felt vulnerable to be honest. I can definitely say that in the first 
few weeks, I was very closed up with - in my mind and just trying to shift ‘why am I here?  
What am I doing?’ There was some kind of resistance in myself and then I was scared and a 
bit desperate in the beginning and stuff. And then I kinda saw it shift after a while at the third 
or so week or something like that... It took a few weeks… then we started having 
conservations and connected and then that’s how it shifted. So then all of a sudden, it became 
a pleasure to - I was looking forward to seeing [my trainer] every time and that kind of 
helped.” This rapport seemed to buffer more challenging experiences: “[My trainer was] 
friendly and approachable and he’s really positive. So even if, on some days, I wasn’t doing 
very well and I said to him, you know, ‘I really don’t feel like doing this today’, he would 
kind of encourage me to keep going or to give it a go and then I would end up doing it and I 
would feel happier for doing it because of just his nature.” – P047-44 (21F, MIPP). 
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Knowledge and expertise 
Participants described leaning heavily upon the knowledge and expertise of the trainer 
in helping them learn more enjoyable, effective and engaging exercise techniques and 
surmount challenges. This was especially so in the Moderate Intensity Personal Preference 
condition, where participants could select the exercise type and format with support from 
their trainer. For instance, participant P047-44 (21F, MIPP) said: “I liked having the really 
good rapport with my trainer. That was really good because it was good to have that 
constant, like I said, the same trainer the whole time and have the really good feedback 
coming and have, you know, the knowledge of the different exercises. So if I wanted to ask 
why I was doing a particular thing, it was good because he could actually tell me exactly the 
reason why I was doing that exercise and what it would do and why we were doing so many 
reps and all of that. So I found that really helpful.”.  
For some, the trainer became a sounding board for future planning whilst the 
knowledge of the trainer added an extra element to the relationship: “being able to interact 
with someone who is a trained professional, perhaps could help me develop strategies for my 
own exercise program, see what would work. I learned a lot about just general exercise 
techniques and stretching and fitness, and that was a very positive relationship, that 
encouraged me to come back. Yeah it was very important to me I think. If I had a trainer that 
didn’t get along with me so much, perhaps it would have been less motivated to do it.” – 
P030-27 (26M, HIIE). 
Accountability 
A sense of accountability, discussed above as facilitating adherence, was often 
implicit within the relationship with the trainer. This seemed to occur through encouragement 
and enjoyment of the relationship yet at other times, through fear about breaking a social 
contract and inconveniencing the trainer. P038-35 (21F, HIIE) recalled: “…having someone 
there to actually push me, to actually get there and do the exercise, because I found it hard to 
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go unless I have someone to say come on, let’s go, let’s go. I found that good. Just motivating 
sort of thing.”. P030-27 (26M, HIIE)  said: “We had a really good rapport and it was 
something to look forward to, something regular to keep coming back to. [He was] very 
supportive and I felt that if I didn’t go I would let him down or waste his time.”. During times 
when it was challenging to exercise regularly, accountability to the trainer seemed to defend 
against the desire to give up: “There were quite a few times where we only did two sessions a 
week just because scheduling didn’t work out. And even though it was hard to gear myself up 
sometimes, I knew I kind of didn’t really have a choice because I’d be letting down my 
trainer and I’d have to do it at some point anyway.” - P035-32 (23F, MISS). For participant 
P014-11 (20F, MISS), the social contract was key: “I told myself I was obligated to come 
because I made an agreement. That was the only reason I went.”. 
Adequate relationships still work, but perhaps not as well 
There were also times when the rapport was described as adequate, but not as robust 
as was experienced by others. Participant P017-14 (42M, HIIE): “I think she tried to chat, 
but I had nothing to talk to her and we didn’t connect, she was very nice but we didn’t 
connect. And I noticed that after a couple of sessions she’d say okay, well done but she just 
let me do it myself. I wasn’t chatting or anything so she just let me do - and she’d do things 
she needed to do and just timed me.”. Participant P011-8 (33F, HIIE) recalled: “It was pretty 
– And don't mean this in a bad way, but it was a pretty shallow relationship, and I guess, for 
me, you go in knowing that you’re gonna have three sessions for six weeks and that’s kind of 
the end of it, so it’s not – You’re not looking to make a friend or anything in it. He just sort of 
an ‘exercise type’ and I guess that’s what it was all about anyway…but that was a little 
weird, not bad, just something that I noticed. It was what it was. So he – shallow – I just 
mean no – there was no – just ‘how was your day?’ ‘Oh.  Yeah.  Cool.’ Straight into it, bit of 
general chit chat, nothing deep, but I thought [my trainer] was a nice guy, who was 
encouraging.” 
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These quotes underscore how important robust rapport with the personal trainer was 
in creating an engaging program, encouraging adherence, problem solving challenges and 
reducing anxieties and fears associated with perceived failures and expected negative social 
judgement. The individuals who had adequate yet not robust rapport with their trainer 
managed to complete the program without having felt fully engaged by, or with their personal 
trainer. 
4.3.7. Sustainability of New Behaviours 
Several participants discussed the sustainability of regular exercise. Some of these 
participants had doubts about being able to maintain regular exercise whilst others had made 
plans or were engaged in regular exercise since completing the program.  
Exercising into the future  
Ten out of 18 participants interviewed continued exercising regularly after the 
program, at home, a local gym, at work or in a range of settings within the community: “I’m 
doing a lot more variety at the gym now, like with a personal trainer I’m doing weights and 
everything as well.  But I’m actually still doing the interval training on the bike and stuff as 
well, which is good. I’ve been going consistently for the last three weeks, because I ended up 
with bronchitis so I had to give it a break for a little bit, but yes, I’ve been doing it 
consistently three days a week for three weeks now.” – P039-36 (25F, HIIE). Another 
returned to a boxing class she had done previously: “And before the program - late last year I 
did some boxing classes and I really enjoyed it - and so after the program I decided I wanted 
to keep going and I knew that was something I enjoyed, so I’ve been going 2-3 times a week 
since I finished the program.” P035-32 (23F, MISS). 
I’m having doubts 
Participants sometimes described doubts about continuing exercise, often citing 
barriers identified previously: “I have reduced my level of exercise…not having the right 
equipment for me - so that was an exercise bike with a variable intensity. I don’t have that 
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equipment or access to that equipment. So I've changed exercise and also not having a fixed 
time or a reason to have a fixed time. So I'm not meeting up with a person at specific times, 
and it’s just left up to myself and my own motivation to continue.” P030-27 (26M, HIIE). 
Other participants who continued exercising after the program experienced doubts 
about the sustainability of their new habits: “I felt accomplished, I felt quite accomplished. I 
don’t know if I ever want to do it again. At first at the very, very end, I was like I am never 
going to ride a bicycle again….and  because the gym is quite far from my home, I couldn’t 
really go there very often, but I wanted to” – P049-46 (20F, MIPP). Likewise, participant 
P045-42 (43F, MIPP) recalled: “my concern was, when I didn't have that structure in place, 
that I would fall off the wayside…. I think the trick now is to find ways to replicate that in  the 
real world, and I'm not sure that that's a necessarily easy thing to do. But that's what I have 
to do to keep going.”. 
Problem solving for sustainability 
Several participants spoke of difficulties in continuing exercise but approached this 
with a problem-solving attitude: “[I’d like to] get back to being physically capable of doing 
different things and also being able to release that stress through doing other exercises, other 
team sports or whatever. Because I’ve had to give up everything [due to prior injuries]. I’m 
not able to play volleyball anymore… Now I’m looking at what else I can do… And I think 
that’s got a lot to do with [my trainer] having the ‘Well you can’t do that, okay, what else can 
we do’ – it’s kind of changed my way of thinking through her encouragement –so if I say to 
myself, ‘Put aside this time in the morning, get yourself up, go for a walk, go and do some 
lunges or step-ups or whatever’, it’s not going to be a huge time thing because the way that 
[my trainer] has designed it, I can do it at home, so there’s no travel time. I don’t have to go 
to a gym to do it. I can do it at home.” – P046-43 (43F, MIPP).  
The theme of accountability, this time through exercising with a friend or companion 
was common in those who remained active, as P024-21 (43F, HIIE) recalled: “Now that I’ve 
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finished [the program] I’m like I’ve got to keep that up so I’ve started jogging with a friend 
couple of times a week and going to yoga twice a week and doing my soccer. So I probably 
do at least three or four things a week at least now, and if I do any less than that I feel like 
I’m not really doing enough. So it’s made me know that I can make that time now and just put 
it in my diary and make sure I work around it.” Similarly, participant P045-42 (43F, MIPP) 
modeled her exercise habit on the accountability she found helpful during the program: “So I 
actually went for a couple of runs, because before we finished - this was one of my concerns 
with [my trainer], was because I had that regular appointment with her, I'd always come and 
show up, because that's what I'm like as a person, if I make an appointment I move hell and 
high water to get there. So I've spoken to one of the girls at work and I've said to her, you 
know when I come in with my stuff, you need to make sure that I keep that appointment with 
myself to go out and do something, This participant also used environmental strategies to 
ensure she was able to continue exercising: “I moved an exercise bike [we have] at home into 
the bedroom, right next to my bed so that - because it was tucked away in a spare room 
somewhere…I put it in my bedroom so that I see it all the time, and [you] can't keep walking 
past it and ignoring it or hanging the clothes on it to hide it or anything like that. So I've sort 
of made room in my days to do those things to keep the exercise going. 
These excerpts highlight that whilst some participants experienced doubts about 
ongoing exercise, often exacerbated by barriers to exercise described previously. Those that 
continued a program after their enrollment used a variety of social (i.e. accountability), 
behavioural (e.g. scheduling) and environmental strategies (e.g. proximity to equipment) to 
assist with adherence. 
4.3.8. A More Ideal Program 
Participants often considered qualities they thought could contribute to a more ideal 
program, including desirable aspects from and potential modifications to their program. Some 
participants realised that whilst exercise alone was helpful, it was not enough in combating 
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depression. Most articulated a desire for a more complete program that included 
psychotherapy and psychoeducation. Within this subgroup, some expressed a desire to 
address their eating behaviours which they believed went hand in hand with being OW/OB 
and clinically depressed.  
Qualities of a good program 
Variety, choice of exercise and companionship were frequently mentioned by participants 
across all conditions and exercise choice especially in the MIPP condition. P004-2 (42F, 
MIPP) asserted: “I liked that the program was not just one thing, the exercises were different. 
And I think that’s what kept me and also my trainer was quite good too. So he was quite 
interactive. And that kept me coming back to the sessions. Yes, no I can say probably exercise 
that I hadn’t done before like the rowing, things like that. So doing some of the exercises that 
I’ve never done before. So I did mixed cardio and weights, like things like that.”. P045-42 
(43F, MIPP) seemed to feel a similar way: “I liked the fact that I could pick what I wanted to 
do, because I find that I can't just do one type of exercise. If I just had to cycle or I just had to 
walk or whatever, unless I was doing it with someone - but by doing it by myself, I have to be 
able to have the option of changing what I do to stay engaged and interested in it. The other 
thing is, if I just had to - like the first day, we just cycled, and there was no change in speed 
or anything like that, it was just cycling, I found that mind numbing. I found I got far more 
enjoyment - because I felt like I'd actually achieved something by doing interval work than 
just riding a bike or going for a walk or something.” 
P049-46 (20F, MIPP), did the same program throughout their study enrollment reflected: 
“I think it would have been nice to do a variety.  It would have been more difficult because I 
think it got easier for me because I kept doing the same thing. But then if we kept switching it 
up, it would have been more interesting and I feel like it would have been more of a workout 
because I would have been exercising different parts.”. Participant P030-27 (26M, HIIE) 
mentioned group programs as potentially appealing, along with greater variety: “Previously I 
 166 
came to understand I preferred exercising with other people around, or interaction with 
other people, rather than doing it with myself. Perhaps time for a group instead of just the 
one other person, just have a group exercise or something. Also more variety, the cycling and 
doing the same pattern every day did get a bit tedious.” Those whose program was on a 
stationary cycle often cited resistance training as an appealing alternative: “I did not like the 
bike. I prefer weights and that stuff. I was the interval cardio one, I don’t know if that’s the 
right name for it. Pretty much only on the bikes.” - P038-35 (21F, HIIE). Participant P011-8 
(33F, HIIE) said “I quite enjoy cycling anyway, but I would’ve enjoyed a weights session as 
well.” For others, the interval training in the HIIE condition added enough variety: “It 
would’ve been pretty boring just doing the same speed the whole time. So I think the intervals 
were good and broke it up a bit.” – P024-21 (43F, HIIE). 
A number of participants made mention of exercise intensity, particularly in regard to 
increasing engagement: “At the beginning it [the exercise session] was kind of hard, but then 
it would sort of be this 15 minutes of, you know, ‘are we there yet?’ kind of thing. For myself, 
because I’m aware of the benefits of high intensity interval training, I probably would do 
that. Plus, it kind of breaks it up so that it’s not just one long 30 minute thing.” – P043-40 
(28M, MISS). Another suggested: “…you could only go moderate intensity. You couldn’t like 
really go hard, which was a bit of a bummer sometimes.” – P035-32 (23F, MISS). 
Only one participant made mention of the duration of the program, and suggested that a 
longer duration might be useful: “Maybe make it run longer… If nothing else was an issue, 
I’d say maybe like 12 weeks or something like that, you know.” – P008-6 (27M, MIPP). 
Exercise alone is not enough 
Some participants described that whilst exercise was helpful in many respects, 
exercise alone might not be sufficient or have a sense of completeness of intervention for 
clinical depression in an OW/OB population. The three broad topics brought up included i) 
desire for formal psychotherapy, ii) an aspect concerning eating behaviours and nutrition and 
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iii) psychoeducation on the essential aspects regarding how exercise programs improve 
depression. 
For example, participant P017-14 (42M, HIIE) wondered: “I thought the research, 
like, okay, through the exercise I’m going to feel better. Really I was thinking there was going 
to be something built in this program will demonstrate to you how by exercising you’re going 
to feel better. I don’t know, how hormones work or how they stimulate what and why it’s 
important.”. Participant P006-4 (36F, MISS) recalled: “I guess I was hoping there was 
gonna be a bit of a dietician side of things involved as well, like just guidelines to follow 
through the process ‘cause you have to be overweight to be able to do it There was none of 
that so that was disappointing.”. Participants seemed to understand that exercise alone might 
not change things overnight, pointing toward a desire for further intervention. Participant 
P004-2 (42F, MIPP) said: “But I think that, you know, I’m still obese but I think also my 
perception about my physical appearance is still the same. You know, there hasn’t – like even 
though my fitness has improved and I feel better about that. There’s still body image issues 
and how do I feel about appearing to other people that kind of stuff. So, you know, many 
years of thoughts like that don’t change overnight. So there’s a sense that okay, my mind has 
changed in the sense that okay I might not be able to do that now, but I can work my way 
towards that if I want too.” Another participant said they had sought psychotherapy 
following completion of the trial program: “I think I have taken steps forward, but when I 
finished the study, I still felt that I needed more. So I booked in to see a counsellor at … and 
had five sessions after the study finished, up until this week.” – P011-8 (33F, HIIE). 
In short, these excepts illustrate that key components of good programs may include 
within and between session variety (e.g. type of exercise, intensity, format), personal 
preference, and companionship with an element of accountability. Further, exercise alone is 
not necessarily sufficient for all participants to feel optimally supported, engaged and 
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underscores the potential benefits that could be derived from incorporating exercise into an 
evidence based psychotherapy designed specifically for this population. 
4.3.9. Summary of Qualitative Results 
The primary aim of the qualitative study was to better understand the experience of adults 
with clinical depression and co-morbid OW/OB in an exercise intervention. We also sought to 
understand what aspects of these interventions might be important for future program design. Six 
main themes included: A) Awareness of self in relation to exercise and exercisers, B) Looking for 
change, C) Managing competing demands, D) Importance of rapport and relationship with the 
personal trainer, E) Sustainability of new behaviours, F) Suggestions regarding a more desirable 
program. A further 16 sub-themes were identified each of which elaborated on participants views 
and experiences. 
4.4. Discussion 
Made-to-measure interventions for clinical depression in adults with OW/OB are 
scarce. To date, these interventions have combined standard treatments for depression and 
weight-loss (Faulconbridge et al., 2011; Pagoto et al., 2013). Exemplars typically involve 
weight management, lifestyle programs and/or cognitive and behaviour therapies for 
depression and often including physical exercise programs in treatment. The aim of the 
present study was to gain a more nuanced insight into the experience of adults with OW/OB 
engaged in exercise as a treatment for clinical depression. Such findings can inform 
development of tailored therapies for depression in adults with OW/OB. Our findings should 
also enhance research understanding and effective utilisation of exercise for depression and 
general health in this population. 
4.4.1. Exercise Self-Efficacy and Confidence to Exercise  
Research indicates that depression leads to lower levels of exercise than the general 
population (Patten et al., 2009), that individuals with depression are likely to discontinue 
exercise (Teixeira et al., 2004) and have lower self-efficacy (Sacco et al., 2005) than 
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euthymic peers. More recent research has suggested this moderating effect of depression on 
self-efficacy may be even higher in individuals with high BMI (Kangas et al., 2015). 
Increasing self-efficacy in clinically depressed, OW/OB populations may be particularly 
challenging. 
We expected all conditions to improve on measures of exercise self-efficacy and 
subjective confidence. We found no substantial change in exercise self-efficacy or confidence 
to exercise over time. Furthermore, no format or type of exercise was superior at improving 
self-efficacy or confidence to exercise. Our qualitative findings however, indicated that some 
participants acquired a subjective increase in confidence and self-efficacy to exercise over 
time. These individuals emphasised feeling supported by their trainer in constructing and 
engaging with their program. They also clearly enunciated a reduction in self-doubts and 
social fears, which amelioration occurred progressively as they continued with the program 
and internalised a problem solving approach to challenges.  
Previous research on exercise interventions and self-efficacy is mixed. To our 
knowledge, no studies exist on exercise self-efficacy in clinically depressed and adults with 
OW/OB. Self-efficacy is frequently lower in adults with depression than within the general 
population (Craft, 2005; Kangas et al., 2015), yet several studies have reported increases in 
exercise self-efficacy in non-depressed and depressed but not exclusively OW/OB samples 
following regular exercise (Jung et al., 2014; McAuley et al., 1995; Singh et al., 2005). 
Across conditions, participants in the present study scored in the lower range of exercise self-
efficacy compared to these and other populations (Everett et al., 2009). This is consistent 
with the described  initial levels of self-doubt and low self-efficacy during qualitative 
interviews. These low scores are not surprising, as our inclusion criteria required that 
participants were not engaged in regular physical activity. The lack of improvement in 
exercise self-efficacy suggests the importance of directly targeting exercise efficacy (e.g. via 
cognitive and behavioural strategies) may be important in depressed, OW/OB cohorts.  
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There is some evidence that programs which incorporate targeted approaches to 
improving exercise self-efficacy are important in the general population. In a 6-month 
program based on self-efficacy theory, obese, sedentary women derived small but significant 
improvements in exercise self-efficacy (Annesi, Unruh, & Whitaker, 2007).  Buckley (2014) 
compared changes in self-efficacy following either a 12-week program which included daily 
cognitive therapy exercises based on Social Cognitive Theory (e.g. identifying why exercise 
is important to oneself, self-regulation tasks and relapse management) or an information only 
control condition for OW/OB women. Buckley found that exercise self-efficacy improved for 
individuals in the intervention group who were inactive at baseline yet remained stable for 
individuals who were active at baseline. Given that individuals with clinical depression are 
often inactive, these findings are very relevant and indicate that structured cognitive 
interventions delivered alongside an exercise program may be required for exercise self-
efficacy to increase in populations with depression and OW/OB. These findings are also in 
line with the comments from participants described previously, in that those who used a 
variety of strategies to enhance exercise and were able to self-regulate were able to continue 
exercising following the program. 
4.4.2. Motivation, Enjoyment and Positive Anticipation  
Motivation, enjoyment and positive anticipation of exercise improved significantly 
over time. This was consistent with qualitative findings, in which participants discussed 
approaching sessions in search of change and, when identifying areas of improvement, 
subsequently feeling motivated to continue exercising.  
Clinical depression leads to behavioural repertoires that limit the opportunity for 
change and especially achievement. In concert, unhelpful cognitions common in depression 
tend discount or minimise success when it occurs (Beck, 1991). Our research indicated that 
participants sometimes felt disappointed with their progress, especially when measured by 
only circumscribed outcomes - often scale weight. Indeed, overweight individuals engaged in 
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exercise report weight loss as a primary motivator to exercise and that failure to lose weight 
strongly dampens motivation for continuing physical activity (Guess, 2012). This is 
particularly important because in such populations, weight loss is rarely mentioned as a 
benefit of exercise (Alvarado, Murphy, & Guell, 2015). When afforded the opportunity to 
measure progress in a variety of ways (i.e. regulation of mood or anxiety, reduced fatigue, 
improved energy, heart rate recovery, body composition, aerobic capacity, strength or 
muscular endurance and completion of goals) participants in our study experienced a sense of 
achievement which became a motivating factor for continuation. Similar to overweight 
women in prior research (Sabiston, McDonough, Sedgwick, & Crocker, 2009), our 
participants typically improved fitness and strength yet described limited changes in physical 
appearance. Several participants remarked with surprise that body composition (i.e. fat loss 
and muscle maintenance or muscle gain) had altered significantly while scale weight 
remained unchanged. This suggests that having multiple markers of progress is especially 
important for persons with co-morbid depression and OW/OB, who may discount success or 
fail to notice achievements other than those more commonly associated with exercise for 
overweight individuals, i.e. primarily weight-loss. 
When considering specific exercise types and formats, individuals in the HIIE 
condition showed the most absolute improvement in motivation, enjoyment and positive 
anticipants yet contrary to our expectations, participant’s post-intervention levels of 
motivation, enjoyment and positive anticipation were comparable across conditions. We 
noted lower scores in the initial week of the intervention within the HIIE condition, which 
having normalised, may account for a large portion of the improvement in motivation and 
positive anticipation seen across conditions. This indicates that whilst HIIE may be 
experienced initially as relatively more challenging, uncomfortable or otherwise aversive, 
this discomfort seems to reduce over time. Indeed, prior research on HIIE interventions has 
shown increasing enjoyment over time (Bartlett et al., 2011; Jung et al., 2014). Bartlett et al. 
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(2011) suggested this may be because HIIE sessions are typically shorter, and that briefer 
activity bouts may be perceived as more enjoyable than longer ones or, that HIIE is more 
enjoyable than alternative exercise formats. Our research provides some support for the latter 
assertion, since participants exercised for the a 30-minute duration irrespective of condition. 
These are important findings as they indicate HIIE is well tolerated and experienced as 
enjoyable, motivating and positively anticipated as alternative forms of exercise (including 
personal preference) and contrary to recent commentary on HIIE that asserts it is not a viable 
intervention for improving a range of health outcomes due to its psychologically aversive 
nature (Biddle & Batterham, 2015).  
Non-specific factors occurring across conditions may have contributed to a lack of 
differentiation between conditions. As exercise trainers worked with participants from each 
condition, the impact of individual trainer rapport cannot be quantitatively accounted for in 
the present study. Nevertheless, participants in the HIIE condition recalled sessions as 
enjoyable and motivating whilst having a goal to achieve specific power output or heart rate 
recovery as displayed via on-board feedback of the Wattbike Pro (i.e. power output and heart 
rate). Participants described variation within sessions as engaging. This was consistent with 
the experience of participants in the MIPP condition and in contrast to participant’s 
experience of steady state cycling (MISS), who indicated that subjective in-session boredom 
was salient. These findings expand upon previous research. Tjønna et al. (2008) asked 
overweight individuals to take part in a 16-week trial of HIIE (treadmill running) vs 
continuous intensity steady state or a control condition. Participants indicated that the interval 
format was motivating due to the varied procedure within each session, where-as participants 
in the continuous exercise format described sessions as not engaging. The current study 
replicates this finding and further suggests that exercise programs based on personal 
preference and HIIE may be engaging due to program and within-session variation and in-
session feedback provided by technology. Our findings also indicate that factors relating to 
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knowledge, expertise, safety, trust and accountability imbedded in the relationship with the 
trainer may be important in ameliorating the negative effects of lower exercise self-efficacy. 
Future research therefore, should clarify how motivation, enjoyment, positive anticipation 
and exercise-self efficacy might be associated with participant-trainer rapport. 
4.4.3. Importance of Social Context 
Comparable to recent work by Danielsson et al. (2016), we found themes centred 
around separateness and not belonging, challenging oneself to achieve some worthwhile goal 
and the importance of the relationship to the trainer. The present research expands on this 
work in several ways. The first is the historical intrapsychic and interpersonal context the 
OW/OB individual brings and the second, how the relationship with the trainer becomes a 
catalyst for change. Participants described that public exercise had often become a powerfully 
self-critical interpersonal and intrapsychic space. This seemed to amplify future expectations 
vis-à-vis negative social evaluation, especially in an exercise context. Similarly, self-criticism 
and over attending to perceived failures show how individuals internalised past experiences, 
ruminating upon them when intending to exercise. In turn, these dynamics might contribute 
to reduced readiness for, less regular use of and lower adherence to exercise to improve 
mental health and wellbeing in this population.  
4.4.4. Facilitating Change, Benefits and Barriers 
The benefits from, and challenges to regular exercise for mental health populations 
has received some qualitative attention (Carter et al., 2016; Danielsson et al., 2016; Rogerson 
et al., 2012; Searle et al., 2011). Exercise for adults with OW/OB who were not clinically 
depressed has been qualitatively examined (Alvarado et al., 2015; Guess, 2012). We believe 
the current research represents the first report of benefits and challenges to regular exercise in 
clinically depressed, OW/OB persons.  
Our research echoes previous findings and confirms similar benefits and challenges to 
overweight, non-depressed and depressed, normal weight persons (Alvarado et al., 2015; 
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Carter et al., 2016; Danielsson et al., 2016; Guess, 2012; Rogerson et al., 2012; Searle et al., 
2011). Benefits reported in the current study included elevated mood, distraction from 
unhelpful thoughts or distressing mood states, socialisation with trainer, a fulcrum for 
structure during one’s day, improved fitness, greater energy levels, better quality sleep, less 
day-time fatigue, relaxation, reduced somatic symptoms, enjoyment of exercise, greater 
general activity levels and changes in eating habits. Many of these benefits became 
facilitators (e.g. improved fitness) and motivators for exercise (e.g. reduced somatic 
symptoms, socialization with trainer). Participants mentioned scheduling, flexibility in 
making up for missed sessions, noticing progress, accountability and the relationship with 
their trainer were additional facilitators to exercise. These findings are similar to prior 
research reporting that psychoeducation (e.g. about specific psychological benefits of 
exercise), social support, provision of strategies (e.g. goal setting) monitoring (e.g. with heart 
rate equipment) and personal preference are common facilitators of adherence to programs 
(Carter et al., 2016; Danielsson et al., 2016; Searle et al., 2011).  
Ten participants (55%) interviewed continued exercising following the program. This 
is slightly lower than in previous quantitative research that reported approximately 64 per 
cent of individuals assigned to an exercise intervention for clinical depression continue to 
exercise at least 12 weeks later (Babyak et al., 2000). One crucial difference between the 
present study and Babyak et al.’s research was that we did not prompt participants to 
continue physical activity following the program, whilst Babyak et al. directly encouraged 
individuals to continue exercise as experienced in the research program. At least three 
participants in the present study made plans yet had not carried them out. Within this latter 
cohort, barriers to exercise were brought up including financial limitations which was not a 
concern whilst participating in the controlled trial. Of those who had continued exercise, 
themes of problem solving, scheduling, goal setting and accountability to a friend or trainer 
were discussed. Many of those who continued exercising based their own programs on 
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templates they learned in the exercise intervention trial. This illustrates that for some, the 
strategies developed over the course of the intervention naturally generalised to use within 
the community. Our research demonstrates the importance of a flexible and collaborative 
problem-solving approach to managing adherence to an exercise intervention and that direct 
encouragement or planning may be necessary to ensure continued use exercise following 
cessation of treatment programs.  
Typical challenges included difficulties with time management, competing demands, 
low moods states, anxiety, fatigue, and low motivation. In overweight but euthymic 
populations, common barriers to exercise include lack of understanding correct technique or 
programming, feeling self-conscious or socially judged, (especially for adults with BMI > 
40), inadequate access to affordable facilities or equipment, narrow awareness of inexpensive 
options and discouraging stereotypes regarding gender oriented activities - for example, 
resistance exercise being perceived as ‘male oriented’ activity or only for those interested in 
‘muscle building’ (Alvarado et al., 2015; Guess, 2012; Sabiston et al., 2009). A unique 
challenge in a population with co-morbid depression and OW/OB that emerged in the present 
study seemed to be the activation of an intrapsychic voice that was critical and punitive, 
discouraging engagement in exercise and discounting success. Over time, a minority of 
participants described becoming ‘kinder’ to themselves and more self-compassionate. Future 
interventions for depression in OW/OB populations, particularly those including cognitive 
therapy might benefit from directly targeting self-critical schemas and cognitions by fostering 
self-compassionate and self-motivating attitudes and beliefs. 
4.4.5. Self-compassion for Clinical Depression in Overweight or Obese Adults  
There is a growing body of evidence supporting compassion focused therapy for 
depression and psychological problems associated with obesity (Gilbert et al., 2006). 
Compassion focused therapy may be especially useful when self-esteem, self-criticism, 
affect-regulation and eating behaviours are significant contributors to distress (Gilbert et al., 
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2014; Gilbert, 2009). It is interesting that approximately one third of participants in the 
primary study met criteria for binge eating disorder and several more engaged in sub-clinical 
binge eating behaviours. Compassion focused therapy may therefore be a clinically useful 
intervention for this population.  
In a compassion focused model it is hypothesised that the affect regulation system 
underpinning a feeling of safety, well-being and reassurance is poorly accessible (Gilbert, 
2009). This is especially so in individuals with high shame and self-criticism. Goss (2011) 
outlined three affect regulation systems: The threat system alerts an individual to social and 
physical threats provoking feelings of anger, anxiety or disgust. In OW/OB persons, this 
might include self-criticism or expected criticism from others and shame. The 
flight/fight/submission behaviours, serotonin and HPA axis dysregulation are hypothesised to 
play a role in the threat system (Gilbert, 2009). Goss notes that threat system activation may 
inhibit positive feelings and lead to the activation of the drive system designed to self-sooth. 
The drive system is posited to orient a person toward pleasure and attainment of important 
rewards and resources. These include food, sexual opportunities, social alliances, nesting 
sites and territories (Gilbert, 2009). Goss suggested that individuals who are OW/OB or 
depressed may be caught oscillating between the threat and drive systems. For example, in 
seeking to exercise or lose weight, being met with slow progress, getting angry, upset and 
self-critisising might subsequently produce pleasure seeking by way of eating to moderate the 
threat system. For individuals who binge eat, the subsequent cycle of guilt, shame and over-
compensation is well established (Burney & Irwin, 2000; Sanftner & Crowther, 1998). 
Depression may compound the issue by keeping failure salient and success discounted (Beck, 
1991). This oscillation is common unless the third system is active. The affiliative soothing 
system only becomes active in the absence of threat or deprivation. It is associated with 
feelings of contentment, attachment or social-connectedness, kindness, compassion and well-
being and may draw on mechanisms of the opiate and oxytocin system (Gilbert, 2009). 
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Furthermore, Gilbert suggested the affiliative soothing system regulates the threat and drive 
systems. One of the critical activators of the affiliative soothing system are caring behaviours 
in an interpersonal context. This is not dissimilar to the dynamic that participants in the 
current research described between themselves and personal trainer whereby they would 
more gently encourage themselves to continue amidst challenging sessions or problem solve 
difficulties that occurred. Therapeutically, Gilbert (2009) outlined how attention tasks, 
imagery, and cognitive therapy for motivation, emotions, behaviour, and thinking or 
reasoning patterns can assist in fostering sensitivity, empathy, distress tolerance and a non-
judgmental self-orientation that may be especially useful for persons with clinical depression 
and co-morbid OW/OB. This compassion focused model may be a valuable framework for 
future cognitive-behavioural interventions for individuals with clinical depression and co-
morbid OW/OB, especially where exercise guided by a compassionate, understanding other 
is part of therapy. 
4.4.6. Importance of Participant-Trainer Relationship 
It is very well established that the relationship between client and therapist is 
important in psychotherapy (Ardito & Rabellino, 2011; Horvath & Luborsky, 1993; Krupnick 
et al., 1996). Recent research also highlights the importance of the relationship between 
participant and physical therapist in exercise based treatments of depression (Danielsson et 
al., 2016). Our findings support especially the idea of collaborative change, in which the 
personal trainer joins with the participant in the process of moving toward a healthier self. 
Our research suggest three key factors might underpin this relationship. The first is the 
knowledge and expertise the personal trainer brings to the partnership. This knowledge and 
expertise allowed the participant to be guided or coached in exercise techniques and habits 
and to navigate challenges and failures effectively. Secondly, when the partnership worked 
well, there was a sense of safety and trust. This was especially important in allowing 
participants to risk being vulnerable in making changes and entering a relationship (i.e. with a 
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personal trainer or close other) which may in the past have been experienced as critical and 
aversive. This relationship may also contribute to a sense of belonging or reduce the negative 
impact of feeling like an outsider in an exercise environment. From this base, the relationship 
appears to become a model of relating-to-self for the participant. When the trainer adopts a 
kind, non-judgmental and problem-solving approach the participant had the opportunity to 
internalise these attitudes and skills. In some cases, participants described applying the same 
approach to broader areas in their lives (e.g. to changing eating habits). This suggests that the 
relationship with the personal trainer permitted greater activation of the affiliative soothing 
system and reduced the impact of the threat system. Finally, the accountability to the trainer 
was helpful for many participants in ensuring adherence. Like participants in Danielsson et 
al.’s study, individuals in the current study needed to exercise with an ally. Exercising for 
oneself was often perceived as an inadequate motivation. This accountability is what allowed 
the participant to engage in exercise in the midst of depression or when intrinsic motivation 
was low. When participants spoke of re-scheduling a session, they did not describe feeling 
criticized or reprimanded. In contrast, they felt supported and encouraged to work with the 
trainer to find a time to reschedule and return to exercising regularly. It could be useful for 
future research to examine whether more robust participant-trainer relationships are 
associated with greater reductions in depression, or improvements in adherence among 
individuals with depression and co-morbid OW/OB who are engaged in exercise. 
4.4.7. Considerations for Future Programs 
We asked participants how they would modify their program if there were no 
limitations to what was possible. Several themes emerged about what might constitute an 
ideal program for this population. Variety and choice of exercise were frequently mentioned. 
Many participants raised the idea of cross training i.e. being able to engage in various aerobic 
activities alongside resistance training. In this and prior themes, partnership with a personal 
trainer was desirable due to their knowledge, expertise and the accountability provided. 
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Intensity of exercise was often mentioned for individuals in the steady state cycling condition 
(MISS). These participants commented that at some junctures in the program, they longed for 
higher intensity and more engaging exercise. Finally, a sub-group of individuals noted that 
exercise alone was not enough to combat depression. These participants mentioned seeking 
psychotherapy following the program, having hoped for information on nutrition and 
modification of eating habits and psychoeducation regarding the mechanisms and essential 
features of exercise programs for depression. Searle et al. (2011) interviewed 33 participants 
engaged in an exercise based controlled trial for depression and similarly found a subset of 
participants believed counselling or medication were a necessity in managing depression. As 
mentioned previously, we believe that evidence-based psychotherapy could be usefully 
informed by compassion focused therapy.  
Broadly speaking, the exercise program became a place where the individual 
experienced a heightened self-awareness, joined in partnership with a supportive other – in 
this case, a personal trainer – and subsequently worked through challenges and made 
constructive changes to their lives; intrapsychic and behavioural. This is an essential parallel 
fragment to what occurs in many forms of evidence-based psychotherapy. Exercise became a 
conduit for achievement, problem solving capacity and a new platform from which to make 
other lifestyle changes.  
4.4.8. Implications for Practice, Limitations and Areas for Future Research 
It is important this research can be applied to clinical practice. Of key importance is 
that health providers, including general practitioners, psychologists, exercise physiologists 
and personal trainers be aware of important issues regarding exercise as treatment for 
depression in an OW/OB population. This includes the value of a good rapport and 
relationship with the personal trainer, working to foster a non-punitive or non-judgemental 
problem-solving approach between clients and clinicians. Furthermore, psychologists should 
consider whether self-criticism, shame and self-compassion are perpetuating concerns for 
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OW/OB clients with depression. If so, clinical benefits could be found in targeting these 
issues. Secondly, when utilising exercise as an intervention for clinical depression in persons 
with low exercise self-efficacy, specific cognitive approaches can be employed to improve 
exercise self-efficacy. Additionally, when measuring success, clinicians should encourage 
clients to consider a broad array of potential indicators of achievement, including reduced 
mood symptoms, fatigue, improved energy, sleep, aerobic capacity, strength, endurance, 
socialisation with others, completion of sessions and faster physiological recovery within 
sessions. Although the emphasis of our research is on amelioration of depression, where 
weight loss may be a consideration for clients, measuring body composition rather than scale 
weight is encouraged. Drawing on described facilitators may help clinicians increase 
adherence and engagement (e.g. through flexibility of scheduling, accountability, in-session 
feedback, enjoyment) and helping clients plan for continued exercise following cessation of 
supervised programs seems important. 
Participants from the current study were drawn from volunteers engaged in a 
randomised control trial. Whilst meeting criteria for clinical depression, it is possible 
individuals were following a trajectory of recovery that facilitated motivation to engage with 
our program. Thus, recovery may have continued without intervention. Without a waitlist 
control, this remains unknown. The applicability of current findings must be interpreted 
cautiously regarding people at various stages of depression. 
The focus on feasibility and piloting the program was such that the primary 
randomised controlled clinical trial was somewhat underpowered. We recruited from various 
locations and online within an Australian metropolitan city however all participants were 
required to attend Murdoch University, typically three times per week. Prior research 
indicates that proximity and travel time are all significant barriers to engagement in exercise 
(Alvarado et al., 2015; Firth et al., 2016). Therefore, future research might consider a multi-
site approach to ensure adequate power is achievable. That the qualitative data drew from a 
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sample of 17 participants, in line with prior research can be considered a strength of this 
mixed methods design, ensuring saturation of themes could occur. A second issue with the 
pilot program was its relative brevity. Motivation, enjoyment and positive anticipation 
measured over 6 weeks are not necessarily indictive of long term engagement with an 
exercise program. Given the benefits of exercise on mood are likely to persist only for as long 
as one regularly ‘takes the medicine’ (Krogh, Nordentoft, Sterne, & Lawlor, 2011) research 
should investigate which factors maintain or enhance engagement in such interventions over 
the long term. 
Following recent research intimating that self-compassion, depression and over-eating 
might occur from common underlying processes, future investigations should aim to shed 
light on targets for treatment via a compassion informed model. Future research should seek 
to clarify what aspects of the relationship between individual and personal trainer are 
important for enhancing adherence, engagement and psychological recovery. This research 
ought to examine interpersonal, programming and contextual factors. We recommend future 
studies investigate tailor-made interventions utilising regular one-to-one moderate to high 
intensity exercise with programming that allow for variety and are developed in collaboration 
with a qualified personal trainer. Group or individual cognitive-behavioural therapy for 
individuals with depression and OW/OB should be incorporated – it is suggested additional 
benefits could be derived if such therapy is informed by compassion focused approaches.  
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Chapter 5 – Study Four. 
Assessing the efficacy of enhanced cognitive behavioural group therapy and 
individual supervised exercise intervention for clinical depression in overweight and 




Assessing the efficacy of enhanced cognitive behavioural group therapy and 
individual supervised exercise intervention for clinical depression in overweight and 
obese adults: Study protocol for a randomised controlled trial. 
5.1. Introduction 
There is a paucity of research into interventions for clinical depression in individuals with 
co-morbid overweight or obesity (OW/OB). Lifetime prevalence for clinical depression is 
almost 15 per cent whilst societal levels of overweight (35%) and obesity (28%) are high and 
rising (Australian Bureau of Statistics, 2012; Bromet et al., 2011). Individuals with 
depression are at elevated risk for developing OW/OB and overweight individuals at elevated 
risk of developing subsequent depression (Faith et al., 2011; Luppino et al., 2010; Stunkard, 
Faith, & Allison, 2003). Nevertheless, many individuals with depression are routinely 
screened out of trials involving overweight individuals, including interventions aimed at 
reducing depressive symptoms (e.g. Andersen et al., 1999; Annesi & Unruh, 2008; Rubin et 
al., 2005). 
Treatments for co-morbid depression and OW/OB currently focus on providing 
concurrent but discrete evidence-based interventions for depression and obesity – usually 
cognitive behaviour therapy and behavioural weight loss or lifestyle change (Faulconbridge, 
Wadden, Berkowitz, Pulcini, & Treadwell, 2011; Pagoto et al., 2013). These could be 
enhanced with elements designed specifically for the underlying difficulties individuals with 
clinical depression and OW/OB face. Recently, interventions based on acceptance and 
commitment therapy or compassion focused therapy have been designed for use with 
individuals with depression or overweight (Berman, Morton, & Hegel, 2015; Gilbert et al., 
2014; Gilbert, 2009) but to our knowledge, few programs have been designed specifically to 
treat clinical depression within an OW/OB population.  
One of the proposed mediators of depression in OW/OB persons relates to an imbalance 
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in chronic and systemic inflammatory markers (Dantzer, 2012; Greenberg & Obin, 2006; 
Köhler, Krogh, Mors, & Eriksen Benros, 2016; Messay, Lim, & Marsland, 2012; Tully et al., 
2015). Many pro-inflammatory markers are present in individuals with depression and 
individuals with obesity (Dowlati et al., 2010; Emery et al., 2007; Howren, Lamkin, & Suls, 
2009; Liu, Ho, & Mak, 2012). Furthermore, administration of anti-inflammatory compounds 
has been shown to reduce symptoms of depression (Köhler et al., 2016). In overweight 
individuals, the major source of pro-inflammatory markers are adipocytes (adipose cells). As 
such, this adiposity-induced pro-inflammatory condition has been associated with depression 
and co-morbid overweight and depression in particular (Shelton & Miller, 2011) and is 
currently a research area of interest. Interventions that reduce adiposity and/or inflammation 
may improve clinical outcomes for adults with clinical depression and OW/OB (Emery et al., 
2007; Köhler et al., 2016; Lopresti, Hood, & Drummond, 2013). Because treatments that 
target the cycle of depression, adiposity and inflammation are few, it is important to shed 
further light on these associations and examine the impact of interventions on inflammation. 
5.2. Development of the Current Intervention 
Cognitive behaviour therapy (CBT) for depression usually focuses on i) psychoeducation 
about depression and the nature of emotions; ii) behavioural techniques to reduce symptoms 
and increase engagement, for example, pleasant or mastery activity scheduling; and iii) 
cognitive therapy to help identify and modify unhelpful automatic thoughts or beliefs. 
Between session tasks are often used to reinforce and generalise these skills and techniques. 
More recent research has highlighted the importance of targeting early maladaptive schema’s, 
especially for chronic depression. Finally, mindfulness-based CBT interventions have gained 
significant interest for re-current depression in particular and are often incorporated into 
traditional CBT interventions (Barlow, 2014; Carr & McNulty, 2006; Teasdale et al., 2000). 
The present study will employ group-based CBT for depression with a component of 
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formal, one-to-one supervised exercise sessions. This program is designed specifically to 
target maintaining factors described by adults with co-morbid depression and OW/OB, being 
informed by recent research and our preceding findings. When participants in our randomised 
control trial (RCT) commenced exercise, they described moving through several common 
phases. Initial feelings self-consciousness, not belonging, self-doubt, and self-criticism were 
described. This was often followed by building an alliance with the personal trainer, 
beginning to feel capable and subsequently, looking for changes in mood, fitness or body 
composition that indicated they were making progress. Finally, some individuals started 
making other general health behaviour changes and preparing for completion of the program 
and continuing exercise themselves. We therefore developed our program to broadly move 
with participants as they progress through these phases. 
Overview 
Participants commence exercise with their personal trainer, who will have been trained by 
a Clinical Psychologist to work from a compassion informed approach, from the outset. 
Meanwhile, the group psychotherapy starts with psychoeducation specific to adults with 
clinical depression and OW/OB, and outlines the rationale for treatment and for combining 
exercise, psychotherapy and modules on nutrition and healthier eating habits. We then 
introduce the compassion focused model which underpins much of the program, linking this 
to aetiological factors described previously. We build on this with exploration of early 
maladaptive schemas and then incorporate specific cognitive and behavioural exercises 
throughout the program, drawn from compassion focused therapy and schema therapy, 
outlined below. After having established a compassionate foundation and progression 
through much of the cognitive and behavioural treatment, we expect to explore nutrition and 
healthier eating habits and to help participants develop strategies for continued self-
regulation, goal setting and maintenance of exercise following completion of the program. 
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Compassion and schema informed interventions will continue throughout the program. The 
program modules are expanded upon below. 
Psychoeducation 
Alongside typical psychoeducation regarding depression and emotions included in CBT 
programs, we developed a conceptualisation of depression that integrates the psychological 
(e.g. failure focus, shame, self-criticism, early maladaptive schemas) physiological (e.g. 
chronic systemic inflammation, adipose tissue build-up, neurochemical and endocrine 
changes, particularly insulin and HPA-axis dysregulation) and behavioural (e.g. reduced 
activity and engagement, discorded eating) factors that predispose and perpetuate symptoms 
in this population. We include psychoeducation on the aetiology of depression and OW/OB , 
the role of exercise on mood states and depression, endocrine and inflammatory pathways. A 
compassion informed model of treatment for ameliorating specific cognitive and behavioural 
patterns is introduced as outlined below in Figure 5.1. These specifically are added to the 
proposed program given that a side effect of engaging in exercise – especially in the presence 
of others - may be to activate self-criticism and shame experiences that may perpetuate 
depression and negatively impact engagement in exercise unless addressed appropriately.  
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Figure 5.1. Compassion formulation for high shame and criticism as described by Gilbert & Procter (2006). 
Many of the pathways depicted in Figure 5.1 have relevance to the aetiological factors for 
depression in adults with OW/OB, as described in Chapter 1. For example, a history of 
teasing or negative verbal commentary as a child or adolescent could contribute to feelings of 
being rejected, hurt, powerless and worthless. Internalised negative internal verbal 
commentary, concern with weight, body shape or eating behaviours, self-criticism and self-
doubt have all been implicated in maintaining depression in adults with co-morbid OW/OB 
(Cooper & Fairburn, 2001; Decaluwe & Braet, 2005; Werrij, Mulkens, Hospers, & Jansen, 
2006) and are not an unlikely outcome of such a background. Individuals might subsequently 
become more sensitive to threat, socially withdraw or engage in other safety behaviours, such 
as inhibition of affect, avoidance of conflict, or emotional eating (Gilbert & Procter, 2006; 
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Goss & Allan, 2014). Meanwhile the ‘unintended consequences’ described in Figure 5.1 (e.g. 
self-attack, cognitive rumination, feeling worthless) are hypothesised to take hold and to 
perpetuate symptoms of depression. These maintaining factors become useful targets for 
treatment. 
Cognitive-techniques 
Thought diary records, functional analysis (e.g. TRAP analysis), identification of values, 
goal-setting and problem solving are included in the basic intervention. Advanced techniques 
targeting shame, self-criticism and focus on failure are linked to a compassion model of 
treatment whilst identifying various opportunities for success is linked to treatment goals and 
exercise related goals. Gilbert (2009) has outlined how attention tasks, imagery, and 
cognitive therapy for motivation, emotions, behaviour, and thinking or reasoning patterns can 
assist in fostering sensitivity, empathy, distress tolerance and a non-judgmental self-
orientation that may be especially useful for persons with clinical depression and co-morbid 
OW/OB . Further, developing compassionate imagery (e.g. compassionate friend) may 
enhance capacity to engage the soothing system, especially when confronting situations that 
form part of treatment (i.e. exercise) that have historically elicited threat.  
Research also indicates that focusing on core schema’s is important in short-term therapy 
for depression (Barlow, 2014). In particular, early maladaptive schemas Mistrust / Abuse, 
Emotional Deprivation, Insufficient Self-Control, Failure, Abandonment/Instability and 
Enmeshment are linked with clinical depression (Renner, Lobbestael, Peeters, Arntz, & 
Huibers, 2012) and reduced quality of life in obese adults (Bidadian, Bahramizadeh, & 
Poursharifi, 2011). We therefore include components of compassion focused approaches and 
basic elements of Young’s Schema Therapy as outlined in (Young, Klosko, & Weishaar, 
2003) as a way of understanding each individual’s core beliefs, increasing psychic continuity 
and to inform experiential opportunities for cognitive and behavioural change. 
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Behavioural-techniques 
We include standard CBT techniques for increasing activity and socialisation, and 
schema techniques for challenging early maladaptive schema’s including pleasant and 
mastery activity scheduling, role-playing, self-monitoring, goal-setting and behavioural 
experiments. Similar to the implementation of cognitive techniques, behavioural strategies 
are applied in the context of a compassion-oriented frame. Regular exercise has also been 
conceptualised as a ‘behavioural cusp’ (Turner & Leech, 2012) that can provide exposure to 
novel environments and new opportunities for positive reinforcement. We therefore include 
exercise as an adjunct to the techniques described above. 
Exercise  
 Exercise is an established treatment for mild to moderate depression (Cooney et al., 
2013; Krogh, Nordentoft, Sterne, & Lawlor, 2011) and a frequent adjunct to standard CBT 
(Pilu, 2007). It may also play a role in reducing inflammation and adiposity (Lopresti et al., 
2013; Vissers et al., 2013). Our research (Chapter 3) indicated that High Intensity Interval 
Exercise, Steady State Exercise and Personal Preference Exercise were effective at reducing 
depression over 18 supervised sessions. Qualitative analysis revealed that exercise intensity, 
ability to select exercises, variety (i.e. ability to utilise various forms of aerobic and resistance 
training) and rapport with the trainer were key to enhancing engagement and enjoyment. We 
therefore provide a template for training that can be modified by the participant, in 
collaboration with their personal trainer. The basic format of exercise is for three one-to-one 
supervised 45-minute exercise sessions per week. Aerobic, including high intensity interval 
training and resistance training techniques are taught and a program developed with the 
personal trainer to ensure moderate or greater average session intensity as measured by power 
output, RPE or % HRmax. Exercise progression, personal preference (i.e. of format, goals, 
exercises etc.) and variety are encouraged. Over the 16-week period, we expect participants 
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will have an opportunity to engage in 48 supervised exercise sessions. 
Nutrition and overeating 
Our qualitative research highlighted a cohort of participants desired and believed they 
would benefit from support and direction in improving nutrition and eating habits. Given the 
subjective, physiological and clinical importance diet and eating behaviour we chose to 
include modules on nutrition and overeating in the current program. Given that systemic 
inflammation, oxidative stress, HPA-axis reactivity and low serotonin are important factors in 
the aetiology and maintenance of depression (Dowlati et al., 2010; Emery et al., 2007; 
Howren et al., 2009; Milaneschi et al., 2012; Miller & Cole, 2012; Newman, O'Connor, & 
Conner, 2007; Pasquali & Vicennati, 2000; Shelton & Miller, 2011).  Research illustrates that 
Mediterranean based diets and certain food constituents including Omega-3 fatty acids and 
saffron can reduce depression, anxiety, systemic inflammation, oxidative stress and HPA-axis 
reactivity to clinically meaningful degrees (Feldeisen & Tucker, 2007; Lopresti & 
Drummond, 2014; Parletta et al., 2017; Su, Matsuoka, & Pae, 2015). Diets low in the amino 
acid Tryptophan, commonly found in nuts, are associated with low serotonin (Heninger, 
Delgado, Charney, Price, & Aghajanian, 1992).  
 Whilst the majority of obese adults do not meet clinical diagnosis for Binge Eating 
Disorder (BED) (American Psychiatric Association, 2013) overeating, emotional eating, 
BED and night eating syndrome are more common in OW/OB populations than normal 
weight controls (Faith, 2002; Faulconbridge & Bechtel, 2014; Fitzgibbon, Stolley, & 
Kirschenbaum, 1993). Approximately one third of the sample in our RCT met criteria for 
BED and many more described sub-clinical levels of over-eating and associated feelings of 
guilt. Research shows that components of mindfulness and intuitive eating reduce the 
likelihood of disordered eating (Bush, Rossy, Mintz, & Schopp, 2014; Goss, 2011). 
Compassion informed eating programs include mindfulness skills and focus on establishing 
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regular eating patterns, reducing ‘high-risk’ foods that are habitually over-eaten, balancing 
energy intake with physiological requirements, developing healthy nutritional balance, 
responding to hunger and satiety cues and learning to enjoy food and eating (Goss, 2011). 
These habits are accompanied by tasks that facilitate and reinforce behaviour change (e.g. use 
of food diary, meal planning, identifying triggers and self-soothing alternatives). 
Relationship with personal trainer 
We view rapport between the individual and personal trainer as important to 
improvement in depression. However, we do not intend to draw participant attention to this 
possibility directly during treatment. Rather, trainers are provided education and training 
from a Clinical Psychologist, informed by previous qualitative data about qualities of 
beneficial trainer relationships. The emphasis will be on working with these clients in 
compassion informed ways, i.e. in a non-judgemental, self-compassionate and empathic 
manner, as outlined previously. This has the advantage of providing an ecological valid 
platform for individuals to engage in a new relationship and partnership. 
5.3. Methods 
5.3.1. Design 
The randomised controlled trial will compare the Schema and Compassion, Exercise 
and Nutrition Enhanced CBT (SCENE-CBT) intervention above to group-based CBT as 
treatment as usual (TAU) and Exercise Alone (EA). Group size will be restricted to 8 – 12 
participants. Both group interventions will be focused on reducing symptoms of clinical 
depression in adults with co-morbid OW/OB. The trial will be conducted at Murdoch 
University, near Perth, Western Australia. Exercise sessions as applicable will take place in 
the University’s Exercise and Sports Science Laboratory which includes a gymnasium 




5.3.2. Aims and Hypotheses 
The primary aim of the trial is to compare the efficacy of SCENE-CBT, EA and TAU 
in reducing symptoms of clinical depression in adults with OW/OB. The secondary aims are 
to compare the effect of these interventions on psychological factors and metabolic health. 
Psychological variables include symptoms of anxiety, disordered eating, self-criticism, 
shame, self-compassion and body-image/dissatisfaction disturbance. We aim to compare the 
effect of these interventions on metabolic health, as measured by body composition, aerobic 
capacity, total physical activity, blood pressure, systemic inflammation and 3-day diet 
records. A tertiary aim is to refine research understanding and clinical implementation of 
individualised and tailored interventions for depression in this population. 
The primary study hypothesis is that individuals in the SCENE-CBT, EA and TAU 
conditions will demonstrate significant improvements in depression, however those in the 
SCENE-CBT condition will improve to a greater degree relative to the alternate conditions. 
5.3.3. Inclusion and Exclusion Criteria 
Participation will be open to men and women aged 18- 45 years, who are experiencing an 
episode of depression according to Structured Clinical Interview. Participants must be willing to 
delay alternative therapy for the duration of participation1, have a BMI greater than 25 and 
understand written and spoken English. Anti-depressant use is permitted provided unchanged dose 3 
weeks prior to participation and throughout the intervention.  
Exclusion criteria include regular psychotherapy, previous cardiovascular incident or 
cardiovascular disease, intellectual impairment, serious or unstable medical conditions, substance 
dependence requiring rehabilitation, personality disorder, current or historical mania, hypomania or 
anorexia nervosa, current or recent bulimia nervosa, current suicidal ideation or self-harm of a 
                                               
1To ensure participants receive appropriate treatment, they will be informed that seeking alternative treatment, 
including starting or changing anti-depressant medication is important and permissible at any time. In such 
cases, the associated data will be excluded from analysis. 
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clinically significant nature or a suicide attempt in the prior 2 years. Women who are pregnant or 
attempting to become pregnant are also excluded from participation.  
5.3.4. Recruitment 
Individuals from the metropolitan community of Perth, Western Australia will be 
recruited via community notices posted at local shopping centre and town tall notice boards, 
cafés, Universities and third parties including General Practitioners and Psychologists. 
Planned recruitment methods include posters, flyers, a newspaper advertisement and social 
media advertisements. 
5.3.5. Randomisation Procedure 
Block randomisation as described by Altman and Bland (1999). A computerised 
random number generator (www.random.org) will be used to create the random number 
series. Random block sizes of 24 with an equal allocation to groups will be used. All 
assessors and clinicians will be blind to block size and condition allocation prior to treatment, 
with a group list provided to the treating psychologists immediately prior to commencement 
of each group. The randomisation schedule will be provided to participants in sealed and 
concealed sequentially numbered envelopes only after their pre-treatment assessment. 
5.3.6. Planned Interventions 
SCENE-CBT, outlined above, is a fully manualised treatment informed by Schema 
and Compassion Focused Therapies and the latest research on exercise and nutrition and 
clinical depression. Treatment as usual will follow the CBT for depression, group therapy 
guidelines as outlined in Bieling, McCabe, and Antony (2006). Both interventions are 
professionally led by Clinical Psychologists and co-facilitated by postgraduate students of 
Clinical Psychology who are under supervision. Groups of 8 to 12 participants engage in the 
program over 16-weeks. Between session tasks will be completed by both groups, however 
the nature of these tasks varies. Participants in the SCENE-CBT and EA condition receive up 
to 48 individually supervised exercise sessions (i.e. an average of 3 per week) of 45 minutes 
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duration. Exercise sessions are supervised by a 4th year Exercise Physiology student receiving 
supervision from an Accredited Exercise Physiologist. Participants in the EA condition 
receive no psychological intervention, however are offered participation in either the superior 
group treatment or 16 weeks of individual psychological therapy provided by Masters or 
Doctorate level post-graduate students at the Murdoch University Psychology Clinic 
following completion of all data collection. 
5.3.7. Treatment Fidelity 
Treatment fidelity is the ongoing assessment and monitoring of treatment 
implementation, which when done effectively can enhance reliability and internal validity of 
a study (Borrelli, 2011). Graduate students in Clinical Psychology students will be supervised 
by an endorsed Clinical Psychologist and trained in the intervention prior to commencing the 
intervention with participants. The psychological intervention will be video recorded to 
ensure treatment fidelity by a study investigator. Observation of trainer skills and role-play 
type practice for working with participants from a self-compassion frame-work will occur for 
exercise trainers prior to assignment of participants. Exercise session fidelity will be ensured 
via the individual trainer assigned to each participant. 
5.3.8. Assessments and Outcome Measures 
Initial Screening and Semi-structured Clinical Interview 
Initial Screening and Semi-Structured Clinical Interview will take place as described 
previously, in Chapter 3. Individuals ineligible to take part will be debriefed appropriately 
and provided with information regarding community resources for psychological or weight-
loss support. Demographic data will be collected during the initial screening phase. 
Primary Outcomes 
Primary outcomes will be measured pre, mid and post assessment and subsequently at 
6-month follow-up. 
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Depression. Severity of depression was measured via the Beck Depression Inventory (BDI-
II; Beck, Steer, and Brown (1996), see Appendix F). The BDI-II is a 21-item self-report 
questionnaire with excellent validity (Wang & Gorenstein, 2013) and reliability (e.g. Cronbach’s a 
= .93; Beck et al., 1996). Scores range from zero to 63, with scores below 13 indicating lower than 
mild depression, above 13 suggesting mild depression, with moderate (20-28) and severe (29 and 
above) depression represented by higher scores. BDI-II scores correlate strongly to SCID-I 
endorsement of items corresponding to Major Depressive Episode with scores above 16 having high 
sensitivity (84%) to clinical depression (Sprinkle, Sprinkle, Lurie, Insko, & Atkinson, 2002). 
Depression, anxiety and stress. The short form Depression, Anxiety and Stress Scale 
(DASS-21; Lovibond & Lovibond, 1995) is a 21 item self-report questionnaire measuring 
depression, anxiety and stress symptoms over the previous week. Reliability of the DASS-21 is high 
in clinical and community samples (Cronbach’s a 0.87 - 0.91) with adequate subscale convergent 
and discriminant validity to validated measures of depression and anxiety and an excellent three 
factor structure  (Antony, Bieling, Cox, Enns, & Swinson, 1998). Scores are multiplied by two to 
allow comparison to normative data for the DASS-42, producing a score up to 42 per subscale. 
Symptom severity is illustrated along with the DASS-21 in Appendix G. 
Secondary Outcomes 
Secondary psychological outcomes will be assessed pre and post intervention, then 
again at 6-month follow-up. We chose to administer secondary outcome measures thrice only 
to reduce the quantity of items and tasks participants would be subject to. Physiological 
measures will be taken pre and post intervention with the exception of the aerobic capacity, 
which will occur pre, mid and post intervention.  
Disordered eating. Eating attitudes and behaviour will be assessed using the Eating 
Disorders Examination-Questionnaire (EDE-Q, Appendix K; Fairburn & Beglin, 2008), a 28 
item self-report questionnaire comprising of four subscales. These subscales measure Dietary 
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Restraint, Shape Concerns, Weight Concerns and Eating Concerns. The EDE-Q has high 
reliability (Cronbach’s a 0.95) for global eating disorder symptomatology. 
Binge eating severity will be assessed with the Binge Eating Scale (BES, Appendix L; 
Gormally, Black, Daston, & Rardin, 1982). The BES is a 16 item self-report questionnaire 
with sound reliability (Cronbach’s a .0.84). Scores range from 0 to 46. Scores above 26 
indicate severe binge eating. 
Self-criticism and shame. Body related guilt and shame will be measured with the 
Weight and Body Related Shame and Guilt Scale (WEB-SG, Appendix M; Conradt et al., 
2007). This 12-item, self-report questionnaire has excellent internal consistency (0.87 – 0.92) 
and adequate test-retest reliability (r = 0.72 – 0.79). 
We will employ the Self-Critical Rumination Scale – (SCRS, Appendix N; Smart, 
Peters, & Baer, 2016) to measure self-critical rumination. The 10 item self-report 
questionnaire has excellent reliability (Cronbach’s a = 0.92), excellent test-retest reliability (r 
= 0.82) and maps to a single factor structure. The SCRS has a moderate positive correlation 
to DASS-21 total scores. 
The Self-Judgement subscale of the Self-Compassion Scale (SCS, Appendix O; Neff, 
2003) will be used to assess self-judgemental attitudes toward the self. Self-judgement is 
defined as being judgemental or disapproving of one’s inadequacies or failures. The SCS is 
described below. 
Self-compassion. Self-compassion will be measured with the Self-Compassion Scale 
(Neff, 2003). This scale measures three components of self-compassion over six subscales; 
self-kindness vs. self-judgement, common humanity vs. isolation and mindfulness vs over-
identified. Overall, the SCS has excellent test-retest reliability (r = 0.93). Internal consistency 
is adequate for each of the subscales, ranging from 0.75 to 0.81. 
Body-image and dissatisfaction. The Physical Self-Description Questionnaire-Short 
Version (PSDQ-S, Appendix P; Marsh, Martin, & Jackson, 2010)  is a 40 item questionnaire 
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used to assess physical self-concept. The full questionnaire includes 11 subscales that have 
reliability of at least 0.80 and adequate test-retest reliability of 0.77. We intend to use three 
sub-scales related to body image and body dissatisfaction as follows; the Appearance 
Subscale (3 items, e.g. “I am good looking”), Global Physical Self-Concept Subscale (5 
items, such as “physically, I feel good about myself”) and the Self-esteem Subscale (5 items, 
for example “overall, I have a lot to be proud of”). Scales are rated on a 6-point Likert scale 
ranging from (1) – ‘false’ to (6) – ‘true’. 
Aerobic capacity. To accurately tailor exercise intensity and assess changes in aerobic 
capacity, the maximum rate (per minute) of oxygen consumption (VO2peak) will be assessed using a 
metabolic cart (Parvo Medics; True One) during an incremental exercise test on the Velotron Pro 
Cycle Ergomter (See Appendix H for protocol). Participants experience incrementally increased 
workload every 2 minutes until they can no longer maintain a cadence of 60 revolutions per minute 
or elect to discontinue the assessment due to fatigue or discomfort. The VO2peak assessments will 
occur pre, mid and post intervention. 
Anthropometric measures and blood pressure. Body composition including visceral fat mass 
will be measured via whole body Dual-energy X-Ray Absorptiometry (DXA) scan (Hologic 
Discovery Series W, Model: 010-1549). Height will be measured using a wall mounted stadiometer. 
We will measure weight using a digital industrial platform scale (accuracy to 0.005 kg). Body 
composition, height and weight are measured with participants barefoot and dressed in light sports 
attire. Blood pressure will be measured using an automated BP monitor (Ormon) by a researcher 
blinded to treatment condition. Measurements will be taken with participants in the seated position 
following 5-minutes rest. 
Inflammation. Following an overnight (>8 h) fast, a venous blood sample (5 ml) will be 
collected by a trained phlebotomist into serum-separating tubes (SST; Becton Dickinson, NJ, USA) 
via venepuncture of the antecubital vein. The sample will be allowed to clot for at least 30 min at 
room temperature, before centrifugation at 1,300g for 15-min. The supernatant will then immediately 
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be aliquoted into Eppendorf containers and stored at -80°C. Samples will then be batch analysed for 
a broad-range of cytokines (Bio-Plex Pro Human TH17 Assay, CA, USA; Inter-assay coefficient of 
variation: 5.9%; Limit of detection: 16.9pg/ml) using the Bio-plex MAGPIX multiplex reader (Bio-
Rad, CA, USA) and for C-reactive protein (CRP) using the COBAS INTEGRA system.  
Total physical activity & 24 hr diet recall. Prior to commencing the program, participants 
will engage in a one week control period at which time they will be instructed to maintain normal 
activities of daily living and dietary habits. During this period, physical activity will be monitored 
with the use of an Accelerometer (Actigraph® GT3X Activity Monitor, Pensacola, FL) worn around 
the hip. Estimates of food intake will be collected by random 24-hour recall (via telephone) two 
times per week using the USDA 5-step multiple-pass method (Conway, Ingwersen, Vinyard, & 
Moshfegh, 2003). The same researcher will conduct all diet-recall assessments and will be blind to 
treatment condition. Mean total daily energy intake, together with the quantity of carbohydrate, fat, 
and protein consumed will be determined from the combined 24 h food recall diaries using a 
commercially available software program (Foodworks; Xyris Software, Queensland, Australia).  
5.3.9. Monitoring Additional Treatments 
Participants will be asked during screening to if they are currently engaged in work with a 
psychologist and what medication they currently use. We will request participants voluntarily 
postpone any changes to their treatment regimens until completion of the study and follow-up 
period. Only participants not currently engaged in psychotherapy will be enrolled in the 
program. Those who seek psychotherapy or who have a change in psychopharmacology or 
blood pressure medication (dose, type) once enrolled will have subsequent data excluded 
from the study. 
5.4. Statistical Considerations and Data Analysis 
Sample size estimation 
 The present study intends to recruit a total sample of n = 189 participants. We based 
this calculation on pilot data and clinical trials of similar interventions compared to treatment 
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as usual. We assumed a small effect size of d = .15, an alpha level of .05 and a 90% 
probability of detecting an effect assuming an intraclass correlation coefficient of 0.39 
estimated from pilot data and effect size from meta-analytic data of psychological 
interventions compared to TAU cited in Chapter 2. Sample size calculation includes 
provision for a 30% drop-out rate. 
Statistical analysis plan 
 Data will be analysed using the latest version of SPSS Software (IBM Analytics). 
Primary outcomes will be analysed using Generalised Linear Mixed Model (GLMM). This 
will permit exploration of standard mean difference and effect sizes which can be compared 
to existing trials. Employment of GLMM will make use of all observations and help protect 
against missing data. Secondary analysis will be analysed using 3 (condition) by 2 (time) 
ANOVA. Type I error will be maintained at 0.05 (two-tailed). To confirm between condition 
homogeneity, demographic data will be examined with a series of One-way ANOVAs (a = 
0.05, two-tailed). 
5.5. Ethics 
Prior to recruitment, the study protocol will be approved by the Human Research Ethics 
Committee at Murdoch University, Australia. The trial will be run according to CONSORT 
guidelines and maintain registration with the Australian and New Zealand Clinical Trials 
Registry. Participants will not be paid for taking part in the research however all interventions 
are provided at no-cost excluding incidental costs such as transportation to and from and 
parking at Murdoch University and purchase of clothing or footwear suitable for exercising. 
The purpose of the research will be concealed from participants, who will be given a brief 
over-view indicating the investigation is examining treatments for clinical depression. 
Following completion of the research, findings will be made available to participants at 
request. Participants will be assigned a unique identification code upon entry to the study 
which will be paired with their results. All data, including the participant identification key 
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will be held in password protected computer files or secure filing cabinets. Should an 
applicant’s condition require alternative care or a participant’s clinical condition deteriorate 
appropriately debrief and removed from the study. For participants who remain clinically 
depressed following completion of the program, resources will be provided for community 
mental health engagement, including encouragement to discuss with their General 
Practitioner. 
5.6. Discussion 
Clinical depression is common, especially amongst adults with OW/OB. Treatment 
options typically combine standard interventions for depression and weight loss concurrently. 
This paper describes the protocol for an RCT for an evidence-based group treatment of 
depression in adults with co-morbid OW/OB. In this experimental design, this novel 
intervention will be compared to standard group-CBT or regular evidence based individually 
supervised exercise for depression. The evidence-based treatment combines individually 
supervised exercise, thorough psychoeducation regarding aetiology and development of 
depression in overweight adults (and vice-versa), perpetuating factors including 
physiological, intrapsychic and behavioural, and psychotherapy based on self-compassion, 
mindfulness and schema therapy for depression. It also includes modules on healthy nutrition 
and overeating, mindfulness, shame and self-criticism. Exercise for depression is a common 
existing treatment modality. We employ a basic framework for exercise as an intervention 
based on research evidence, including our prior findings. These attributes lead to an exercise 
program with suggested formats, types, volumes and intensities which participants are able to 
modify based on personal preference. Preliminary evidence suggests these modules and 
individually supervised evidence-based exercise should enhance CBT for depression when 
utilised for this population. In addition to measuring changes in depression, we will examine 
treatment effects on anxiety, stress, eating behaviour, shame, self-criticism, self-compassion, 
and body image. We will also investigate the effect on physiological variables including 
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aerobic fitness, blood pressure, body composition, visceral fat mass and inflammation. If 
SCENE-CBT enhances outcomes for depression beyond traditional approaches, it may have 
important implications for the prevention and treatment of depression in this population and 
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General Discussion and Conclusions 
6.1. Introduction 
 As outlined in previous chapters, clinical depression is a major social and public 
health concern in modern society (Bromet et al., 2011; Ferrari et al., 2013; Spijker et al., 
2004). Similarly, OW/OB is a significant issue in the western world (Aballay, Eynard, Diaz 
Mdel, Navarro, & Munoz, 2013; Cameron, Shaw, & Zimmet, 2004; Kahn, Hull, & 
Utzschneider, 2006; Ruhm, 2012). An important bi-directional relationship seems to exist 
between clinical depression and OW/OB such that either condition significantly increases 
risk for developing the other and makes treatment of the underlying issues more complex (de 
Wit et al., 2010; Faith et al., 2011; Luppino et al., 2010; Stunkard, Faith, & Allison, 2003). 
Indeed, it is likely a unique set of psychosocial and physiological risk factors exist in the 
OW/OB and depressed individual. To date however, treatment options have been limited to 
standard treatments for OW/OB and depression run in parallel or in sequence (e.g. 
Faulconbridge, Wadden, Berkowitz, Pulcini, & Treadwell, 2011; Pagoto et al., 2013). Despite 
some promising results, intervention options for co-morbid clinical depression and OW/OB 
as discrete concerns are not optimal. Furthermore, research investigating such interventions 
are scarce. A custom designed intervention for depression in OW/OB persons is likely to 
enhance treatment outcomes in this population. The overarching aim of the present research 
was to develop an evidence-based intervention for clinical depression in individuals with co-
morbid OW/OB. Subsequently, there were four primary investigations in the current research 
project.  
6.2. Summary of Main Findings and Conclusions 
As prior chapters have compared the current research to existing literature, in this 
section, we provide a summary of our main findings and conclusions only. Study one 
(Chapter 2) sought to systematically understand existing interventions that are effective at 
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reducing symptoms of depression in adults with OW/OB, compared to existing treatments or 
waitlist controls.  
We found that existing treatments for depression, including behavioural activation, 
cognitive behaviour therapy, pharmacotherapy, lifestyle and behavioural weight loss 
interventions, and exercise are commendable to clinicians seeking to treat depression in an 
OW/OB population. Compared to inactive control or placebo, pharmacotherapy or evidence-
based psychotherapy were effective at reducing symptoms of depression. In contrast, no class 
of modified intervention was superior to active treatment-as-usual, primarily due to modified 
and active TAU being effective for reducing symptoms of depression. Dietary and exercise 
interventions for clinical depression in adults with OW/OB remain under-researched. Despite 
exercise and physical activity being included in several treatment arms, exercise alone 
appeared in only two investigations and in both cases, control groups were engaged in active 
interventions. Whilst results were positive, further research investigating the use of exercise 
interventions for treatment of clinical depression in adults with OW/OB is needed - especially 
given that exercise is recommended as a treatment for mild to moderate depression in the 
general population (NICE, 2004) and has well established benefits for OW/OB (Ekelund et 
al., 2015; Irving et al., 2008; Myers et al., 2015; Swift, Johannsen, Lavie, Earnest, & Church, 
2014). Dietary interventions may be useful, however the studies included in our review 
differed in methodological approach so significantly as to preclude generalisations. Very few 
studies were conducted on clinically depressed adult with co-morbid OW/OB which clearly 
highlights the need for further research in the field. Overall, our meta-analytic and systematic 
review suggests that psychotherapy (CBT, BA, and possibly mindfulness-based therapy), 
pharmacotherapy (e.g. fluoxetine, duloxetine), exercise (aerobic or resistance) and lifestyle 
interventions could be useful in populations with co-morbid clinical depression and OW/OB. 
 Study two (Chapter 3) - a randomised controlled clinical trial - examined the 
feasibility and effectiveness of three exercise interventions for clinical depression in adults 
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with OW/OB. We found that all interventions were similarly effective for reducing elevated 
depression symptomatology and at reducing mild to moderate levels of anxiety and stress. 
Our findings suggest that format, type and intensity may be of secondary importance to dose, 
engagement and adherence. To our knowledge, this was the first study to show HIIE and 
moderate intensity, personally selected interventions are well tolerated and effective at 
reducing depressive symptoms in clinically depressed adults with co-morbid OW/OB. 
 Study three (Chapter 4) sought to expand on previous research and more holistically 
understand important factors associated with participant engagement and experience of 
exercise as treatment for clinical depression. It was also designed to inform the subsequent 
protocol paper via a mixed methods approach. We found that participant motivation, 
enjoyment and positive anticipation for sessions improved significantly over time. By mid-
intervention, subjective motivation was similar across conditions. This is an important 
finding as prior commentary has discounted the utility of HIIE for regular use by the general 
public, due to a perception of it being psychologically aversive (Biddle & Batterham, 2015). 
Indeed, our qualitative findings suggested that repeated bouts, the challenging nature of 
sessions and onboard feedback of physiological recovery were engaging and rewarding 
aspects of HIIE. There were no substantive changes in exercise self-efficacy across 
conditions, nor any between condition differences. Whilst exercise self-efficacy often 
increases for the general population following an exercise program, individuals with 
depression and co-morbid OW/OB may require targeted cognitive interventions on a regular 
basis to improve exercise self-efficacy. Strategies including expanding markers of success, 
goal-setting, scheduling, accountability to a friend or trainer and collaboration and support 
from a personal trainer may also be of use to clinicians seeking to help clients increase 
exercise self-efficacy in this population. 
Six categories and 16 sub-themes emerged from qualitative interviews. We 
discovered that participants experienced a heightened awareness of self in relation to exercise 
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and other exercisers, including frequent self-criticism and fear of negative social evaluation, 
questioning their ability to complete the program, and feeling like an outsider. Change was 
described as slow and at times frustrating. Participants who looked for a variety of markers 
for success seemed to experience greater satisfaction from their participation in the program 
that those more typically focused on weight-loss. The relationship between participant and 
exercise trainer emerged as a key contributor to engagement. Important aspects of this 
relationship were explored. Key to these were a sense of safety and trust; the trainer’s 
knowledge and expertise; and accountability to the trainer. From a compassion oriented 
model, these are conceptualised to have activated the soothing system and helped reduce the 
effects of the treat system (Gilbert, 2009). In the minds of participants, these factors appeared 
to contribute to greater engagement, enjoyment and benefit from the program. In turn, these 
led to increased motivation and commitment to exercise sessions. These factors also seemed  
to foster intrapsychic and behavioural change, possibly by way of internalisation of an 
encouraging, problem solving approach and modelling of trainer behaviour. Other facilitators 
included scheduling, flexibility in making up for missed sessions and noticing progress. 
Typical challenges included difficulties with time management, competing demands, low 
moods states, anxiety, fatigue, and low motivation. These challenges are potential targets for 
intervention.  
Various aspects of more desirable programs were discussed. Suggestions included 
including evidence-based psychotherapy, psychoeducation regarding depression, exercise and 
mechanisms of benefit related to exercise, and nutritional or dietary recommendations. 
Regarding exercise, variety and choice were favourably mentioned by participants. We 
briefly discussed potential candidates for evidence-based psychotherapy in this population, 
particularly those targeting shame and self-critical schemas and cognitions. We suggest 
fostering self-compassionate and self-motivating attitudes and beliefs, via a compassion and 
schema informed approach to CBT may be useful. Indeed, research indicates these therapy 
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approaches may be especially useful for individuals with depression and who have 
difficulties with weight or over eating (Barlow, 2014; Gilbert, Baldwin, Irons, Baccus, & 
Palmer, 2006; Gilbert & Procter, 2006; Goss & Allan, 2014). 
 Finally, the closing paper (Study four, Chapter 5) discussed the design of a novel, 
evidence-based approach to treating depression in adults with OW/OB and proposes a viable 
investigation comparing this novel treatment to existing treatments (exercise alone or CBT) 
for clinical depression in adults with OW/OB. The 16-week intervention draws on elements 
of schema therapy, compassion focused therapy and cognitive behaviour therapy. It also 
incorporates modules on nutrition and eating behaviours and a regular exercise program with 
a personal trainer. The exercise program is founded on moderate to high intensity exercise of 
the individuals choice and selected in collaboration with the trainer. We believe this 
intervention is one of the first to propose a specific program for depression in adults with co-
morbid OW/OB. 
6.3. Overall Project Strengths 
The current research has several strengths. Unlike past research, which has sought to 
treat depression in adults with OW/OB by applying existing treatments without modification, 
we sought to design an intervention “from the ground up”. We started with a meta-analytic 
review and followed this with a randomised control clinical trial, mixed methods research 
and finally a proposed intervention. We believe the meta-analysis, randomised controlled 
clinical trial, qualitative interviews and the protocol paper represent the first explicit series of 
investigations of clinical depression in adults with OW/OB in their respective field. 
In respect to strengths of the meta-analytic review, we investigated changes to 
symptoms of depression in adults with OW/OB from any treatment. Furthermore, there was 
no date cut-off. We discussed several papers that did not quite meet inclusion criteria but 
were otherwise highly applicable to our research questions. These factors help develop our 
understanding within a very limited field of research on clinically depressed individuals with 
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co-morbid OW/OB by including a wide pool of studies. The methodological approaches in 
subsequent studies included a randomised control clinical trial and mixed methods approach 
to developing a proposed intervention. By doing so, we believe we have struck a sound and 
holistic balance between quantitative analysis and qualitative exploration of potential 
treatment efficacy and important clinical issues - especially in how these findings, stemming 
from knowledge and research can be translated into clinical practice. Inclusion of mixed 
methods in particular allows for an investigation into a more complete and broad range for 
research questions (Johnson & Onwuegbuzie, 2004). As revealed by our systematic review, 
registered clinical trials are rare in this field of research. The importance of trial registration 
should not be overlooked however, especially as it affects transparency, reducing publication 
bias and selective reporting (Aslam, Imanullah, Asim, & El-Menyar, 2013). We encourage it 
in future research.  
Unlike prior research, which often screens out individuals with more severe 
depression (e.g. Andersen et al., 1999; Annesi & Unruh, 2008; Rubin et al., 2005) or 
measured changes in depressive symptoms in relatively euthymic individuals (e.g. Arnold et 
al., 2002; Bacon et al., 2002; Esmaily et al., 2015; Ghroubi et al., 2016; Ruusunen et al., 
2012), our randomised control clinical trial and subsequent studies included individuals only 
with clinical depression regardless of severity (unless actively suicidal) and permitted 
inclusion of individuals with binge-eating or various anxiety disorders, further enhancing 
applicability and ecological validity. Measurement of a variety of other quantitative variables 
including anxiety, stress, exercise self-efficacy, engagement, enjoyment, positive 
anticipation, body composition, aerobic capacity allowed us to examine the impact of the 
intervention from a broad standpoint. The use of individually supervised exercise as opposed 
to unsupervised sessions inherently ensured treatment fidelity.  
6.4. Overall Project Limitations and Areas for Future Research 
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Despite the promising findings in the current research, it is important to consider the 
limitations of the research project as a whole. We have discussed in prior chapters specific 
limitations of each study and so in this section, we highlight what we consider to be the 
primary limitations of the research overall. 
Participation in Study Two and Study Three were voluntary. Volunteering in itself has 
been shown to improve depression, especially when there is an inferred benefit for others 
(Yeung, Zhang, & Kim, 2018). Participants may have been more likely to have sufficient 
capacity to engage in the program as advertised and may not have been representative of 
more severely depressed individuals, particularly those with greater motivational or hedonic 
deficits. Nevertheless, research has indicated that symptomatic volunteers have very similar 
demographic backgrounds, compliance rates and treatment outcomes compared to clinically 
referred samples (Thase, Last, Hersen, Bellack, & Himmelhoch, 1984). We also cannot rule 
out spontaneous recovery i.e. that participants were on a natural trajectory toward recovery 
when they enrolled. Whilst we tried to minimise the impact of this issue by conducting 
structured clinical interviews, future research could use a wait-list control comparison. 
Our overall research was constrained by lack of follow-up. Whilst short-term 
treatment effects of exercise for depression are well established, less is known about 
subsequent exercise continuation and continued remission. Regarding exercise as a stand-
alone intervention, meta-analytic reviews indicate that mood enhancing effects persist only 
for as long as an individual regularly engages in adequate volumes of exercise (Krogh, 
Nordentoft, Sterne, & Lawlor, 2011). When considering combined interventions (i.e. those 
that include evidence-based psychotherapy) follow-up remains important and we encourage 
more investigations use reasonable long-term (e.g. 12-months) follow-up when possible. 
Assisting participants with strategies to continue exercise long after clinical intervention has 
ceased appears to be an important aspect of effective treatment. 
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The final paper proposed a tailored intervention for clinical depression in adults with 
OW/OB. It remains unknown whether such interventions actually confer benefit over and 
above existing treatments for depression. This is especially applicable considering that 
exercise alone is inexpensive and relatively simpler to engage in compared to comprehensive 
group therapy and exercise or lifestyle programs that must employ a team of professionals. 
6.5. Final Conclusions 
Our research revealed that certain pharmacotherapy, evidence-based psychotherapy, 
lifestyle, diet and exercise interventions may benefit people with symptoms of depression and 
co-morbid OW/OB compared to no treatment. Some commonalities of effective 
psychotherapy included behavioural activation, cognitive therapy, problem solving skills and 
social support. 
We found that moderate intensity steady state, moderate intensity personal preference 
and high intensity intermittent exercise were comparably effective at reducing symptoms of 
depression in clinically depressed adults with OW/OB. These interventions also had positive 
effects on anxiety and stress. We showed that high intensity exercise is suitable and well 
tolerated in this population. 
Qualitative analysis illuminated the importance of the relationship between participant 
and personal trainer, some common intrapsychic dynamics including concerns about failure, 
shame, self-criticism, feeling like an outsider and expectations of negative social evaluation. 
An important implication of our findings is for clinicians to keep these dynamics in mind 
when treating depression in adults with OW/OB and for exercise trainers to be educated in 
more compassionate approaches to engaging clients who may struggle with such concerns. 
Barriers and facilitators were examined in detail and were, in the main, similar to prior 
research regarding exercise and adults with OW/OB. Key parameters for a more ideal 
evidence-based program utilising exercise were discussed and included evidence-based 
psychotherapy, psychoeducation, modules on nutrition and over-eating, problem-solving 
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supports, variety of type, format and intensity within exercise sessions and scope for personal 
preference. We also put forward compassion-focused and schema-based therapies as potential 
candidates to be incorporated into an evidenced based cognitive behaviour program for 
depression. These findings should be useful in developing future interventions for depression 
in this population 
We then discussed a protocol paper outlining a 16-week, tailored group-based 
psychotherapy and individual exercise program and an experimental design comparing this to 
exercise alone or standard CBT for clinical depression. The results of this proposed 
investigation should provide a useful first iteration of a new generation of programs designed 
specifically for depression in individuals with co-morbid OW/OB.  
The findings of the current research project will spur further investigations into 
treatments for clinical depression in adults with OW/OB and allow clinicians to take a more 
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Combinations of keywords used in meta-analytic and systematic review : 
1. Depress* OR Dysth*
2. Obes* OR Overweight OR Adipos* OR Weight Loss OR Body Fat
3. Adult
4. RCT OR "randomized controlled trial" OR "clinical trial"
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Appendix B 
Above: Funnel Plot of all studies included in meta-analysis 
Above: Funnel plot of all studies with inactive control conditions included in meta-analysis
Above: Funnel plot of all studies with active (TAU) control conditions included in meta-analysis 
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1. What is your age? ________________ years
2. Your sex □ Male □ Female
3. How would you describe your political preferences on most issues?  Please tick one box that comes closest to your view.  ‘Right







4. Your education level?
□ Did not complete Secondary School
□ Completed Secondary School
□ Vocational Training (part or completed)
□ Undergraduate Diploma (part or completed)
□ Bachelor Degree (part or completed)
□ Higher Degree (e.g., PhD, Masters) (part or completed)
5. Ethnic/Cultural Background
  Aboriginal and/or Torres Strait Islander 
  African  
  Asian  
  Caucasian/European 
  Indian  
  Middle Eastern 
  Pacific Islander 
 Other__________________ 
6. What suburb do you currently live in? _______________________ 
7. What is your marital status?





8. How many hours per week do you USUALLY work at your job?
o 35 hours a week or more
o Less than 35 hours a week
o I am not currently employed
9. Do you currently engage in regular exercise (i.e. walking, running, swimming, team sports, gym etc)?
o Yes
o No
10. If you answered “yes” to the above question (# 9), how many times per week do you currently engage in regular exercise? 
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Depression, Anxiety and Stress Scale-21 
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Appendix H 
Aerobic Capacity Assessment Protocol (VO2peak) 
Aerobic capacity was measured on a calibrated computerised gas analysis system 
(ParvoMedics TrueOne mortaraMetabolic System) whilst a customised script was created using 
VeletronCS2008 software (Velotron, Racemate, Inc.) for automatic control of and constant workload 
on the cycle ergometer. The protocol commenced at a workload of 50w and increased incrementally 
by 25w every 2 minutes to a maximum of 400w (maximum of 30 minutes). Heart rate (Polar T31 
Transmitter) and Rate of Perceived Exertion (RPE; Borg and Löllgen (2001)), every 2minutes were 
recorded throughout. The aerobic capacity assessment terminated when the participant could no 
longer maintain 60 revolutions per minute (RPM) or elected to discontinue the test due to fatigue or 
discomfort. Trainers were to terminate aerobic capacity assessments if testing became potentially 
unsafe (e.g. participant indicated pain, dizziness, nausea). Participants were instructed to abstain 
from alcohol or caffeine in the 12h prior to their aerobic capacity assessment. 
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Appendix I 
Bandura Exercise Self-Efficacy Scale 
Self-Efficacy to Regulate Exercise 
A number of situations are described below that can make it hard to stick to an exercise routine. 
Please rate in each of the blanks in the column how certain you are that you can get yourself to 
perform your exercise routine regularly (three or more times a week). 
Rate your degree of confidence by recording a number from 0 to 100 using the scale given below: 
0 10 20 30  40 50 60 70 80 90  100 
Cannot     Moderately High certainty 
do at all        can do can do. 
1. When I am feeling tired
2. When I am feeling under pressure from work
3. During bad weather
4. After recovering from an injury that caused me to stop exercising
5. During or after experiencing personal problems
6. When I am feeling depressed
7. When I am feeling anxious
8. After recovering from an illness that caused me to stop exercising
9. When I feel physical discomfort when I exercise
10. After a vacation
11. When I have too much work to do at home
12. When visitors are present
13. When there are other interesting things to do
14. If I don’t reach my exercise goals
15. Without support from my family or friends
16. During a vacation
17. When I have other time commitments







Eating Disorders Examination-Questionnaire 
1 
ID:   Date: 
EATING QUESTIONNAIRE 
Instructions: The following questions are concerned with the past four weeks (28 days) 
only. Please read each question carefully. Please answer all of the questions.  Please only 
choose one answer for each question. Thank you. 
Questions 1 to 12: Please circle the appropriate number on the right. Remember that the questions 
only refer to the past four weeks (28 days) only. 













1 Have you been deliberately trying to limit the 
amount of food you eat to influence your shape or 
weight (whether or not you have succeeded)? 0 1 2 3 4 5 6 
2 Have you gone for long periods of time (8 waking 
hours or more) without eating anything at all in 
order to influence your shape or weight? 0 1 2 3 4 5 6 
3 Have you tried to exclude from your diet any foods 
that you like in order to influence your shape or 
weight (whether or not you have succeeded)? 0 1 2 3 4 5 6 
4 Have you tried to follow definite rules regarding 
your eating (for example, a calorie limit) in order to 
influence your shape or weight (whether or not you 
have succeeded)? 
0 1 2 3 4 5 6 
5 Have you had a definite desire to have an empty 
stomach with the aim of influencing your shape or 
weight? 0 1 2 3 4 5 6 
6 Have you had a definite desire to have a totally flat 
stomach? 0 1 2 3 4 5 6 
7 Has thinking about food, eating or calories made it 
very difficult to concentrate on things you are 
interested in (for example, working, following a 
conversation, or reading)? 
0 1 2 3 4 5 6 
8 Has thinking about shape or weight made it very 
difficult to concentrate on things you are interested 
in (for example, working, following a conversation, 
or reading)? 
0 1 2 3 4 5 6 
9 Have you had a definite fear of losing control over 
eating? 0 1 2 3 4 5 6 
10 Have you had a definite fear that you might gain 
weight? 0 1 2 3 4 5 6 
11 Have you felt fat? 
0 1 2 3 4 5 6 
12 Have you had a strong desire to lose weight? 
0 1 2 3 4 5 6 
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Questions 13-18: Please fill in the appropriate number in the boxes on the right. Remember that 
the questions only refer to the past four weeks (28 days). 
Over the past four weeks (28 days)……. 
13 Over the past 28 days, how many times have you eaten what other people 
would regard as an unusually large amount of food (given the circumstances)? 
…………….. 
14 ….On how many of these times did you have a sense of having lost control 
over your eating (at the time that you were eating)? 
…………….. 
15 Over the past 28 days, on how many DAYS have such episodes of overeating 
occurred (i.e. you have eaten an unusually large amount of food and have had 
a sense of loss of control at the time)? 
…………….. 
16 Over the past 28 days, how many times have you made yourself sick (vomit) 
as a means of controlling your shape or weight? 
…………….. 
17 Over the past 28 days, how many times have you taken laxatives as a means 
of controlling your shape or weight? 
…………….. 
18 Over the past 28 days, how many times have you exercised in a “driven” or 
“compulsive” way as a means of controlling your weight, shape or amount of 
fat or to burn off calories?  …………….. 
Questions 19-21: Please circle the appropriate number. Please note that for these questions the 
term “binge eating” means eating what others would regard as an unusually large amount of food 
for the circumstances, accompanied by a sense of having lost control over eating. 
19 Over the past 28 days, on how many days have 
you eaten in secret (ie, furtively)?......Do not 















0 1 2 3 4 5 6 
20 On what proportion of the times that you have 
eaten have you felt guilty (felt that you’ve done 
wrong) because of its effect on your shape or 
weight? 





















0 1 2 3 4 5 6 
21 Over the past 28 days, how concerned have you 
been about other people seeing you eat? 
......Do not count episodes of binge eating 
Not at 
all 
Slightly Moderately Markedly 
0 1 2 3 4 5 6 
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Questions 22-28: Please circle the appropriate number on the right. Remember that the questions 
only refer to the past four weeks (28 days) 
What is your weight at present? (Please give your best estimate). ……………………………. 
What is your height? (Please give your best estimate). ……………………………. 
If female: Over the past three-to-four months have you missed any menstrual periods? …………… 
If so, how many? ……………………………. 
Have you been taking the “pill”? ………………….. 
THANK YOU 
EDE-Q reproduced with permission.  Fairburn and Beglin (2008).  In Fairburn, C. G. (2008). Cognitive Behavior Therapy and Eating 
Disorders.  Guilford Press, New York. 
On how many of the past 28 days …… Not at all 
Slightly Moderately  Markedly 
22 Has your weight influenced how you think about 
(judge) yourself as a person? 0 1 2 3 4 5 6 
23 Has your shape influenced how you think about 
(judge) yourself as a person? 0 1 2 3 4 5 6 
24 How much would it have upset you if you had been 
asked to weigh yourself once a week (no more, or 
less, often) for the next four weeks? 0 1 2 3 4 5 6 
25 How dissatisfied have you been with your weight? 0 1 2 3 4 5 6 
26 How dissatisfied have you been with your shape? 0 1 2 3 4 5 6 
27 How uncomfortable have you felt seeing your body 
(for example, seeing your shape in the mirror, in a 
shop window reflection, while undressing or taking 
a bath or shower)? 
0 1 2 3 4 5 6 
28 How uncomfortable have you felt about others 
seeing your shape or figure (for example, in 
communal changing rooms, when swimming, or 
wearing tight clothes)? 
0 1 2 3 4 5 6 
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Eating habits checklist 
Instructions. Below are groups of numbered statements. Read all of the statements in 
each group and mark on this sheet the one that best describes the way you feel about 


























1 don’t feel self-conscious about my weight or body size when I’m with others. 
I feel concerned about how I look to others, but it normally does not make me 
feel disappointed with myself. 
I do get self-conscious about my appearance and weight which makes me feel 
disappointed in myself. 
I feel very self-conscious about my weight and frequently, I feel intense shame 
and disgust for myself. I try to avoid social contacts because of my self- 
consciousness. 
I don’t have any difficulty eating slowly in the proper manner. 
Although I seem to “gobble down” foods, I don’t end up feeling stuffed 
because of eating too much. 
At times, I tend to eat quickly and then, I feel uncomfortably full afterwards. 
I have the habit of bolting down my food, without really chewing it. When 
this happens I usually feel uncomfortably stuffed because I’ve eaten too 
much. 
I feel capable to control my eating urges when I want to. 
I feel like I have failed to control my eating more than the average person. 
I feel utterly helpless when it comes to feeling in control of my eating urges. 
Because I feel so helpless about controlling my eating I have become very 
desperate about trying to get in control. 
I don’t have the habit of eating when I’m bored. 
I sometimes eat when I’m bored, but often I’m able to “get busy” and get my 
mind off food. 
I have a regular habit of eating when I’m bored, but occasionally, I can use 
some other activity to get my mind off eating. 
I have a strong habit of eating when I’m bored. Nothing seems to help me 
break the habit. 
I’m usually physically hungry when I eat something. 
Occasionally, I eat something on impulse even though I really am not hungry. 
I have the regular habit of eating foods, that I might not really enjoy, to 
satisfy a hungry feeling even though physically, I don’t need the food. 
Even though I’m not physically hungry, 1 get a hungry feeling in my mouth 
that only seems to be satisfied when I eat a food, like a sandwich, that fills my 
mouth. Sometimes, when I eat the food to satisfy my mouth hunger, I then 
spit the food out so I won’t gain weight. 
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#6 
(0) 1. I don’t feel any guilt or self-hate after I overeat. 
(1) 2. After I overeat, occasionally I feel guilt or self-hate. 
(3) 3. Almost all the time I experience strong guilt or self-hate after I overeat. 
#7 
(0) 1. I don’t lose total control of my eating when dieting even after periods when I 
overeat. 
(2) 2. Sometimes when I eat a “forbidden food” on a diet, I feel like I “blew it” and 
eat even more. 
(3) 3. Frequently, I have the habit of saying to myself, “I’ve blown it now, why not 
go all the way” when I overeat on a diet. When that happens I eat even more. 
(3) 4. I have a regular habit of starting strict diets for myself, but I break the diets 
by going on an eating binge. My life seems to be either a “feast” or “famine.” 
#8 
(0) 1. I rarely eat so much food that I feel uncomfortably stuffed afterwards. 
(1) 2. Usually about once a month, I eat such a quantity of food, I end up feeling 
very stuffed. 
(2) 3. I have regular periods during the month when I eat large amounts of food, 
either at mealtime or at snacks. 
(3) 4. I eat so much food that I regularly feel quite uncomfortable after eating and 
sometimes a bit nauseous. 
#9 
(0) 1. My level of calorie intake does not go up very high or go down very low on a 
regular basis. 
(1) 2. Sometimes after I overeat, I will try to reduce my caloric intake to almost 
nothing to compensate for the excess calories I’ve eaten. 
(2) 3. I have a regular habit of overeating during the night. It seems that my routine 
is not to be hungry in the morning but overeat in the evening. 
(3) 4. In my adult years, I have had week-long periods where I practically starve 
myself. This follows periods when I overeat. It seems I live a life of either 
“feast or famine.” 
#lO 
(0) 1. I usually am able to stop eating when I want to. I know when “enough is 
enough.” 
(1) 2. Every so often, I experience a compulsion to eat which I can’t seem to control. 
(2) 3. Frequently, I experience strong urges to eat which I seem unable to control, 
but at other times I can control my eating urges. 
(3) 4. I feel incapable of controlling urges to eat. I have a fear of not being able to 
stop eating voluntarily. 
#11 
(0) 1. I don’t have any problem stopping eating when I feel full. 
(1) 2. I usually can stop eating when I feel full but occasionally overeat leaving me 
feeling uncomfortably stuffed. 
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(2) 3. I have a problem stopping eating once I start and usually I feel uncomfortably 
stuffed after I eat a meal. 
(3) 4. Because I have a problem not being able to stop eating when I want, I 
sometimes have to induce vomiting to relieve my stuffed feeling. 
#I2 
(0) 1. I seem to eat just as much when I’m with others (family, social gatherings) as 
when I’m by myself. 
(1) 2. Sometimes, when I’m with other persons, I don’t eat as much as I want to eat 
because I’m self-conscious about my eating. 
(2) 3. Frequently, I eat only a small amount of food when others are present, 
because I’m very embarrassed about my eating. 
(3) 4. I feel so ashamed about overeating that I pick times to overeat when I know 
no one will see me. I feel like a “closet eater.” 
#I3 
(0) 1. I eat three meals a day with only an occasional between meal snack. 
(0) 2. I eat 3 meals a day, but I also normally snack between meals. 
(2) 3. When I am snacking heavily, I get in the habit of skipping regular meals. 
(3) 4. There are regular periods when I seem to be continually eating, with no 
planned meals. 
#14 
(0) 1. I don’t think much about trying to control unwanted eating urges. 
(I) 2. At least some of the time, I feel my thoughts are pre-occupied with trying to 
control my eating urges. 
(2) 3. I feel that frequently I spend much time thinking about how much I ate or 
about trying not to eat anymore. 
(3) 4. It seems to me that most of my waking hours are pre-occupied by thoughts 
about eating or not eating. I feel like I’m constantly struggling not to eat. 
#15 
(0) 1. I don’t think about food a great deal. 
(1) 2. I have strong cravings for food but they last only for brief periods of time. 
(2) 3. I have days when I can’t seem to thinkaabout anything else but food. 
(3) 4. Most of my days seem to be pre-occupied with thoughts about food. I feel like 
I live to eat. 
#16 
(0) 1. I usually know whether or not I’m physically hungry. I take the right portion 
of food to satisy me. 
(1) 2. Occasionally, I feel uncertain about knowing whether or not I’m physically 
hungry. At these times it’s hard to know how much food I should take to 
satisfy me. 
(2) 3. Even though I might know how many calories I should eat, I don’t have any 
idea what is a “normal” amount of food for me. 
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Appendix M 
Weight and Body Related Shame and Guilt Scale 
Instructions: Please rate how often you experienced the following in the previous 6-
months using the following 5-point scale:  
0 = never, 1 = rarely, 2 = sometimes, 3 = often, 4 = always.  
1. When I have eaten more than I want, I experience feelings of guilt. _____ 
2. When I am in a situation where others can see my body (e.g. pool, changing room), I feel 
ashamed. _____ 
3. When I eat fattening food (e.g. tarts) I get distressed by the feeling that I did something 
wrong. _____ 
4. The appearance of my body is embarrassing for me in front of others. _____ 
5. When I can’t manage to work out physically, I feel guilty. _____ 
6. When I think of the possibility that others can see my naked body, I would rather hide 
somewhere. _____ 
7. I am ashamed of myself when others get to know how much I really weight. _____ 
8. When I can’t get a grip on my weight, I blame myself. _____ 
9. I blame myself when I break a good resolution concerning my eating. _____ 
10. I avoid exerting myself physically in front of others since I feel embarrassed. _____ 
11. When I watch myself in the mirror, I feel guilty and decide to do more for my figure. 
_____ 
12. Since the size of my clothes is embarrassing for me, I would rather avoid shopping for 




Self-Critical Rumination Scale 
Instructions: Please rate how well each item describes you using the following scale: 
1 = not at all, 2 = a little, 3 = moderately, 4 = very much. 
1. My attention is often focused on aspects of myself that I’m ashamed of. ____
2. I always seem to be rehashing in my mind stupid things that I’ve said or done.____
3. Sometimes it is hard for me to shut off critical thoughts about myself. ____
4. I can’t stop thinking about how I should have acted differently in certain situations. ____
5. I spend a lot of time thinking about how ashamed I am of some of my personal habits. ____
6. I criticize myself a lot for how I act around other people. ____
7. I wish I spent less time criticizing myself. ____
8. I often worry about all of the mistakes I have made. ____
9. I spend a lot of time wishing I were different____





_____ 18. When I’m really struggling, I tend to feel like other people must be having an easier 
time of it. 
_____ 19. I’m kind to myself when I’m experiencing suffering. 
_____ 20. When something upsets me I get carried away with my feelings. 
_____ 21. I can be a bit cold-hearted towards myself when I'm experiencing suffering. 
_____ 22. When I'm feeling down I try to approach my feelings with curiosity and openness. 
_____ 23. I’m tolerant of my own flaws and inadequacies. 
_____ 24. When something painful happens I tend to blow the incident out of proportion. 
_____ 25. When I fail at something that's important to me, I tend to feel alone in my failure. 




Physical Self-Description Questionnaire - Short Version 
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Physical Self-Description Questionnaire – Short 
The purpose of these next questions is to see how people describe themselves 
physically . You will be asked to think of yourself physically: for example, how 
strong you are, how flexible you are, or how attractive you are and so on. 
Answer each statement as quickly as you can and do not skip any. 
There are six possible responses to each statement: “true” or “false”, and four 
responses in between. Select the answer that is most true for you. 
1 = False 
2 = Mostly False 
3 = More false than true 
4 = More true than false 
5 = Mostly True 
6 = True 
1. I have a nice looking face
2. I am better looking than most of my friends
3. I am good looking
4. I feel confident when doing coordinated movements
5. Controlling movements of my body comes easily to me
6. I am good at coordinated movements
7. I can perform movements smoothly in most physical activities
8. I find my body handles coordinated movements with ease
9. I can run a long way without stopping
10. I can be physically active for a long period of time without getting tired
11. I am good at endurance activities e.g. distance run, aerobics, swim, cross
country, ski
12. Overall, most things I do turn out well
13. Overall, I am no good*
14. Most things I do, I do well
15. Overall, I have a lot to be proud of
16. Nothing I do seems to turn out right*
17. I am quite good at bending, twisting, and turning my body
18. My body is flexible
19. I think I would perform well on a test measuring flexibility
20. Physically, I am happy with myself
21. Physically, I feel good about myself
22. I feel good about who I am physically
23. I am physically a strong person
24. I have a lot of power in my body
25. I would do well in a test of strength
26. I often do exercise or activities that make me breathe hard
27. I do physically active things (i.e. jog, dance, bicycle, aerobics, gym,
swim) at least three (3) times per week
28. I do lots of sports, dance, gym, or other physical activities
29. I do sports, exercise, dance, or other physical activity almost everyday
30. My waist is too large
31. I have too much fat on my body
